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Nichts ist verblüffender als die einfache Wahrheit, nichts ist exotischer als 
unsere Umwelt, nichts ist phantasievoller als die Sachlichkeit. Und nichts 
Sensationelleres gibt es in der Welt als die Zeit, in der man lebt. 
E.E. Kisch 
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 1 Abstract 
Astrocytes perform many functions in the adult brain and even act as neural 
stem cells after brain injury (Buffo et al., 2008) or in regions where 
neurogenesis persists, e.g. in the subependymal zone of the lateral ventricle. 
The stem cell astrocytes possess an apicobasal polarity as they are coupled by 
adherens junctions to neighbouring ependymal cells and possess an apical 
membrane domain with CD133 and Par complex proteins and a basolateral 
membrane domain including contact of processes to the basement membrane 
(BM). This is notably different from parenchymal astrocytes that only have 
contacts to the BM under physiological conditions. The major underlying 
question is how differences between neural stem cells and 'normal' astrocytes 
are generated and how polarity mechanisms may be involved in generating this 
difference. Here, I set out to determine the role of BM contact and the Par 
complex for astrocyte function in the normal brain parenchyma as well as in the 
neurogenic niche.  
First, I examined the influence of BM-mediated signaling by conditional deletion 
of β1-integrin, one of the major BM receptors in the CNS. The use of specific 
Cre lines resulted in a loss of β1-integrin protein only at postnatal stages either 
in both glia and neurons or specifically in neurons. Strikingly, only the former 
resulted in reactive gliosis, with the hallmarks of reactive astrocytes comprising 
astrocyte hypertrophy and upregulation of the intermediate filaments GFAP and 
Vimentin as well as pericellular components, such Tenascin-C and the 473HD 
proteoglycan. This reaction to the loss of β1-integrin was further accompanied 
by non-cell autonomous activation of microglial cells. However, neither reactive 
astrocytes nor microglia divided, suggesting that the loss of β1-integrin-
mediated signaling is not sufficient to elicit proliferation of these cells. 
Interestingly, this partial reactive gliosis appeared in the absence of cell death 
and blood-brain barrier disturbances. As these effects did not appear after 
neuron-specific deletion of β1-integrin, we conclude that β1-integrin-mediated 
signaling in astrocytes is required to promote their acquisition of a mature, non-
reactive state. Interestingly, neural stem cell astrocytes in the SEZ were not 
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affected in their proliferation and fate, suggesting that β1-integrins are not 
involved in the regulation of these stem cell properties. However, loss of β1-
integrins interfered with the normal dedifferentiation of astrocytes into stem cells 
after brain injury.  
Next, I examined the role of Cdc42, a key activator of the Par complex, but also 
a mediator of β1-integrin signalling in adult stem cell astrocytes. Therefore, I 
genetically deleted this small RhoGTPase in astroglia at adult stages. In 
contrast to what has been observed during development, loss of Cdc42 had no 
influence on proliferation or fate of subependymal zone astrocytes. These 
effects on adult astroglia-like stem cells differ profoundly from effects on 
parenchymal astrocytes upon injury. Here, deletion of Cdc42 resulted in severe 
defects of astrocyte polarity as measured by centrosome reorientation and 
oriented process extension in the scratch assay in vitro. In vivo, astrocytes 
could still orient towards the injury site suggesting the existence of 
compensating signaling pathways. However, the increase of astrocyte numbers 
around the injury site was reduced. Impaired proliferation certainly contributes 
to this phenotype. Most importantly, loss of Cdc42 resulted in a significantly 
increased size of brain injury enlightening the importance of this pathway in the 
wound reaction towards brain injury. Conversely, no effects were seen by 
Cdc42 deletion in astrocytes in the absence of injury, suggesting that integrin-
mediated signaling from the BM maintains the hallmarks of mature non-reactive 
astrocytes while Cdc42, most likely via activation of the Par complex, regulates 
polarity and dedifferentiation after injury.  
Taken together, this work elucidated for the first time specific signaling 
pathways regulating the role of astrocytes as stem cells during wound reaction 
of the injured brain. 
 2 Introduction 
Astrocytes are a class of cells comprising various different cell types with 
diverse functions. As the topic of this thesis is how the diversity of types and 
functions is influenced by polarity I will first introduce the term “astroglia”, 
relevant astrocyte types and their functions. 
2.1 Neuroglial cells in the adult brain – A brief 
historical view about the term astroglia 
For the most of the 19th century researchers argued about the organization of 
the nervous system. Two opposing concepts existed at this time: The 
reticularists thought of the nervous system as a large network of tissue, or 
reticulum, formed by the fused processes of nerve elements. The neuronists, on 
the other hand argued that the nervous system consisted of distinct elements 
(E. Clarke and O'Malley, 1996). In 1838 Theodore Schwann and Matthias 
Schleiden proposed that the cell was the basic functional unit of all living things. 
The cell theory was not, however, believed to apply to the nervous system, and 
it was not until the end of the 19th century that it became generally accepted that 
the brain, too, consisted of cells. The term and concept ‘neuroglia’ (Nervenkitt) 
has been introduced by the pathologist Rudolf Virchow in a German medical 
journal in 1856 actually before the establishment of the cell concept and was 
therefore also rather addressing an interstitial substance (Figure 2-1):  
“…According to my investigations, the ependyma [of the cerebral ventricles] 
consists not only of an epithelium, but essentially a layer of connective tissue 
covered with epithelium. Although it can be separated without difficulty from the 
surface, yet it does not constitute an isolated membrane…but only a layer of 
interstitial connective tissue of the brain substance which is prominent on the 
surface. This connective substance, which is in the brain, the spinal cord, and 
the special sense nerves, is a kind of glue (neuroglia) in which the nervous 
elements are embedded.” (Virchow, 1856; Kettenmann and Ransom, 2005) 
When Virchow gave a lecture in 1858 he mentioned that neuroglia contains a 
certain number of cellular elements, but was not referring to a “glial cell” yet. 
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Rather, Heinrich Müller’s Müller Cells in the retina were the first depicted glial 
cells and soon after Otto Deiters described stellate cells in the cortical white and 
gray matter as component parts of the connective tissue. At the end of the 19th 
century neuroglia could be further classified into astrocytes, oligodendrocytes 
and microglia by the use of different silver staining methods developed by 
Camillo Golgi, Santiago Ramón y Cajal, Carl Weigert and Pío del Río Hortega 
on the basis of their morphology (Somjen, 1988).  
Finally, the term astrocyte was coined by Michael von Lenhossek in 1893 to 
refer to star-shaped neuroglial cells:  
“…Astrocytes are the small elements, which form the supportive system of the 
spinal cord. They are star shaped and indeed no other comparison describes 
their form so clearly. While the term spider cell introduced by Jastrowitz has 
become popular and gives a proper impression of the cells, one should regard 
Gierke’s note, namely that nobody has seen a spider with so many feet as 
these cells have processes.” (Lenhossék, 1893; Kettenmann and Ransom, 
2005). 
Although the human brain contains 3 times more astroglial than nerve cells the 
stigma of being just brain glue stack to these cells and astrocytes were 
regarded as passive participants as they are not electrically excitable as 
neurons. However, in the late 1980s it has been shown that astrocytes express 
voltage-gated channels and neurotransmitter receptors pointing to a 
participation of these cells in intercellular communication (for review see Ritchie, 
1992; Oh, 1997; Kettenmann and Ransom, 2005). In recent years, exciting 
discoveries unraveling the miscellaneous functions, including the control of 
synapse formation and function, as well as the regulation of the vascular tone 
and their role as adult neural stem cells (NSCs) led to a decisive rethinking 
about astroglial cells. 
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Figure 2-1 Drawing of “Nervenkitt” by Rudolf Virchow 
Between Ependyma and nerve fibers “the free portion of the neuroglia with numerous 
connective tissue corpsules and nuclei” is illustrated. E ependymal epithelium, V blood 
vessel, N nerve fibers (Virchow, 1858). 
 
2.2 Astrocyte subtypes 
The term astrocyte is an umbrella term for a heterogeneous population of cells 
that are highly adapted to their local environment and to the developmental 
stage. During development radial glia (RG) function not only as a scaffold for 
neuroblast migration, but are indeed progenitor cells giving rise to neurons and 
glial cells (Figure 2-2 and Malatesta et al., 2000). In the adult brain various 
astrocyte subtypes have been described comprising the more familiar 
protoplasmic astrocytes of the gray matter (Figure 2-3 A) and the fibrous 
astrocytes of the white matter (Figure 2-3 B), but also the bipolar shaped stem 
cell astrocytes at the lateral wall of the lateral ventricle (Figure 2-4 A, B) that 
show strong similarities to RG, the radial astrocytes of the retina and 
cerebellum, the velate astrocytes with their processes ensheeting cerebellar 
glomeruli (Chan-Palay and Palay, 1972) or dendritic segments and 
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periglomerular cells in the olfactory bulb (Valverde and Lopez-Mascaraque, 
1991), and the interlaminar astrocytes that have a long process that projects 
through several cortical layers in primates (Oberheim et al., 2009). These types 
of astrocytes do not only differ in their morphological appearance and territorial 
organization across brain regions and species but also in their marker 
expression (see Table 2-1) and functional properties (for an overview see 
Kettenmann and Ransom, 2005). In the cerebral cortex astrocytes seem to 
have various sources of origin including RG and glial restricted progenitors in 
the subventricular zone (SVZ) and within the parenchyma. Interestingly, it has 
also been suggested that some progenitors could be generated directly from 
neuroepithelial cells, which are the progenitors of RG (Figure 2-2 and Levison et 
al., 1993; Levison and Goldman, 1993; Hartfuss et al., 2001). Recently, NG2-
positive glia or polydendrocytes, a fourth glial cell type besides the well known 
astrocytes, oligodendrocytes and microglia, came into focus as glial progenitors. 
They have intriguingly been demonstrated to be a source of exclusively ventral 
gray matter astrocytes, although otherwise it is entirely unclear how the 
differences between astrocyte subtypes are generated and whether a certain 
origin is associated with a defined astrocytic morphology or function. As 
postnatal development proceeds radial glia cells transform into ependymal cells 
and type B stem cell astrocytes that can give rise to neurons, oligodendrocytes 
and astrocytes throughout adulthood (Figure 2-2). Again, it is still unsolved, 
which signals allow this particular astrocytic subpopulation to escape maturation 
and keep their stem cell potential throughout adulthood. 
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Figure 2-2 Progenitor cells in the SVZ/ SEZ during ontogenesis 
Neuroepithelial cells in early development divide symmetrically to generate more 
neuroepithelial cells, some may also generate early neurons. As embryogenesis 
proceeds neuroepithelial cells convert into radial glial (RG) cells. RG divide 
asymmetrically to generate neurons directly or indirectly through intermediate progenitor 
cells/basal progenitors (nIPCs). Radial glia have an apical-basal polarity: apically (down), 
RG contact the ventricle, where they project a single primary cilium; basally (up), RG 
contact the meninges, basal lamina, and blood vessels. At the end of embryonic 
development, most RG begin to detach from the apical side and convert into astrocytes. 
Production of astrocytes may also include some IPCs (not illustrated here). A 
subpopulation of RG retains apical contact and continues functioning as NSCs in the 
neonate. These neonatal RG continue to generate neurons; some convert into ependymal 
cells, whereas others convert into adult SVZ astrocytes (type B cells) that continue to 
function as NSCs in the adult. B cells maintain an epithelial organization with apical 
contact at the ventricle and basal endings in blood vessels. B cells continue to generate 
neurons and oligodendrocytes. Neither the generation of oligodendrocytes via oIPCs has 
been finally proven, nor the generation of oligodendrocytes from adult NSCs in vivo 
(taken from A. Kriegstein and A. Alvarez-Buylla, 2009). 
IPC intermediate progenitor cell, MA mantle, MZ marginal zone, NE neuroepithelium, 
nIPC neurogenic progenitor cell, oIPC oligodendrocytic progenitor cell, RG radial glia, 
SVZ subventricular zone, VZ ventricular zone 
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2.2.1 Protoplasmic astrocytes of the gray matter 
Protoplasmic astrocytes are scattered through all layers of the cortical gray 
matter and throughout the brain parenchyma. Rodent gray matter astrocytes 
have three to four main processes emanating more or less radially from the cell 
body and extend thousands of finer branches resulting in a high surface to 
volume ratio (Figure 2-3 A). Although the volume of astroglia accounts for only 
10% to 20% of the total gray matter volume, astrocyte processes contact most 
of the available neuronal surfaces (Volterra et al., 2002). Gray matter astrocytes 
extend two types of processes: fine perisynaptic processes covering synapses 
and large diameter vascular endfeet that are closely ensheeting blood vessels 
(Iadecola and Nedergaard, 2007). These astrocytes have a high density, but 
show a surprisingly low overlap of less than 5% and thus occupy separate 
anatomical domains (Bushong et al., 2002; Oberheim et al., 2008). At the sites 
of contact protoplasmic astrocytes are interconnected with each other through 
gap junctions. Gap junctions are distributed evenly along astrocytic processes 
and therefore do not only couple neighboring cells, but also neighboring 
processes derived from the same cell minimizing the differences between 
individual processes by mediating the sharing of all molecules with molecular 
weights of less than 1000 kDa (Nedergaard et al., 2003). Fascinatingly, the glia-
to-neuron index, which is largely determined by the number of protoplasmic 
astrocytes, increases as a function of brain size. Indeed, the human brain has a 
higher glia-to-neuron ratio than most other species although the astrocyte size 
disproportionally increased from rodents to humans pointing to the intriguing 
hypothesis that enlargement of the astroglial domain and glial numbers are 
associated with an increase in intellectual capacity during phylogeny (Oberheim 
et al., 2006; Oberheim et al., 2009).   
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Figure 2-3 Gray and white matter astrocytes 
Astrocytes of the gray (A) and white matter (B) are labeled with green fluorescent protein 
(green). White matter astrocytes are additionally positive for GFAP (red). 
 
2.2.2 Fibrous astrocytes of the white matter 
Fibrous astrocytes are found in white matter tracts, in optic nerve, and in the 
nerve fiber layer of the mammalian vascularized retinae. They are less complex 
than protoplasmic astrocytes extending straighter and less branched fibers that 
run frequently in parallel to nerve fibers (Figure 2-3 B). The surface to volume 
ratio is less pronounced than in gray matter astrocytes. Often their cell bodies 
lie in rows between axon bundles. They are not organized in domains; instead 
processes of adjacent astrocytes intermingle and overlap frequently, although 
the cells are found equidistant from one another. The less complex appearance 
and relative uniformity of fibrous astrocytes points to a mainly supportive 
function (for review see Kettenmann and Ransom, 2005; Oberheim et al., 
2006). Nevertheless, white matter astrocyte processes have been shown to 
contact the nodes of Ranvier where they play a role in signal transduction (D. D. 
Wang and Bordey, 2008). In adult rodents fibrous astrocytes are characterized 
by high expression levels of the intermediate filament glial fibrillary acidic 
protein (GFAP), whereas GFAP protein is not detected in most astrocytes in the 
brain parenchyma or only to a low extent in some layer I astrocytes in the 
cortical gray matter (Table 2-1). 
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2.2.3 Subependymal zone stem cell astrocytes 
The maybe most amazing role of astrocytes in the adult brain is their function as 
stem cells throughout adulthood. It was traditionally believed that the brain loses 
its capacity of regeneration during maturation. However, NSCs were found to 
reside in two regions of the adult brain, the subgranular zone (SGZ) of the 
hippocampus and the subependymal zone (SEZ) at the lateral ventricle (Altman 
and Das, 1965; Altman, 1969; Reynolds and Weiss, 1992; Doetsch et al., 1997; 
Eriksson et al., 1998; Doetsch et al., 1999). These cells fulfill all characteristics 
of stem cells as they self-renew and are pluripotent giving rise to the three 
major CNS cell types, neurons, astrocytes and oligodendrocytes (for review see 
Mori et al., 2005). In the SEZ the slow proliferating astroglia-like stem cells, also 
called type-B cells, give rise to fast proliferating transit amplifying precursors 
(type-C cells), which further specify to type-A neuroblasts (for review see (Ihrie 
and Alvarez-Buylla, 2008). These newborn neurons migrate through the rostral 
migratory stream (RMS) towards the olfactory bulb (OB), where they 
differentiate into interneurons (for review see Lledo et al., 2006). Interestingly, 
neuroblasts have been observed to leave their conserved path after brain injury 
and migrate into the site of brain damage, thus possibly displaying an intrinsic 
source for brain repair (Shin et al., 2000; Kokaia and Lindvall, 2003; Lindvall 
and Kokaia, 2004; Lindvall et al., 2004; Brill et al., 2009). However, most of 
these neuroblasts do not further mature and subsequently die; only a very small 
proportion of migrating neuroblast are able to integrate upon targeted projection 
neuron degeneration, an injury paradigm largely devoid of glial reactivity (Shin 
et al., 2000; Brill et al., 2009).  
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Figure 2-4 Stem cell astrocytes of the subependymal zone 
Schematic drawing modified from Z. Mirzadeh et al., 2008 depicting the polarized 
appearance of SCA with an apical membrane site at the ventricular surface and a basal 
membrane domain where a process makes contact with the basement membrane 
surrounding blood vessels (A). Astrocytes at the SEZ can be labeled with GFAP and GFP 
expressed in GLAST-positive NSCs (B). NSC Neural stem cell, SEZ subependymal zone, 
GFP green fluorescent protein, GFAP glial fibrillary acidic protein. 
 
What does capacitate astroglia-like stem cells in the SEZ to preserve their stem 
cell potential that is otherwise lost in maturating astrocytes as development 
proceeds? Are these cells more closely related to parenchymal astrocytes, 
which are of the same RG origin, or to ependymal cells with which they share 
the niche in addition? The niche is the microenvironment that may regulate 
stem cell survival, self-renewal and differentiation. Key niche components and 
interactions include growth factors, cell-cell contacts and cell matrix adhesions 
(Discher et al., 2009). Comparative transcriptome analysis of parenchymal 
astrocytes, NSCs and ependymal cells revealed that NSCs share 
characteristics of astrocytes and ependymal cells and that NSC are 
intermediate between those two (P. Tripathi et al., 2010), which was surprising 
as their marker expression and morphology rather resembles their RG 
progenitors. In contrast to ependymal cells that have a cuboids shape, they 
have a unique bipolar morphology with one cilium-bearing process that has 
access to the lateral ventricle and thus possess an apical membrane domain 
(Mirzadeh et al., 2008). Their second process contacts the basement 
membrane (BM) enwrapping blood vessels within the SEZ (Figure 2-4 A). 
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Lately, this basal membrane component has been discussed to be especially 
important for the stemness of NSCs (Shen et al., 2008; Tavazoie et al., 2008). 
Like RG, they express the marker brain lipid-binding protein (BLBP), the 
intermediate filaments Nestin, Vimentin and GFAP, as well as the extracellular 
matrix molecule Tenascin-C (ECM TN-C; see Table 2-1). This marker profile is 
rather characteristic for immature cells during development and differs 
profoundly from the one of mature astrocytes (Table 2-1). Interestingly, it largely 
overlaps, though, with protein expression in reactive astrocytes after acute or 
chronic brain injury, which will be discussed in more detail below.  
Table 2-1 Marker expression in neuroepithelial cells and various astrocyte subtypes 
 Neuroepitheli
al Cell 
Radial 
Glia 
Neural 
Stem 
Cell 
adult white 
matter 
Astrocytes 
adult gray 
matter 
Astrocytes 
Reactive 
Astrocytes 
Glycogen 
granules 
- + + + + + 
GLAST - + + + + + 
Glutamine 
synthetase 
- + + + + + 
S100β - + + + + + 
GFAP - not in 
rodents 
+ + - + 
Vimentin - + + - - + 
Nestin/ RC2 + + + - - + 
TN-C - + + - - + 
BLBP + + + - - + 
modified from Mori et al., 2005; Pinto and Gotz, 2007 
 
2.3 Diversity of astroglial functions  
2.3.1 Functions in the intact adult brain 
Astrocytes, the most abundant glial cell type in the brain, are possibly as 
heterogeneous as nerve cells in regard to their morphology and function. 
Astrocytic tasks in the healthy brain can be subdivided in three groups; those 
that provide housekeeping functions to keep neurons healthy, those that are 
involved in shaping synaptic function (D. D. Wang and Bordey, 2008) and their 
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role as stem cells in the adult brain (see above). In regard to their housekeeping 
functions, astrocytes are involved in fostering neurons by buffering potassium 
and neurotransmitters like glutamate, providing nutrient and structural support 
around synapses, and enhancing neuronal survival and neurite function by 
secretion of growth factors including nerve growth factor (NGF), brain-derived 
neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and fibroblast growth factor 
(FGF) in all brain regions (Ojeda et al., 2000). They are not only the major 
source of the ECM, but also secret proteolytic enzymes, in particular the 
metalloproteinases (MMPs) that play a role in ECM degradation and remodeling 
(Shapiro, 1998; Yong et al., 1998; Rosenberg, 2009). More recently, astrocytes 
have been shown to transmit signals to neurons that directly modulate synaptic 
strength or even contribute to synaptic transmission by release of transmitters 
that directly stimulate postsynaptic neurons (for review see Haydon, 2001; 
Newman, 2003). But not only that, changes in intracellular calcium in astrocytes 
reflect a mode of astrocyte excitability. Astrocytes can sense neuronal activity 
through activation of ion channels, transporters and receptors reacting with fast 
depolarization and/ or increase in intracellular calcium (D. D. Wang and Bordey, 
2008) that can be communicated to neighboring cells via gap junctions. 
Nevertheless, the overlap of processes of adjacent astrocytes is minimal. The 
functional consequence of their domain organization is not fully understood, but 
one could imagine that all synapses lying within a given volumetrically defined 
compartment might be under the influence of a single astrocyte, which would 
then provide a higher integrative order (Nedergaard et al., 2003). Furthermore, 
through their contact to blood vessels astrocyte domains might provide the 
unique structure to fine tune the cerebral blood flow according to synaptic 
activity and coherent metabolic demands within this functional unit of the brain 
(Iadecola and Nedergaard, 2007).  
 
2.3.2 Astrocytes respond to brain injury  
Astrocytes, together with microglia cells and NG2 glia, mediate the reaction to 
every kind of brain injury including trauma, infection, ischemia and 
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neurodegeneration with a process called ‘reactive gliosis’. Reactive gliosis 
starts when trigger molecules at the injury site drive astrocytes to become 
activated. During this process astrocytes gradually change their morphology 
and biochemical profile (see Figure 2-5 and Table 2-2) dependent on the 
severity of the injury. They also release factors that mediate or enhance an 
inflammatory response and tissue remodeling (Figure 2-5 b). In severe cases a 
tight glial scar is formed that is inhibitory for neuronal regeneration (Figure 2-5 
e). Early morphological and molecular changes in astrocytes comprise 
hypertrophy, upregulation of intermediate filament proteins, such as GFAP, 
Vimentin, Synemin and Nestin and secretion of ECM components, e.g. 
Tenascin-C and chondroitin sulfate proteoglycans (CSPGs) (Mathewson and 
Berry, 1985; Dobbertin et al., 2003; Jing et al., 2007; Pekny et al., 2007; Buffo 
et al., 2008). Despite the protection from secondary damage by isolation of the 
injured region from other brain parts and sealing of the blood-brain barrier 
(BBB), another potentially beneficial aspect of astrogliosis derives from the 
finding that a subset of reactive astrocytes can recapitulate stem cell/ progenitor 
features in response to brain damage (Buffo et al., 2005; Buffo et al., 2008). 
Thus, 7 days after cortical stab wound injury around half of all GFAP-positive 
astrocytes incorporated the thymidin base analogue Bromodeoxyuridin (BrdU) 
(Buffo et al., 2005; Buffo et al., 2008). In vivo, however, these proliferating cells 
do not switch fate, but give rise to astrocytes only. Nevertheless, if the injured 
tissue is dissociated and cells are cultured as neurospheres in vitro, reactive 
astrocytes are able to differentiate into all three major neural cell types, 
astrocytes, oligodendrocytes and neurons (Buffo et al., 2008). These findings 
indicate that astrocytes after injury possess the intrinsic capacity to 
dedifferentiate towards a stem cell like cell. However, the inhospitable 
environment may not allow or even inhibit astrocytes to evolve their full stem 
cell-like potential.  
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Figure 2-5 Changes in astrocytes after brain injury 
Upon CNS injury, activated astrocytes increase their homeostatic and trophic functions 
(a), the production of growth factors and cytokines, as well as the release of nucleotides 
and toxic compounds (b). Their secretion is regulated via complex autocrine and 
paracrine loops (b). Astrogliosis includes cell proliferation (c) and possibly migration 
towards the lesion site (d). Reactive astrocytes participate in glial scar formation, and 
contribute to the resealing of the damaged blood–brain barrier, thus excluding infiltrating 
leukocytes and meningeal fibroblasts from the injured tissue (e) (modified from Buffo et 
al., 2010).  
Nt/ Nu nucleotides/ nucleosides, BBB blood–brain barrier.  
 
Despite the fact that astrocyte reactivity has long been known to accompany 
brain pathology and many molecules have been shown to be differentially 
regulated after different injury paradigms (see Table 2-2), the molecular signals 
dissecting beneficial and detrimental effects are poorly understood (for review 
see Sofroniew, 2009; Buffo et al., 2010). Nonetheless, it becomes more and 
more clear that it is the reaction of glia, which determines initiation, course and 
outcome of the majority of brain insults and the glial performance decides upon 
the balance of neuroprotection, neuroregeneration and neural death, thus 
controlling the pathology of the brain. Therefore, it is of great interest to 
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examine the molecular pathways regulating and differentiating between the 
various nuances of the glial reaction (see also Table 2-3). 
Table 2-2 Molecular changes in reactive astrocytes 
Functional categories Molecular changes in reactive astrocytes 
Structural GFAP, Vimentin, Nestin, Synemin 
transcriptional regulators NF-kappaB, Stat3 , cAMP, Olig2, mTOR, Sox9 
ECM and cell-cell interactions CSPGs, integrins, collagens, cadherins 
laminins, ephrins, metalloproteases 
Inflammatory cell regulators cytokines, growth factors, glutathione 
fluid and ion homeostasis Aqp4, Na/K transporters 
extracellular transmitter clearance glutamate transporters 
vascular regulators NO, PGE 
Purines, pyrimidines and receptors P2Y, P2X, P1; ATP, ADP, UTD, UDP, Ado 
oxidative stress and protection NO, NOS, SOD, glutathione 
gap junctions proteins Cx43 
energy provision lactate 
synapse formation and remodeling Thrombospondin, complement C1q 
modified from Sofroniew, 2009; Buffo et al., 2010 
  
2.3.3 Signaling after brain injury 
Numerous molecules and pathways have been implicated in mediating the 
response of astrocytes towards brain injury (for review see Sofroniew, 2009; 
Buffo et al., 2010) and Table 2-3). Obvious candidates for initiating the 
astrocytic response to injury are purine (ATP, ADP) and pyrimidine (UTP, UDP, 
and UDP-sugars) nucleotides, because they are released in massive amounts 
from damaged cells at early stages after brain injury. This is a consequence of 
cytoplasm leakage of dying cells and increased excitotoxic transmission or 
astrocyte exposure to plasma components like thrombin (Melani et al., 2005; 
Kreda et al., 2008; Lecca and Ceruti, 2008). Astrocytes are able to sense 
changes in nucleotide levels as they express all known G-protein coupled 
metabotropic P2Y-receptors and 7 ionotropic P2X subtypes (Fumagalli et al., 
2003; Di Virgilio et al., 2009). Indeed, astrocytic proliferation, the extension of 
long branched astrocytic processes and cytoskeleton dynamics through integrin 
2.3  Diversity of astroglial functions  17 
interactions, as well as cyclooxigenase-2 (COX-2) upregulation and secretion of 
arachidonic acid seem to be triggered by P2Y receptors activation (for review 
see Buffo et al., 2010). The P2X7 receptor has recently been shown to 
modulate the synthesis of cytokines and inflammatory mediators and is 
predominantly activated by pathological high ATP levels (for review see Cotrina 
and Nedergaard, 2009). Upon activation it leads to the opening of a membrane 
pore that allows cytokine release and promotes cell death (Di Virgilio, 2007). 
Systemically administration of the P2X7 receptor antagonist Brilliant blue G 
after spinal cord injury in rats reduced local activation of astrocytes and 
microglia, as well as neutrophil infiltration (Peng et al., 2009).  
After injury, purinergic factors promote the release of cytokines (Cotrina and 
Nedergaard, 2009; Di Virgilio et al., 2009), which are a family of low molecular 
weight proteins and include, but are not limited to, interleukins (ILs), 
chemokines, interferones (INF-alpha, beta and gamma), tumor necrosis factor 
(TNF-α and TNF-β), colony stimulating factors (CSFs, IL-3 and some other ILs), 
and growth factors (Transforming growth factor, TGF α and β, EGF, FGF, 
PDGF, LIF, CNTF, IL-6) (Ebadi et al., 1997). Cytokines participate in a wide 
range of biological responses, including growth, development and modulation of 
inflammation, immune responses and regulation of homeostasis.  
Acute brain injury leads to the release of pro-inflammatory cytokines such as 
TNF-α, IL1β, IL-6, and INFγ mainly from microglia (for review see Kim and de 
Vellis, 2005). Nonetheless, astrocytes do not only possess a large variety of 
cytokine receptors enabling them to sense microglial signals, but also release 
proinflammatory and immunomodulatory cytokines themselves, giving rise to an 
autocrine/ paracrine loop of glial cell activation (Figure 2-7 and Hauwel et al., 
2005; Farina et al., 2007; Kahn et al., 1995; Levison et al., 2000). IL-1β as well 
as IL-1 receptor knockout mice show a delay in GFAP-upregulation, whereas in 
the latter induction of CSPGs, S-100β, GLAST and glutamate transporter-1 
(GLT-1), and glutamine synthetase (GS) were not affected (Herx and Yong, 
2001; Lin et al., 2006). Conversely, IL1β and TNF-γ seem to mediate GFAP 
upregulation in Creutzfeld Jacob Disease, a neurodegenerative disorder 
(Kordek et al., 1996). On the contrary, immunomodulatory cytokines such as IL-
18   Introduction  2 
10, INFγ and Epo attenuate gliosis after spinal cord injury or ischemia 
respectively (Vitellaro-Zuccarello et al., 2008; de Bilbao et al., 2009; Ito et al., 
2009).  
Upon injury, also growth factors such as ciliary neurotrophic factor (CNTF), 
vascular endothelial growth factor (VEGF), epidermal growth factor (EFG), and 
basic fibroblast growth factor (bFGF) are released (Buffo et al., 2010). They 
trophically support damaged neurons and oligodendrocytes, promote 
revascularization, and may play a role in activating progenitors in some injury 
paradigms (Buffo et al., 2008; Sirko et al., 2009).  
These primary mediators then lead to a secretion of secondary mediators like 
arachidonic acid metabolites, nitric oxide (NO), and enzymes including MMPs 
that can contribute to the long-lasting astrocytic response to injury for example 
in chronic neurodegenerative diseases. In addition, they trigger intracellular 
signaling pathways. The molecular pathways mediating between injury-derived 
signals and astroglia reactivity are numerous and their intracellular interactions 
are largely unclear. Intracellular cascades can either mediate changes at the 
cytoplasmic level including cytoskeletal rearrangements or translational 
modifications, or gene expression can be modified through activation of 
intracellular cascades leading to nuclear responses. Below three main 
pathways will be discussed that regulate proliferation, hypertrophy and GFAP 
upregulation in astrocytes.  
 
Pathways triggering a proliferative response of astrocytes after brain 
injury  
In vitro, exposure of astrocytes to a number of growth factors including EGF and 
bFGF, or VEGF induced typical features of reactive astrocytes like cell 
proliferation, upregulation of GFAP, as well as emission of long and branched 
processes (Buffo et al., 2010). In addition, microarray analysis revealed that 
treating astrocytes in culture with EGF leads to the upregulation of various 
genes related to brain injury including CSPG 2 (Versican), Tenascin C, MMPs, 
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tissue inhibitor of metalloproteinase, some collagens, Syndecan, Nestin, 
Endothelin A receptor, FGF, LIF, TGF-β1 and TGF-β1-receptor, whereas GS, 
Vimentin, IL-6, laminin, and PTEN seems to be regulated via EGF-R-
independent pathways (Liu et al., 2006). 
After injury in vivo, astrocytes strongly upregulate the expression of these 
cytokines or their receptors (Sun et al., 2010; Nieto-Sampedro et al., 1988; 
Leadbeater et al., 2006; Krum et al., 2008; R. B. Tripathi and McTigue, 2008). 
The absence of the potent mitogen FGF-2 in knockout mice revealed a baseline 
decrease in GFAP immunoreactivity in cortical gray and white matter and the 
striatum and a reduction of proliferating cells after traumatic brain injury (Reuss 
et al., 2003; Yoshimura et al., 2003). After blocking of VEGF-mediated signaling 
with neutralizing antibodies against VEGF receptor-1 (flt-1) administered by a 
minipump, less astrocytes were expressing FGF-2 and the number of 
proliferating astrocytes was dramatically reduced (Krum et al., 2008). 
Furthermore, rapid upregulation of EGF-R (ErbB-1-4) and its ligands (TGFα, 
and EGF are ErbB-1 ligands) in astrocytes has been demonstrated after acute 
brain injury and neurodegenerative diseases (Nieto-Sampedro, 1988; Nieto-
Sampedro et al., 1988; Liu and Neufeld, 2007). Upon activation, EGF-R 
signaling modulates the ECM composition by upregulation of CSPG proteins 
including phosphacan and neurocan via the EGF-R ErbB1 (McKeon et al., 
1999; G. M. Smith and Strunz, 2005) and induces astrocyte proliferation. 
Stimulation of the EGF-R cascade by TGFα and EGF induces astrocyte 
proliferation in vitro (Liu and Neufeld, 2004; Sharif et al., 2006). Conversely, 
astrocyte proliferation is impaired in EGF-R deficient mice in vivo (Sibilia et al., 
1998). Overexpression of TGF-α in vivo triggers an increase of the expression 
of its receptor (EGF-R) (Rabchevsky et al., 1998; White et al., 2008), 
upregulation of intermediate filaments and hypertrophy of GFAP-positive cells. 
However, astrocytes did not re-enter the cell cycle in this particular study 
(Rabchevsky et al., 1998). On the contrary, the TGF-α deficient mouse mutant 
waved-1 shows a reduction in GFAP expressing postnatal astrocytes (Weickert 
and Blum, 1995).  
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Taken together, the growth factors EGF, FGF, and VEGF trigger mainly the 
proliferative response of astrocytes to brain injury (Sibilia et al., 1998; Levison et 
al., 2000; Yoshimura et al., 2003; Liu and Neufeld, 2004; Sharif et al., 2006; 
Krum et al., 2008). How these extracellular stimuli are then translated into this 
specific biological response in the cell?  
Rheb-mTOR pathway and phosphatase tensin homolog (PTEN) 
The serine/threonine kinase mTOR (mammalian target of rapamycin) is a key 
regulator of cell size and proliferation downstream of growth factor receptors 
and has a role in mediating cell responses to nutrients at the translational level 
(for review see Chiang and Abraham, 2007; Ma and Blenis, 2009). In cultures of 
adult spinal cord astrocytes EGF activates the mTOR pathway through Akt-
mediated phosphorylation of the GTPase activating protein Tuberin. In its 
phosphorylated form Tuberin is unable to inactivate the small GTPase Rheb, 
which is required for EGF-dependent mTOR activation. In an ischemic model of 
spinal cord injury elevated mTOR signaling was detected in reactive astrocytes. 
Treating injured rats with the mTOR inhibitor rapamycin leads to an overall 
decrease of GFAP and Vimentin levels (Codeluppi et al., 2009). Conversely, 
deletion of the mTOR negative regulator phosphatase tensin homolog (PTEN) 
and thus pronounced mTOR signaling promotes astrocyte hypertrophy and 
proliferation (Fraser et al., 2004). 
The mitogen-activated protein kinase/ extracellular signal-regulated kinase 
pathway 
Mitogen-activated protein kinases (MAPK) are proline-directed serine/ 
threonine-specific protein kinases responsible for most cellular responses to 
cytokines and external stress signals and crucial for regulation of the production 
of inflammation mediators. Increased activity of MAPKs in activated microglia 
and astrocytes is regulating intracellular events including gene expression, 
proliferation, differentiation, cell apoptosis and survival respectively (Pearson et 
al., 2001). The signaling cascade involves a MAP kinase kinase kinase 
(MAP3K), e.g. EGF-R or FGF-R (Sundaram, 2006; Neary et al., 2008). The 
MAP3K is sensing the extracellular stimuli, which subsequently phosphorylates 
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a MAP kinase kinase (MAP2K). MAP2K likewise phosphorylates a MAPK at its 
serine and threonine residues leading to specific biological responses (Figure 
2-6). Six different groups of MAPKs have been characterized in mammals. In 
signaling after brain injury the classical MAP kinase ERK1 and ERK2, the c-
JUN N-terminal kinases/ stress activated protein kinases (JNK/ SAPK), and p38 
pathways have been implicated. 
The extracellular signal-regulated kinase (ERK)/ MAPK pathway mediates the 
effects of extracellular nucleotides, growth factors including NGF, EGF, and 
FGF-2, as well as the vasoactive factor endothelin, which are released after 
brain injury (Brambilla et al., 2002; Irving and Bamford, 2002; Carbonell and 
Mandell, 2003; Neary et al., 2004; Gadea et al., 2008; Neary et al., 2008). 
Shortly after stab wound injury the ERK/ MAPK pathway is activated in a subset 
of GFAP-positive astrocytes, suggesting a specific functional activation of these 
cells. Furthermore, a downstream target of the ERK/ MAPK cascade, cAMP 
response element-binding (CREB) protein, has been shown to be 
phosphorylated in perilesional astrocytes with a peak at 7 days after the injury 
(Carbonell and Mandell, 2003). Endothelin-1 (ET-1), a potent vasoactive 
neuropeptide, and the endothelin receptors (ET(A)R and ET(B)R), expressed in 
astrocytes during development and in the adult brain, are strongly upregulated 
in astrocytes after brain injury (Nie and Olsson, 1996; Barnes and Turner, 1997; 
Schinelli, 2006). Infusion of ET(B)R agonists induced hypertrophy of astrocytes 
even in the intact brain (Rogers et al., 2003). Conversely, infusion or injection of 
ET(B)R antagonists where associated with a reduction in GFAP-upregulation 
and hypertrophy in different injury paradigms (Baba, 1998; Peters et al., 2003; 
Rogers et al., 2003). ET-1 can activate all three MAPK pathways inducing 
transcription or phosphorylation of the transcriptional regulators CREB, and the 
AP1 complex components c-fos and c-jun (Schinelli et al., 2001; Schinelli, 2006; 
Gadea et al., 2008). The induction of CREB in astrocytes is induced via an ERK 
and p38-dependent MAPK pathway after Endothelin-1 (ET-1) stimulation 
(Schinelli et al., 2001). Interestingly, the Rap1/ PKC/ ERK-dependent pathway 
induces the phosphorylation of activating transcription factor-1 (ATF-1), CREB 
and Elk-1, whereas the p38MAPK pathway only induces phosphorylation of 
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CREB. ET-1 induced transcription of the immediate early gene c-fos requires 
the concomitant activation of both pathways (Schinelli et al., 2001). Recently, 
another study showed that ET-1 induces a combined activation of ERK and 
JNK-dependent MAPK pathways that synergistically act to phosphorylate c-fos 
and c-jun, which subsequently modulate astrocyte proliferation and GFAP 
expression (Gadea et al., 2008). Conversely, it has been shown that Interferon-
γ (INF-γ) attenuates GFAP-upregulation and astrocyte proliferation by reduction 
of mitogen-activated ERK-regulating kinase (MEK)/ ERK phosphorylation 
(Figure 2-6) after spinal cord injury, which is correlated to a better functional 
outcome (Ito et al., 2009). 
 
Figure 2-6 Mitogen-activated protein kinase/ extracellular signal-regulated kinase 
cascade 
Upon sensing an extracellular stimulus a mitogen-activated protein (MAP) kinase kinase 
kinase phosphorylates a MAP kinase kinase, which subsequently phosphorylates a MAP 
kinase leading to a specific biological response (adapted from Cell Signaling 
Technology®). 
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CNTF triggers JAK/STAT mediated signaling leading to hypertrophy and 
upregulation of GFAP  
Astrogliosis is directly initiated by the pro-inflammatory cytokines IL-6 and CNTF 
(Fattori et al., 1995; Kahn et al., 1997; Klein et al., 1997; Okada et al., 2004), 
which belong to a cytokine family involved in astrocyte fate specification during 
development. The interleukin (IL)-6 family of cytokines, which includes IL-6 
itself, leukemia inhibitory factor (LIF), cardiotrophin-1 (CT-1) and ciliary 
neurotrophic factor (CNTF) are able to activate the CNTF receptor that 
promotes differentiation of cerebral cortical precursor cells into astrocytes and 
at the same time inhibits the differentiation along the neuronal lineage in culture 
(Bonni et al., 1997). Ligand binding at the corresponding receptor induces 
homo- or heterodimerization of the co-receptor Gp130 that is shared by several 
receptor complexes as a critical component for signal transduction. Neither 
Gp130 nor its dimer partners possess an intrinsic tyrosine kinase domain. 
However, dimerization of Gp130 leads to an activation of the Janus Tyrosine 
Kinase/ Signal Transducers and Activators of Transcription (JAK/ STAT) 
pathway (Stahl et al., 1994; Taga and Kishimoto, 1997; Levy and Darnell, 
2002). The activated transcription factors STAT1 and/ or 3 dimerize and 
translocate to the nucleus where they bind specific sites in the DNA. 
Furthermore, STATs can bind cofactors of the p300/ CREB-binding protein 
group (CBP). These cofactors bridge between STAT1/ 3 and the RNA-
Polymerase II leading to an increase in transcription. STATs have been shown 
to bind to the promoter region of genes encoding astrocytic proteins (e.g. GFAP 
and S100β) after stimulation of precursor cells with IL-6, CT-1, LIF or CNTF, 
promote the transcription of astrocytic genes and thus astrocytic fate 
specification or re-expression of GFAP after injury (Bonni et al., 1997; Namihira 
et al., 2004; He et al., 2005). Among the genes activated by STAT1/ 3 are 
components of the JAK/ STAT signaling cascade itself, including Gp130, JAK1, 
STAT1 and STAT3 suggesting that STAT signaling induces an autoregulatory 
loop that reinforces itself and stabilizes the astrocytic phenotype (Kessaris et 
al., 2008). As most of these studies are done in culture, the question arises 
whether all of the cytokines are of relevance after brain injury in vivo. Genetic 
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ablation of IL-6 in mice as well as pharmacological blocking of the IL-6 receptor 
leads to less phosphorylation of STAT3, a less pronounced GFAP upregulation, 
a lower number of proliferating astrocytes and to a reduction in microglia 
activation and proliferation (Klein et al., 1997; Swartz et al., 2001; Okada et al., 
2004). Conversely, neuron-specific overexpression of human IL-6 mediated 
upregulation of GFAP and an increase in microglial numbers most likely due to 
IL-6 secretion from neurons. Neuronal damage, however, has not been 
excluded (Fattori et al., 1995) and could also be the cause for astrocyte and 
microglia activation in this model. These mice displayed strongly elevated levels 
of proinflammatory cytokines including murine IL-6, IL-1β, and TNF after 
intracerebroventricular injection of lipopolysaccharide (Di Santo et al., 1996), 
suggesting a faster and amplified production of these cytokines after an 
inflammatory stimuli either because of the elevated baseline of human IL-6, or 
due to already activated astrocytes and microglia. Similarly, CNTF levels are 
elevated after CNS injury (Kahn et al., 1995; Krum et al., 2008; R. B. Tripathi 
and McTigue, 2008) and CNTF-injection into the intact brain promotes GFAP-
upregulation but not astrocyte proliferation (Kahn et al., 1995; Kahn et al., 
1997).  
IL-6 and CNTF are well known activators of the JAK/ STAT pathway and 
indeed, activation of the JAK2/ STAT3 pathway in astrocytes could be shown to 
precede GFAP upregulation in vivo after 1-Methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP) induced neurodegeneration. After MPTP-induced 
damage of striatal dopaminergic nerve terminals phosphorylation of STAT3 and 
translocation to the nucleus was observed in astrocytes. Pharmacological 
inhibition of Janus kinase-2 (JAK2) attenuated both, STAT3 phosphorylation 
and GFAP upregulation (Sriram et al., 2004). Conditional deletion of STAT3 by 
either using Nestin-Cre or mGFAP-Cre led to attenuated upregulation of GFAP, 
reduced hypertrophy of astrocytes after spinal cord injury, limited migration of 
astrocytes into the injury site and more widespread infiltration of inflammatory 
cells. This resulted in an increase in injury volume and impaired recovery of 
motor functions several weeks after the injury (Okada et al., 2006; Herrmann et 
al., 2008). Conversely, conditional knockout of the protein suppressor of 
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cytokine signaling 3 (Socs3) is associated with higher levels of phosho-STAT3, 
an increase in astrocytic migration into a lesion and enhanced contraction of the 
lesioned area, as well as improvement of functional recovery after spinal cord 
injury (Okada et al., 2006).  
Thus, IL-6 or CNTF induced activation of the JAK/ STAT pathway mediates the 
expression of GFAP and induces hypertrophy in astrocytes after brain injury. 
 
Bone morphogenic protein/ TGF-β signaling through Smads leads to the 
acquisition of an astrocytic cell fate 
Cytokines of the transforming growth factor-β (TGF-β) superfamily, including 
TGF-βs and bone morphogenetic proteins (BMPs) are upregulated in response 
to different injury paradigms in brain and spinal cord (Ebadi et al., 1997; 
Setoguchi et al., 2001; Buisson et al., 2003; Vivien and Ali, 2006; Z. Zhang et 
al., 2006; Hampton et al., 2007). This is in particular of interest as during 
development BMP signaling promotes acquisition of an astrocytic fate and may 
explain why proliferating astrocytes after brain injury stay within their lineage 
and do not efficiently acquire an neuronal fate in vivo, even upon forced 
expression of neurogenic transcription factors (Buffo et al., 2005; Berninger et 
al., 2007; Buffo et al., 2008; Heinrich et al., in press). Cytokines of the TGF-β 
family bind to specific serine/ threonine kinase type II receptor, which recruits a 
type I receptor and allows the transphosphorylation-mediated activation of this 
receptor. Subsequently, signaling mother against decapentaplegic peptides 
(Smads), intracellular nuclear effectors of transforming growth factor-beta (TGF-
β) family members, are activated. Whereas Smad2 and Smad3 are 
phosphorylated by TGF-β type I receptors, and activin type I receptors, Smad1, 
Smad5 and Smad8 act downstream of BMP type I receptors (BMPRI). Activated 
receptor-regulated Smads (R-Smads) form heteromeric complexes with 
common-partner Smads (Co-Smads), e.g. Smad4, which translocate efficiently 
to the nucleus. In the nucleus they regulate, in co-operation with other 
transcription factors, coactivators and corepressors, the transcription of target 
genes (for review see (Itoh et al., 2000; Miyazono, 2000).  
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Interfering with BMP-signaling by astrocyte-specific deletion of BMPRIα or full 
knockout of BMPR1β followed by spinal cord injury, leads to opposing effects 
on astrogliosis (Sahni et al., 2010). Whereas loss of BMPRIα is attended by a 
less tight glial scar and reduced GFAP levels accompanied by increased 
inflammatory infiltration and lower functional recovery, GFAP-levels were 
elevated in BMPR1β KOs leading to reduced lesion areas shortly after injury 
(Sahni et al., 2010). Interestingly, astrocytes do not only upregulate BMPs, but 
also the BMP inhibitor noggin after cortical stab wound and spinal cord injury 
(Hampton et al., 2007). Infusion of a noggin-blocking antibody directly after 
injury leads to an increase of GFAP-positive cells and also the number of BrdU-
incorporating GFAP cells is increased. The authors, however, suggest that this 
is due to an upregulation of GFAP in anyway proliferating astrocytes rather than 
an increase in astrocyte proliferation as total numbers of BrdU-positive cells are 
not elevated (Hampton et al., 2007).  
Partial deletion of TGF-β signaling by the use of Smad3 null mice results in a 
reduction in GFAP-positive cells, as well as microglia and NG2-positive cells 
after cortical stab wound injury (Y. Wang et al., 2007). Surprisingly, the authors 
could not detect any proliferating astrocytes in wildtype and in Smad3 KO mice. 
This is in sharp contrast to many other studies describing a proliferative 
response after astrocytes after brain injury (for review see Costa et al., 2010; 
Buffo et al., 2008). However, the reduction in the inflammatory response in 
Smad3 null brains leads to a reduced wound cavity size 3 and 7 days after 
injury (Y. Wang et al., 2007). This is in contrast to the above mentioned study, 
where higher GFAP levels are indicative for smaller lesion areas, whereas lower 
GFAP levels lead to an increase in infiltration or activation of microglia and 
more damage (Sahni et al., 2010). This controversial outcome may be due to 
regional differences of the astrocytic reaction to injury, as one study is 
performed in spinal cord and the other one in the cerebral cortex. 
So far, it is not fully clear whether TGF-β/ BMP-signaling is involved in 
upregulation of GFAP in already existing astrocytes or whether it is involved in 
defining the fate of newly generated cells after brain injury in vivo. 
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Figure 2-7 Triggers and molecular regulators of reactive gliosis 
A huge variety of factors trigger astrogliosis by activation of molecular pathways that are 
numerous as well (taken from Sofroniew and Vinters). 
 
Interaction of signaling cascades  
Above three major pathways regulating different aspects of astrogliosis, namely 
proliferation, upregulation of GFAP and hypertrophy, and acquisition of an 
astrocytic cell fate, have been discussed. These pathways are mainly activated 
by growth factors and cytokines. Given the multitude of cytokines and growth 
factors, which are released after injury and the various effects and pathways 
that are initiated by these factors, the level of astrogliosis may be regulated by 
the interplay of multiple factors. Thus, one factor is able to activate several 
pathways and there is a cross-talk between different pathways, which regulates 
and fine tunes the biological response. For example, IL-6-type cytokines are not 
capable to promote astrocyte proliferation alone, but enhance EGF-stimulated 
astrocyte proliferation suggesting an interaction of the EGF-R/ MAPK and JAK/ 
STAT pathway (Kahn et al., 1995; Levison et al., 2000). Also P2 purinergic 
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receptors seem to signal via the MAPK pathway to STAT3 in astrocytes. Both, 
P2Y and P2X receptors can stimulate STAT3 phosphorylation not directly, but 
via the interaction with the ERK/ MAPK pathway. Activation of P2Y and P2X 
receptors can stimulate Tyrosin-705 STAT3 phosphorylation, whereas only P2Y 
mediates additional Serin-727 STAT3 phosphorylation. As described above, 
purinergic signaling via P2 receptors activates ERK signaling. If this pathway 
was inhibited by U0126, a potent and selective inhibitor of MEK1, the upstream 
activator of ERK, phosphorylation of Ser727-STAT3 was blocked. Thus, specific 
phosphorylation of STAT3 at Ser727 is a possible mechanism of cross-talk 
between ERK/ MAPK and the STAT pathway (Washburn and Neary, 2006). 
Interestingly, extracellular ATP acting via P2Y receptors has been shown to 
synergistically enhance the ability of FGF2, a mitogen upregulated after injury, 
to induce proliferative effects, whereas P2X receptors inhibit the ability of FGF2 
to stimulate DNA synthesis in rat cortical astrocyte cultures (Neary et al., 1994; 
Neary and Kang, 2005). One difference between these two pathways may be 
the different phosphorylation state of STAT3. Furthermore, P2 receptors can 
couple to extracellular signal-regulated protein kinases (ERK) and blocking ERK 
signaling is preventing Serin-727 STAT3 phosphorylation showing that signaling 
pathways modulating astrogliosis are strongly interconnected (Figure 2-7 and 
(Washburn and Neary, 2006). One well established function of STAT3 upon 
activation is to bind to the GFAP promoter and enhance transcription. 
Interestingly, the GFAP promoter contains non-overlapping binding sites for 
STAT3 and Smad1 with the co-factor p300 bridging between the both, thus 
providing a mechanism for the synergistic effect of the JAK/ STAT and BMP/ 
Smad signaling pathway (for review see Kessaris et al., 2008). 
 
Interpretation of these studies 
These were only few examples showing the complexity of signaling pathways 
and their interaction after brain injury, which is only partially understood. For the 
most part, these data were achieved in vitro through biochemical and immuno-
cytochemical analysis of postnatal astrocyte cultures treated with different 
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cytokines or growth factors and agonists or antagonists of different pathways. 
Whether this indeed resembles the reaction of adult and mature astrocytes is 
disputable, as culturing astrocytes from the adult brain has so far not been 
successful. Thus, in vivo studies of genetic mouse models are preferable. 
However, to investigate the role of a certain gene mostly full knockout mice 
were used. In these models a gene of interest is deleted from the genome and 
protein expression is therefore missing throughout ontogenesis in all cell types 
and tissues. This makes the study of widely expressed genes, e.g. genes 
encoding cytokines, growth factor and their receptors, difficult or even 
impossible, if gene deletion is fatal at early developmental stages. Furthermore, 
astrogliosis is a common secondary effect due to developmental abnormalities 
or impairment of other neural cell types. Accordingly, analysis of GFAP-
expression and microglia activation alone may be misleading and does not 
cover the entire range of the gliotic reaction, especially as the functional 
outcome in terms of wound healing or locomotor recovery cannot be predicted 
from these parameters and can even be opposed dependent on the injury 
paradigm (see above). 
To circumvent some of these problems, in this study I took advantage of the 
Cre/ loxP system allowing cell type specific gene deletion. This is achieved by 
genetically manipulating the sequence of a certain gene by inserting loxP sites 
in non-coding regions of the gene (floxed allele). LoxP sites are recognition 
sequences for the Cre recombinase that is a cyclization recombination protein 
of the P1 bacteriophage, normally not encoded in the mammalian genome. 
However, Cre can be expressed in transgenic or knock-in mouse lines under 
the control of cell type-specific promoters. In order to delete genes containing 
loxP sites, mice containing floxed alleles were mated to lines encoding the Cre-
recombinase under a specific promoter (Figure 2-8 A), e.g. hGFAP-Cre or 
Nex::Cre with the former expressing Cre in radial glia with an onset at E13.5 
(Zhuo et al., 2001) and the latter expressing Cre in neurons from E11.5 
(Goebbels et al., 2006). After translation in the cytoplasm, the Cre-recombinase 
shuttles to the nucleus, where it recognizes and cuts the sequence in between 
two loxP sites from the genome (Figure 2-8 B). Thus gene deletion occurs from 
30   Introduction  2 
the time point of promoter expression. To be able to delete a gene in astrocytes 
at a chosen time point, I took advantage of the Glast::CreERT2 mouse line 
(Mori et al., 2006). In this line the Cre recombinase is under control of the 
astrocyte specific Glast promoter and the Cre recombinase is fused to a 
modified estrogen receptor that allows translocation to the nucleus only upon 
administration of the estrogen analogue Tamoxifen (Figure 2-8 C). Thus, gene 
deletion takes place in specific cell types at a given time point and does not 
interfere with general development. 
 
Figure 2-8 The Cre/ loxP systems allows cell type specific gene deletion 
Mice expressing Cre under a specific promoter were mated to mice containing floxed 
alleles (A). In the offspring gene deletion occurs in cell types expressing this promoter 
by recombination of the sequence in between loxP sites (B). To be able to specify the 
time point of recombination, the Cre recombinase was fused to a modified estrogen 
receptor allowing translocation to the nucleus only upon administration of Tamoxifen (C) 
(A and B taken from http://de.wikipedia.org/wiki/Cre/loxP-System and C modified from 
Mori et al., 2006). 
 Table 2-3 Pathways mediating certain components of reactive gliosis 
pathway IMF 
 
hypertrophy proliferation ECM microglia references 
purinergic 
signaling 
P2Y 
P2X7 
P2Y 
P2X7 
P2Y not 
investigated 
P2Y 
P2X7 
(Franke et al., 2001; Neary and Kang, 2005; Bianco et al., 
2006; Peng et al., 2009) 
cytokines IL-6, IL6-R, 
CNTF, 
TNF-α, IL-
1α, IL-1β, 
IL-1R1 
Epo, IFN-β 
IL-6, IL6-R, 
CNTF, TNF-
α 
VEGF 
no effect (IL-
6, IL6-R, 
CNTF, TNF-
α) 
IFN-β 
no effect 
(IL1-R1) 
Epo 
IL-6, IL6-R, 
CNTF, TNF-α, 
IL-1α, IL-1β, IL-
1R1 
(Fattori et al., 1995; Kahn et al., 1995; Di Santo et al., 1996; 
Kordek et al., 1996; Kahn et al., 1997; Klein et al., 1997; 
Herx and Yong, 2001; Okada et al., 2004; Lin et al., 2006; 
Krum et al., 2008; Vitellaro-Zuccarello et al., 2008; Ito et al., 
2009) 
EGF-R EGF-R, 
EGF, TGF-
α 
TGF-α EGF-R, EGF, 
TGF-α 
EGF-R, EGF, 
TGF-α, TGF-
β1 
no effect (Nieto-Sampedro et al., 1988; Weickert and Blum, 1995; 
Rabchevsky et al., 1998; Levison et al., 2000; Liu and 
Neufeld, 2004; G. M. Smith and Strunz, 2005; Liu et al., 
2006; Sharif et al., 2006; Liu and Neufeld, 2007; White et 
al., 2008) 
MAPK/ 
ERK 
ET-1 
INF-β 
ET-1 ET-1  
INF-β 
not 
investigated 
not investigated  (Baba, 1998; Peters et al., 2003; Rogers et al., 2003; 
Gadea et al., 2008; Ito et al., 2009) 
BMP/ 
Smad 
BMP-2/4, 
7, Smad3, 
BMPRIα 
BMPRIβ 
no effect (Smad3?) Smad3 Smad3 (Sahni et al., ; Hampton et al., 2007; Y. Wang et al., 2007; 
Sabo et al., 2009) 
Rheb/ 
mTOR 
Pten Pten Pten not 
investigated 
not investigated (Fraser et al., 2004; Codeluppi et al., 2009) 
JAK/ STAT CNTF 
STAT3 
Socs3 
CNTF 
STAT3 
Socs3 
FGF not 
investigated 
CNTF 
STAT3 
Socs3 
(Neary et al., 1994; Neary and Kang, 2005; Okada et al., 
2006; Herrmann et al., 2008) 

 2.4 Polarity cues as candidates for defining astrocytic 
properties 
One still unresolved question is which mechanisms drive parenchymal 
astrocytes towards a quiescent, non-proliferative state, whereas a subset of 
astroglial-like cells in the subependymal zone preserves its ability to self-renew. 
Along these lines it is highly debated whether cell intrinsic or environmental 
factors play a major role in keeping the stemness of some astrocytes in defined 
regions. After injury, environmental factors trigger signaling pathways known 
from development in parenchymal astrocytes, which consequently lead to 
expression of more immature marker in reactive astrocytes that are 
characteristic as well for adult NSCs (Table 2-1). Strikingly, some of these 
astrocytes at the injury site even re-enter the cell cycle and regain stem cell 
properties, self-renewal and multipotency in vitro. Given the fact that after acute 
brain trauma, as well as in neurodegenerative diseases massive neuronal loss 
occurs, the idea of an intrinsic source of cells able to generate new neurons is 
intriguing. However, in vivo the proliferating astrocytes stay within their lineage 
and do not reprogram towards a neuronal cell fate or with a very low efficiency 
even after forced expression of transcription factors promoting neurogenesis 
(Buffo et al., 2005). On the contrary, astrocytes contribute to the generation of a 
very tight glial scar and an inhospitable environment not only for newly 
generated neurons, but also for axonal regeneration of neurons from 
surrounding regions. Identifying molecular pathways differentiating between the 
beneficial and detrimental role of astrocytes after brain insult is thus of great 
value. While many studies examined the role of growth factors and cytokines 
after injury, virtually nothing is known about the role of cell polarity for astrocyte 
function in the normal and injured brain. Cell polarity is involved in processes 
such as cell division, cell migration and signaling and is defined as asymmetry 
in cell shape, protein distributions or cell functions (Nelson, 2003). A hallmark of 
mature astrocytes in the adult brain is the contact of their endfeet to the 
basement membrane surrounding blood vessels, which they share with stem 
cell astrocytes and which are characterized by a polarized protein distribution 
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towards this endfeet. The astrocyte-BM contact is mediated by integrins and 
dystroglycan, both of them acting as receptors for various ECM molecules 
including laminin. Stem cell astrocytes are further polarized and possess - 
similar to radial glia cells during development - not only a basal membrane 
domain (Figure 2-9 A and B), but also an apical membrane domain delineated 
by their junctions to the ependymal cells (Figure 2-9 B). At this site, proteins of 
the Par complex, such as Par6, the atypical protein kinase and the small 
RhoGTPase Cdc42 are localized. Interestingly, also astrocytes in an in vitro 
injury model develop a rather bipolar shape and localize the Par complex to the 
tip of their leading process (Etienne-Manneville and Hall, 2001, 2003; Etienne-
Manneville et al., 2005). After injury in vivo, a subpopulation of the astrocytes at 
the injury site re-enters the cell cycle dedifferentiating to a more immature state 
possibly in between a multipotent stem-cell astrocyte and a mature astrocytic 
cell. Polarity molecules from the basal or apical site are possible candidates 
mediating changes in the potential of different astrocyte subtypes. Therefore, I 
examined the here both sets of molecules, integrins at the basal site of 
astrocytes and Cdc42, a major regulator of the Par complex activity. 
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Figure 2-9 Polarity of radial glia and adult neural stem cells 
Radial glia (A, blue) and adult neural stem cells (B, blue) have both contact to the 
basement membrane (red) at the pial or blood vessel (BV) surface. At the ventricular 
surface they possess an apical membrane domain (green). In the adult brain ependymal 
cells (E) are lining the ventricle and neural stem cells extend their process through the 
ependyma layer (B) (drawing provided by Magdalena Götz). 
 
2.4.1 The astrocytic basal site is major part of the 
neurovascular unit 
A hallmark of parenchymal astrocytes is their contact to the BM surrounding the 
vasculature, which is thoroughly covered by astrocyte endfeet. Therefore, 
astrocytes can be understood as mediators between neurons and the 
vasculature as they are capable of regulating the local blood flow in response to 
energy demands of the neurons. To fulfill this function an asymmetric 
intracellular organization of astrocytes is required. A functional neurovascular 
unit consists of neurons with their associated astrocytes, which interact with 
endothelial and smooth muscle cells on the microvessels (Figure 2-10 and 
Abbott et al., 2006). 
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Figure 2-10 The neurovascular unit is characterized by the interplay of astrocytes, 
endothelial cells and neurons 
Endothelial cells are responsible to reduce the paracellular flux of substances to the 
brain by forming tight junctions. The endothelial cells are surrounded by a basement 
membrane and astrocytic perivascular endfeet with the entire complex and embedded 
pericytes forming the blood-brain barrier (b). Astrocytes provide a link between the 
vasculature and neurons ensuring brain energy and transmitter metabolism through a 
specialized transporter system (for endothelial part of transporter system see a)  (taken 
from (Abbott et al., 2006). 
 
The vascular supply of the brain is provided by four large arteries, the carotid 
and vertebral arteries, which merge to form the circle of Willis at the base of the 
brain. The arteries which arise from the circle of Willis run along the brain 
surface giving rise to pial arteries. These arteries branch into smaller vessels 
penetrating the brain parenchyma and are separated from the brain tissue by an 
extension of the subarachnoidal space, which is called Virchow-Robin space 
(Iadecola and Nedergaard, 2007). The Virchow-Robin space includes 
leptomeningeal cells, macrophages and other antigen-presenting cells and is 
bordered by two basement membranes on one side towards the endothelial 
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compartment and on the other side towards the glia limitans (Figure 2-11). The 
inner basement membrane is formed by endothelial cells and pericytes, 
whereas the outer basement membrane is generated by astrocytes. Around 
smaller vessels the outer vascular membrane fuses with the membrane of the 
glia limitans (fused gliovascular membrane) thereby excluding the Virchow-
Robin space (Krueger and Bechmann). Basement membranes are thin, 
specialized extracellular matrices surrounding most metazoan tissues. One 
function of BMs is to provide structural support for cells, to separate tissue 
compartments and form a barrier, for example against T cell invasion into the 
brain parenchyma (Sixt et al., 2001). Furthermore they are high capacity 
binders of growth factors and other ECM molecules and the individual ECM 
composition provides distinct spatial and molecular information influencing cell 
migration, proliferation, differentiation and survival. Neural BMs are composed 
mainly of laminin, type IV collagen, nidogen, and the heperan sulfate 
proteglycan perlecan. Different isoforms of these components expressed in 
temporal and spatial different patterns define structurally and functionally 
distinct basement membranes (for review see Hallmann et al., 2005). Thus, it is 
possible to differentiate between the inner endothelial and the outer astrocytic 
BM around larger vessels on the basis of their laminin isoforms. The endothelial 
BM contains laminin 8 composed of the laminin chains α4, β1, and γ1 and 
laminin 10 (α5β1γ1), whereas the parenchymal BM generated by astrocytes 
contains laminin 1 (α1β1γ1) and 2 (α2β1γ1) (Sixt et al., 2001). The BM around 
microvessels consists of laminin 2, 8 and 10 and hence combines both, 
astrocytic derived and endothelial derived BM (Figure 2-11 and Sixt et al., 
2001). 
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Figure 2-11 Epithelial and astrocytic basement membranes contain distinct laminin 
isoforms 
Larger blood vessels consist of an inner endothelial cell layer with basement membrane 
(containing the laminin subunits α4 and α5), bordered by the meningeal epithelium and 
its basement membrane (containing the laminin subunit α1), and an outer astroglial 
basement membrane (containing the laminin subunit α2) and astrocyte endfeet. The 
meningeal and astroglial basement membranes are collectively termed the parenchymal 
basement membranes as they delineate the border to the brain parenchyma. Only at sites 
of local inflammation are the endothelial and parenchymal basement membranes clearly 
distinguishable and define the inner and outer limits of the perivascular space where 
leukocytes accumulate before infiltrating the brain parenchyma. Microvessels where no 
epithelial meningeal contribution occurs appear to have a composite basement 
membrane containing the endothelial cell laminins (α4 and α5), and laminin subunit α2 
produced by the astrocytes and deposited at their endfeet (taken from Sixt et al., 2001). 
 
At the contact points of astrocyte endfeet with the BM, parenchymal astrocytes 
possess a highly specialized membrane domain characterized by enrichment of 
proteins of the dystrophin associated glycoprotein complex (DAG), the water 
channel Aquaporin4 (Aqp4), and the potassium channel Kir4.1 (Figure 2-12 and 
for review see Wolburg et al., 2009a; Wolburg et al., 2009b) displaying a special 
kind of basal polarity in mature astrocytes. The DAG links the BM with the 
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astrocytic cytoskeleton and is furthermore needed for localization of Aqp4 and 
Kir4.1 at the astrocyte endfeet (Figure 2-12 and Bragg et al., 2006). 
 
Figure 2-12 The dystrophin-associated glycoprotein complex at the blood-brain interface 
The illustration displays the interaction of proteins of the dystrophin-associated 
glycoprotein complex (DAG) in astrocyte endfeet, which is necessary to properly localize 
the water channel Aquaporin4 (Aqp4). In endothelial cells the DAG is composed slightly 
different excluding the proteins α-Syntrophin, α-Dystrobrevin-2 and Dystrophin (taken 
from Bragg et al., 2006). 
 
Interestingly, this polarity has been reported to be interconnected with BBB 
integrity (Wolburg et al., 2009b). The BBB is a biological barrier between blood 
and brain tissue located within the epithelium and formed by tight junctions 
between endothelial cells that restrict the paracellular flux protecting the brain 
tissue from neurotoxic substances that circulate in the blood (Figure 2-10). 
Furthermore, it consists of a specialized transporter system that ensures the 
brain energy and transmitter metabolism (for review see Wolburg et al., 2009a). 
The tightness of this barrier depends not only on endothelial cells, but also on 
the surrounding BM and the cells in close proximity to the endothelium including 
pericytes and astrocytes. Pericytes do not only provide physical support for 
endothelial cells; together with astrocytes they also secrete soluble factors, 
such as Angiopoietin-1, TGF-β, and Src-suppressed C kinase substrate protein 
that regulate the expression of tight junction proteins like occludin (for review 
see Lee et al., 2009). Astrocytes have been implicated in the formation of the 
BBB during development and in BBB maintenance in the adult brain. During 
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development angiogenesis precedes barriergenesis in the brain and this 
process is tightly regulated by the complex coordination of various extracellular 
factors, e.g. VEGF, TGF-β and Angiopoietin. Until now it is not fully understand 
whether astrocytes, pericytes or both secret these factors and a dialogue 
between several cell populations of the neurovascular unit and possible 
compensatory mechanisms have been suggested (for review see Krueger and 
Bechmann, 2010; Lee et al., 2009). In addition, most of these results have been 
obtained in vitro in co-culture models of endothelial cells and astrocytes and/or 
pericytes and in vivo evidence is still lacking. Interestingly, development of the 
BBB and maturation of astrocytes as defined by the basal polarization of 
astrocytes, seem to be closely correlated during development (Nico et al., 
2001). Also after brain injury a correlation between BBB disruptions, loss of 
polarized protein distribution towards the endfeet and astrocytic reactivity could 
be observed (Dobbertin et al., 2003; Wolburg-Buchholz et al., 2009), although 
the causality is not yet clear. It is well known that reactive astrocytes also 
contribute to remodeling of the ECM by upregulation of ECM molecules 
including the glycoprotein Tenascin C and the chondroitin proteoglycan 
phosphacan/ DSD-1 (Laywell et al., 1992; Garwood et al., 2001; Joester and 
Faissner, 2001; Sirko et al., 2007). Interestingly, these molecules are also 
expressed in high amounts during development and in adult neurogenic niches 
and degrading CSPGs in vivo by injecting the enzyme chondroitinase ABC 
interferes with progenitor proliferation (Sirko et al., 2007). However, the 
signaling at the gliovascular interface and from the ECM/ BM has not been 
addressed in regard to its influence on parenchymal astrocytes so far; 
especially relatively little is known about the precise effects of signals from the 
BM to glial cells in regard to CNS pathology. ECM-mediated signaling is clearly 
of major importance in wound reactions in other systems like skin or kidney 
(Brakebusch et al., 2000; Kagami and Kondo, 2004; Tran et al., 2004), but 
ECM-glia signals have so far been difficult to study in the CNS in vivo. 
Therefore, I aimed here to examine the effects of β1-integrin deletion in 
astrocytes in vivo, as integrins are receptors for various ECM molecules.  
 
2.4  Polarity cues as candidates for defining astrocytic properties  41 
Integrins are basement membrane receptors 
Indeed, a possible role of ECM-mediated signaling to astrocytes is particularly 
relevant as astrocyte endfeet of parenchymal astrocytes as well as stem cell 
astrocytes in the neurogenic niches are in close contact to the basement 
membrane (BM) surrounding blood vessels in the intact, uninjured brain 
(Brightman, 1968; Brightman and Kaya, 2000; Sixt et al., 2001; Bragg et al., 
2006). This contact is obviously interrupted after invasive injury, such as a 
trauma or stab wound injury, but it is not known to which extent the possible 
loss of BM-contact may contribute to the changes seen in reactive gliosis. The 
major receptors for BM proteins are members of the integrin family and 
dystroglycan (Figure 2-13), which is a central component of the DGC (del 
Zoppo and Milner, 2006). Interestingly, conditional deletion of dystroglycan 
resulted in GFAP upregulation, suggesting a possible role of signaling via this 
complex in astroglia activation (Moore et al., 2002). However, dystroglycan was 
already lost at early developmental stages in these conditional knock-out mice, 
resulting in defects in neuronal migration and midline fusion as well as severe 
disruptions of the glia limitans (Moore et al., 2002), suggesting that either 
developmental aberrations or abnormal cell contacts to the subarachnoidal 
space may be involved in this phenotype. As the DGC has been implicated in 
targeting the water channel Aqp4 and the inward-directed potassium channel 
Kir4.1 to astroglial endfeet (Sievers et al., 1994b, a; Bragg et al., 2006). These 
channels are redistributed after injury and may contribute to the glial reactivity, 
in particular the astrocyte swelling (Iandiev et al., 2006; Nesic et al., 2006; 
Ulbricht et al., 2008). Taken together, these data raise the possibility that 
alterations in BM-astrocyte signaling may play a crucial role in the reaction to 
brain injury.  
In order to better understand the role of ECM-mediated signaling to astrocytes, I 
focused here on the role of the β1-integrin subunit that is part of most integrin 
receptors in the CNS (Takada et al., 2007). Integrins are transmembrane 
receptors, which link the ECM to the intracellular actin cytoskeleton. They form 
heterodimers consisting of an α and a β subunit. Depending on their subunit 
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composition, they bind different ligands in the ECM and perform distinct 
functions (Reichardt and Tomaselli, 1991; Brakebusch and Fassler, 2005; 
Takada et al., 2007). Conditional deletion of β1-integrin containing heterodimers 
during brain development led to defects in axonal guidance and 
synaptogenesis, as well as in glial differentiation and cell migration (Reichardt 
and Tomaselli, 1991; Graus-Porta et al., 2001; Blaess et al., 2004; Belvindrah et 
al., 2006; Huang et al., 2006; Belvindrah et al., 2007a). However, virtually 
nothing is known about the role of β1-integrins after later deletion in the 
postnatal brain.  
 
 
Figure 2-13 The laminin receptors integrin, dystroglycan and Lutheran blood group 
glycoprotein 
Three major transmembrane receptor types are responsible for cell binding to laminins: 
the integrins (principally β1- and β3-integrins), α-dystroglycan of the dystrophin-
glycoprotein complex (DGC), and the Lutheran blood group glycoprotein with the latter 
not expressed in astrocytes (taken from Hallmann et al., 2005). 
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2.4.2  Small RhoGTPases at the apical side and after injury 
The small RhoGTPases Rac1, RhoA and Cdc42 are downstream effectors of 
integrins (Schwartz and Shattil, 2000), as these molecules control signal 
transduction pathways linking membrane receptors to the cytoskeleton and 
thereby influencing cell polarity, morphological plasticity, cell migration and cell 
fate decisions (for review see Hall, 2005). The activity of RhoGTPases is 
regulated by signals from different classes of surface receptors like G protein 
coupled receptors, tyrosine kinase receptors, cytokine receptors, and adhesion 
receptors such as integrins. RhoGTPases function as tightly regulated 
molecular switches cycling between an inactive GDP-bound state and an active 
GTP-bound state (Figure 2-14) (Heasman and Ridley, 2008). 
 
 
Figure 2-14 Regulation of small RhoGTPases by GAPs, GEFs and GDIs 
Guanine nucleotide-exchange factors (GEFs) activate RhoGTPases by promoting the 
release of GDP and the binding of GTP. GTPase-activating proteins (GAPs) inactivate 
RhoGTPases by increasing the intrinsic GTPase activity of Rho proteins. Guanine 
nucleotide-dissociation inhibitors (GDIs) bind to C-terminal phenyl groups on some Rho 
proteins, sequestering them in the cytoplasm away from their regulators and targets 
(modified from Heasman and Ridley, 2008). 
 
The small G-proteins, Cdc42, Rac and Rho, seem to mediate the initial signals 
leading to the polarization of migrating cells. The balance of activities of the 
three RhoGTPases must be tightly controlled between the front and the rear of 
the cell. A simplistic view is that Cdc42 and Rac are gradually activated toward 
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the front edge where they control actin and microtubule re-arrangements to 
promote protrusive activity, whereas Rho is rather active at the rear of the cells 
where, by inducing actomyosin contractility, it controls rear-end retraction and 
allows forward movement (for review see Etienne-Manneville, 2008). 
Besides acting downstream of β1-integrins, Cdc42 functions also with the Par 
complex (PAR6-PAR3-aPKC) that has been proposed to mediate the capture 
and stabilization of microtubules at the front of the cell and to orientate golgi and 
microtubule organizing center (MTOC) during the establishment of migratory 
polarity in astrocytes and other cell types (Etienne-Manneville and Hall, 2003; 
Pegtel et al., 2007).  
Small RhoGTPases have been implicated in establishment of this astrocyte 
polarity in vitro by the use of dominant negative or constitutively active 
constructs (Etienne-Manneville and Hall, 2001; Cau and Hall, 2005). However, 
often these constructs are directed against guanine exchange factors (GEFs) or 
guanine nucleotide dissociation inhibitors (GIDs), which are known to be not 
specific for a single RhoGTPase but rather act on several members of the 
family. To overcome this limitation and to examine the specific role of certain 
small RhoGTPases, but particularly to investigate their role on astrocyte polarity 
and migration in vivo, I took advantage of transgenic mice carrying Cre-
recombinase recognition sequences (loxP sites) within the genes for the small 
RhoGTPases Cdc42, Rac1 or RhoA allowing deletion of these genes in 
astrocytes in vitro and in vivo. 
Whereas mechanisms controlling cell migration in vitro are relatively well 
understood in some experimental models (Lauffenburger and Horwitz, 1996; 
Ridley et al., 2003; Puklin-Faucher and Sheetz, 2009), less is known about the 
mechanisms and molecules promoting the motility of individual cells in vivo, for 
example after brain injury. Although it is widely assumed that astrocytes migrate 
after CNS injury and, indeed, they do so in in-vitro assays, that has not been 
shown in vivo so far.  
Besides its effect on cytoskeletal rearrangements and migration, Cdc42 has 
been implicated in cell fate determination following cell division by regulating 
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cell polarity in different cell types (Cappello et al., 2006; Chen et al., 2006; X. 
Wu et al., 2006; Yang et al., 2007). For instance, genetic deletion of Cdc42 from 
radial glia cells during development interferes with proper recruitment of the Par 
complex and localization of adherens junctions at the apical site of VZ stem 
cells causing a failure in stem cell self-renewal and premature neurogenic 
differentiation (Cappello et al., 2006). Accordingly, downregulation of Par3 using 
siRNA leads to premature cell-cycle exit and neurogenic differentiation, 
whereas overexpression of Par3 or Par6 promoted the generation of self-
renewing progenitors (Costa et al., 2008). The influence of Cdc42 on adult 
astroglia-like stem cells has not been investigated so far. 
 
 3 Aims of this study 
Main objective of this thesis is to unravel the role of two major polarity signaling 
molecules in astrocytes in the healthy and injured brain. Conditional deletion of 
β1-integrin and the small RhoGTPase Cdc42 aim to identify the function of 
these pathways in astrocytes. The consequences of early postnatal deletion of 
β1-integrin in the progeny of radial glia cells will be analyzed in regard to 
morphology, marker expression, and proliferation of gray matter astrocytes in 
vivo in the intact adult brain and after stab wound injury. The impact of β1-
integrins on stem cell astrocytes will be investigated with respect to proliferation 
and self-renewing capacity in the same genetic mouse model. Cell type specific 
deletion of Cdc42 in the adult brain allows exploring the functions of this 
molecule on parenchymal astrocytes and astroglia-like stem cells. Proliferation 
of adult NSCs and parenchymal astrocytes after stab wound injury will be also 
investigated in this model. Moreover, in vitro and in vivo analysis of cell polarity 
after injury will be conducted and the influence of Cdc42 on wound healing after 
injury will be examined by determining the lesion size in mice deficient for 
Cdc42. 
 
 4 Abbreviations 
aPKC  atypical protein kinase C 
APS  Ammonium persulfate 
Aqp4  Aquaporin-4 
ATF-1  Activating transcription factor-1 
BBB  Blood-brain barrier 
BDNF  Brain-derived neurotrophic factor 
bHLH  basic helix-loop-helix 
BLBP  Brain lipid-binding protein 
BM  Basement membrane 
BMP  Bone morphogenic protein 
BMPR Bone morphogenic protein receptor 
Bp  Base pairs 
BrdU  5-bromo-2-desoxy-uridine 
CB  Citrate buffer 
cDNA  complementary DNA 
CL  Contralateral 
CNS  Central nervous system 
CNTF  Ciliary neurotrophic factor 
Cre  Cyclization recombination protein of the P1 bacteriophage 
CREB  cAMP response element binding (protein) 
CsCl  Cesium chloride 
CSPG  Chondroitin sulfate proteoglycan 
CSPG-2 Versican 
CTX  Cortex 
Da  Dalton 
DAG  Dystrophin associated glycoprotein complex 
DAPI  4, 6-damindino-2-phenyl-indol 
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Dcx  Doublecortin 
DIV  Days in vitro 
DNA  Desoxyribonucleic acid 
DPL  Days post lesion 
dNTP  Deoxynucleotidetriphosphate 
E  Embryonic day 
EAE  Experimental autoimmune encephalomyelinitis 
ECM  Extracellular matrix 
EDTA  Ethylendiamine tetraacetate 
EGF  Epidermal growth factor 
EGF-R Epidermal growth factor receptor 
ERK  Extracellular signal-regulated kinase 
Epo  Erythropoietin 
ET  Endothelin 
ET-1  Endothelin-1 
ET(A/ B)R Endothelin (A/ B) receptor 
EtBr  Ethidium bromide 
EtOH  Ethanol 
FACS  Fluorescent activated cell sorting 
FBS  Fetal bovine serum 
FCS  Fetal calf serum 
(b)FGF (basic) FGF 
Fig.  Figure 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 
GDNF  Glial cell-line derived neurotrophic factor 
GEF  Guanine exchange factor 
GFAP  glial fibrillary acidic protein 
(e)GFP (enhanced) GFP 
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GID  Guanine nucleotide dissociation inhibitors 
GLAST Glutamate-aspartate transporter 
GLT-1 Glutamate transporter-1 
GM  Gray matter 
GPCR G-protein coupled receptor 
GS  Glutamine synthetase 
HBSS  Hank’s buffered salt solution 
Hepes 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
hGFAP human glial fibrillary acidic protein 
HPI  Hours after injury 
HRP  Horse radish peroxidase 
IFN  Interferon 
Ig  Immunglobulin 
IGF-1  Insuline growth factor-1 
IL  Interleucin 
IMF  Intermediate filaments 
IP  Intraperitoneal 
(n/ o) IPC (neurogenic/ oligodendrogenic) Intermediate progenitor cell 
IRES  Internal ribosomal entry site 
JAK  Janus kinase 
JNK  c-Jun N-terminal kinase 
kDa  Kilo Dalton 
KO   Knockout 
LIF  Leucemia inhibitory factor 
loxP  originally: locus of crossing-over on P1 bacteriophage DNA 
  recognition sequence for Cre recombinase 
LTR  Long terminal repeat 
LV  Lateral ventricle 
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MA  Mantle 
MAG  Myelin associated glycoprotein 
MAPK Mitogen-activated protein kinase 
MAP2K Mitogen-activated protein kinase kinase 
MAP3K Mitogen-activated protein kinase kinase kinase 
MBP  Myelin basic protein 
MEK  Mitogen-activated ERK regulating kinase 
mGFAP mouse glial fibrillary acidic protein 
MMP  Metalloproteinases 
mRNA messenger ribonucleic acid 
MTOC Microtubule organization center 
mTOR mammalian target of rapamycin 
n  number of samples 
NE  Neuroepithelium 
NeuN  Neuronal nuclei 
NF  Neurofilament 
NGF  Nerve growth factor 
Ngn  Neurogenin 
NGS  Normal goat serum 
NO  Nitric oxide 
NSC(s) Neural stem cell(s) 
Nt  Nucleotides 
NT-3  Neurotrophin-3 
Nu  Nucleosides 
OB  Olfactory bulb 
ON  Overnight 
OPC  Oligodendrocyte precursor cell 
P  Postnatal day 
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p  p-value – observed significance level 
PBS  Phosphate buffered saline 
PCR  Polymerase chain reaction 
PDGF  Platelet-derived growth factor 
PLO  poly-L-ornithine 
PFA  Paraformaldehyde 
PTEN  Phosphatase and tensin homolog 
RFP  Red fluorescent protein 
RG  Radial glia 
RMS  Rostral migratory stream 
RNA  Ribonucleic acid 
ROS  Reactive oxygen species 
Rpm  Rounds per minute 
RT  Room temperature 
SD  Standard deviation 
SDS  Sodium dodecylsulfate 
SDS-PAGE SDS-polyacrylamid gel electrophoresis 
SEM  Standard error of the mean 
SEZ  Subependymal zone 
SGZ  Subgranular zone 
Shh  Sonic hedgehog 
Smad  Signaling mother against decapentaplegic peptide 
Socs3 Suppressor of cytokine signaling 3 
STAT  Signal transducer and activator of transcription 
SVZ  Subventricular zone 
TAP  Transit-amplifying precursor 
Taq  DNA polymerase of bacterium Thermus aquaticus 
TBS  Tris buffered saline 
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TEMED N, N, N’, N’-tetramethylethylenediamine 
TF  Transcription factor 
TN-C  Tenascin-C 
TGF  Transforming growth factor 
TNF  Tumor necrosis factor 
TSA  Tyramide signal amplification 
Tx  Tamoxifen 
TX  TritonX 
UTR  Untranslated region 
VEGF  Vascular endothelial growth factor 
VZ  Ventricular zone 
WM  White matter 
WT  Wildtype
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5.1.1 Equipment 
description company 
Binocular MZ6 Leica 
Cell culture incubator Binder 
Centrifuge 5430 Eppendorf 
Centrifuge 5810R Eppendorf 
Centrifuge Mikro22R Hettich 
Centrifuge Rotofix32  (cell culture) Hettich 
Centrifuge Sorvall Evolution RC Thermo Fisher 
Centrifuge (table centrifuge) neolab 
Centrifuge Optima™ LE-80K (Ultracentrifuge) Beckman Coulter 
Cold-light source KL1500LCD Leica 
Cryostate CM 3050 Leica 
Dounce tissue grinder (1 ml) Wheaton 
Freezer Privileg, Liebherr 
Geldoc™ XR BIO-RAD 
Laminar flow Bdk 
Magnetic stirrer IKAMAG® RCT Bachofer 
Microscope Axiovert 40CFL with fluolamp 
HXP120 (Kübler) and camera A640 (Canon) 
Zeiss 
Microscope SPE (confocal microscope) Leica 
Microscope SP5 (confocal microscope) Leica 
Microscope LSM700 (confocal microscope) Zeiss 
Microscope Fluo Olympus BX61 (fluorescence 
microscope) 
Olympus 
Microscope Observer.Z1 (timelapse 
microscope) 
Zeiss 
Microwave Privileg 
Odyssey Scanner LI-COR 
Perfusion pump Gilson 
pH meter WTW 
Picopump PV 820 connected to Jun-Air 
compressor (Condor) 
WPI 
 
Pipette grinder EG-44 Narishige 
Power supply Power Pac 200 BIO-RAD 
Power supply ST606 Gibco BRL 
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description company 
Pulse/delay generator PDG 204 Scientific Instruments 
Refrigerators Privileg, Liebherr 
Scale Scaltec 
Scale analytic (precision scale) Sartorius 
Semi-Dry Transfer Cell Trans-Blot® SD BIO-RAD 
Shaker IKA-Vibrax-VXR electronic 
Shaker RM5 (rotary shaker) Assistant 
Shaker Duomax 1030 Heidolph 
Shaker Vortemp56EVC Uniequip 
Spectral photometer Prim advanced Secoman 
Stereotactic apparatus Stoelting 
Thermocycler 3000  Biometra 
Thermomixer comfort  Eppendorf 
Ultrasonic bath 2510 Branson 
Ultrathorax Sonopuls Bandelin 
Vertical pipette puller 720 David Kopf Instruments 
Vibratome VT1000S Leica 
Vortex IKA MS 3  Basic 
Vortex-Genie Bender & Hobein AG 
Water bath (cell culture) Memmert 
Table 5-1 Equipment 
 
5.2 Consumables 
description company 
Augen- und Nasensalbe Bepanthen 
BC assay reagent A Uptima 
BC assay reagent B Uptima 
Cell culture flask with filter lid Cellstar® (T25, 
T75, T175), PS red 
greiner bio-one 
Drill  Foredom 
  
filaments (Vicryl, 4-0, SH-1 plus, 21.8 mm ½c, 
70 cm) 
Ethicon 
filter/strainer 70 µm BD Transduction Laboratory 
gloves (latex) Diana Baronin von Schaezler 
gloves Nitra-Tex® (nitrile) Ansell 
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description company 
insulin needles, U-100, 1 ml BD Micro Fine 
(PZN: 324870) 
Kwik-Fil Borosilicate glass 
capillaries 
WPI 
(1B150F-4) 
Millex HV low protein binding PVDF, 0.45 µm 
syringe filters, yellow rim, 33 mm diameter 
(SLHV033RS) for viral supernatants 
Millipore 
OptiSeal tube (11.2 ml) Beckmann 
Parafilm PM-996 Parafilm 
pipette tips  
Phase Lock Heavy 50 ml tube  
Reaction tube( 0.5 ml, 1.5 ml, 2 ml) Plastibrand 
Reaction tube (15 ml, 50 ml) greiner 
Serological pipettes (5 ml, 10 ml, 25 ml) Sarstedt 
Steritop filter (250 ml, 500 ml) Millipore 
Sugi Kettenbach GmbH 
(REF 31603) 
Syringes 30 ml Sarstedt 
V-Lance™ Knife, 19 Gauge Alcon® Surgical (8065 911901) 
Table 5-2 Consumables 
 
5.3 Chemicals 
Chemical  M in g/mol company 
catalogue 
number 
Acetone C3H6O 58.08 Roth 9372.4 
Acetic acid glacial C2H4O2 60.05 Roth 3738.4 
Acetic anhydride (CH3CO)2O 102.09 Sigma 32,010-2 
Agarose    Serva 11404 
Ammonium 
bicarbonate 
NH4HCO3 79.06 Roth A-6141 
Ammonium chloride NH4Cl 53.49 Sigma A-9434 
Ammonium nitrate NH4NO3 80.04 Sigma 256064-25g 
Ammonium 
peroxidisulfate 
(NH4)2S2O8 228.28 Roth 9592.3 
Brilliant blue R C45H44N3O7S2Na 826 Sigma B-7920 
Bromophenol blue C19H9Br4O5SNa 691.9 Sigma B-8026 
5-Bromo-2′-Deoxy-
Uridine 
BrdU 307.1 Sigma B5002-5g 
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Chemical  M in g/mol company 
catalogue 
number 
Calcium chloride 
dihydrate 
CaCl2 x 2H2O 147.0 Sigma C-7902 
Cesium chloride CsCl 168.36 Roth 8627.2 
Chloral hydrate C2H3Cl3O2 165.4 Sigma C-8383 
4′,6-diamidino-2-
phenylindole, dilactate 
(DAPI) 
 457.5 Invitrogen D-3571 
Corn oil   Sigma C-8267 
Diethyl ether (C2H5)2O 74.12 Merck K37257821 
729 
Dimethylarsinic acid 
sodium salt trihydrate 
C2H6AsNaO2 x 
3H2O 
 
214.05 Merck 8.20670.0100 
Ethanol C2H6O 46.07 Roth 9065.4 
70% Ethanol C2H6O 46.07 Roth T913.3 
Ethanolamine C2H7NO 61.08 Sigma E0135-100ML 
Ethylene glycol HOCH2CH2OH 62.07  Sigma 10,246-6 
Ethylene glycol-bis-
N,N,N’,N‘, Tetraacetic 
acid (EGTA) 
C14H20N2O10Na4 468.3 Sigma E-8145 
Ethylenediamine-
tetraacetic acid 
(EDTA) 
C10H14N2O8Na2 x 
2H2O 
372.2 Sigma E-5134 
Formaldehyde CH2O 30.03 Roth 4979.1 
Formamide CH3NO 45.04 Roth 6749.1 
D(+)-Glucose-
Monohydrat 
C6H12O6 x H2O 198.17 Merck 1.08342.1000 
Glutaraldehyde 25% 
solution in water 
C5H8O2  Serva 23115 
Glycerol C3H8O3 92.09 Sigma G6279-1L 
Glycine C2H5NO2 75.07 Sigma G8790-1KG 
HEPES C8H18N2O4S 238.31 Sigma H3375-1KG 
Hydochloric acid HCl 36.46 Merck 1-13386.2500 
Igepal CA-630 (C2H4O)n x C14H22O  Sigma I3021-50ML 
Isoamyl alcohol C5H12O 88.15 Sigma I-9392 
10% Ketamin   cp-pharma  
Lead(II)nitrate Pb(NO3)2  Sigma 22,862-1 
Magnesium sulphate 
heptahydrate 
MgSO4 x 7H2O 246.5 Sigma M-1880 
Magnesium sulphate MgSO4  x 6H2O 203.3 Merck 1.05833.0250 
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Chemical  M in g/mol company 
catalogue 
number 
hexahydrate 
2-Mercaptoethanol C2H6OS 78.13 Sigma M7522-100ML 
0,9% NaCl solution NaCl  Braun  
Osmium tetroxide 
solution, 4 % 
OsO4 254,23 Sigma 75632 
Paraformaldehyde   Sigma P6148 
2-Propanol C3H8O 60.1 Roth 6752.5 
Polyethylene glycol 
6000 
HO (C2H4O)nH  Merck 12033.0100 
Polyvinyl alcohol 4-88   Fluka 81381 
Potassium acetate C2H3KO2 98.15 Roth T874.2 
Potassium chloride KCl 74.56 Sigma P-9541 
Potassium dihydrogen 
phosphate 
KH2PO4 136.09 Merck 1.04873.1000 
Potassium phosphate K2HPO4 174.2 Sigma P-3786-500G 
Potassium hydroxide KOH 56.11 Sigma P-5958 
Potassium 
permanganate 
KmnO4 158.04 Fluka 60459 
Potassium phosphate KH2PO4 136.1 Sigma P-0662 
Putrescine 
dihydrochloride 
C4H12N2 x 2H2O 161.1 Sigma P-5780 
Pyridine C5H5N 79.1 Sigma 49,441-0 
Saccharose  C12H22O11 342.3 Merck 1.07651.1000 
Silver nitrate AgNO3 169.88 Sigma 20,913-9 
Sodium acetate 
trihydrate 
C2H3NaO2 x 3H2O 136.08 Roth 6779.1 
Sodium cacodylate 
trihydrate 
C2H6AsNaO2 x 
3H2O 
214.0 Sigma C0250-100G 
Sodium bicarbonate NaHCO3 84.01 Sigma S-5761 
Sodium carbonate Cna2O3 105.99 Fluka 71345 
Sodium chloride NaCl 58.44 Sigma S-3014 
Sodium citrate 
dehydrate 
 C6H5Na3O7 x 2H2O 294.1 Sigma S-4641 
Sodium dodecyl 
sulphate 
C12H25O4SNa 288.4 Sigma L-4509 
di-Sodium hydrogen 
phosphate dihydrate 
Na2HPO4 x 2H2O 177.99 Merck 1.06580.1000 
Sodium hydroxide NaOH 40 Fluka 71690 
Sodium hydroxide 
pellets 
NaOH 40 Sigma S-5881 
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Chemical  M in g/mol company 
catalogue 
number 
Sodium nitrite NNaO2 69.0 Fluka 71759 
Sodium phosphate NaH2PO4 x H2O 138 Sigma S-9638 
Sodium 
pyrophosphate 
decahydrate 
Na4P2O7 x 10H2O 446.1 Sigma S-6422 
di-Sodium tetraborate Na2B4O7 201.22 Merck 1.06306.0250 
Sodium thiosulfate Na2S2O3 158.11 Sigma S7026-250G 
Sudan black B C29H24N6 456.54 Sigma 19,966-4 
5-Sulfosalicylic acid 
dihydrate 
C7H6O6S x 2H2O 254.22 Roth 4119.1 
Tamoxifen C26H29NO 371.52 Sigma T-5648 
TO-PRO-3   Invitrogen T-3605 
Triethanolamine 
Hydrochloride 
C6H15NO3 x HCl 185.7 Sigma T-1502 
Triton X-100 (C2H4O)n x C14H22O  Sigma X100-1L 
Trizma base C4H11NO3 121.14 Sigma T-1503-1KG 
Urea CH4N2O 60.06 Roth 2317.1 
2% 
Xylazinhydrochlorid 
  Bayer  
Xylene cyanole C25H27N2O6S2Na2 538.6 Sigma X-4126 
Table 5-3 Chemicals 
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5.4 Plasmids  
For packaging of viral vectors by 293T cells for lentiviral production the following 
plasmids were used: 
pCMV∆R8.9 packaging vector (2nd generation; Naldini L., Trono D.): expressing 
HIV structural proteins, HIV reverse transcriptase, and the HIV transactivator 
TAT. 
Lentiviral expression plasmid (Pfeifer et al., 2001): containing the insert of 
interest under an internal promoter, a self-inactivating 3’LTR and retroviral 
regulatory sequences for efficient processing of viral genomic RNA and proviral 
DNA. 
pVSVG envelope vector: expressing a pseudotyping viral envelope 
glycoprotein, here vesicular stomatitis virus glycoprotein under the CMV 
promoter. 
 
5.5 Solutions and Media 
5.5.1 DNA preparation and genotyping PCR 
Lysis buffer 
1 M    NaCl 
1 M    Tris/HCl pH 8.5 
10 %    SDS 
0.5 M    EDTA 
10 mg/ ml   Proteinase K 
in H2Odd  
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10 mM Tris buffer to solve DNA 
1.211g   Tris base 
ad 1000 ml H2Odd, pH 8.0 
 
10 x PCR buffer (A) 
500 mM   KCl 
100 mM   Tris/ HCl  
pH 8.7 
 
10 x PCR buffer (B) 
500 mM  KCl 
100 mM   Tris base 
150 mM  (NH4)2SO4 
15 mM  MgCl2 x 6 H2O 
 
dNTP mix 
2.5 mM each  dATP, dTTP, dGTP, dCTP 
in H2Odd  
 
50 x TAE 
242 g    Tris 
32.2 g   Na2EDTA 
57.1 mg   acetic acid (100 %) 
 ad 1000 ml H2Odd , pH 8.0  
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4 x DNA loading buffer 
20 ml    100% Glycerin 
1 ml    50 x TAE 
200 μl   Bromophenol blue  
500 μl   Xylene cyanol solution 
ad 50 ml H2Odd  
 
5.5.2 tissue preparation 
Tamoxifen 
40 mg/ ml   Tamoxifen 
10 %    Ethanol 
in corn oil 
to solve shake at 37 °C 3-4 h  
 
BrdU – drinking water 
1 mg/ ml   5-Bromo-2-desoxyuridin 
10 mg/ ml   Saccharose 
in Aqua 
 
20 % Paraformaldehyd (PFA) stock 
 67 g    Na2HPO4 x 2 H2O in 800 ml H2Odd  
heat to 60 °C 
200 g    PFA 
ca. 10 ml   NaOH 
filtrate by the use of paper filters 
ad 2 l H2Odd, pH 7.4  
freeze 50ml aliquots at -20 °C 
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2 % Paraformaldehyd 
50ml    PFA 20 % 
ad 500 ml H2Odd 
 
4% Paraformaldehyd 
100ml   PFA 20 % 
ad 500 ml H2Odd 
 
Phosphate buffer 0.25M, pH 7.2-7.4 
0.025 N   HCl 
1 M    NaOH 
0.85 M  NaH2PO4 
 
30 % Saccharose solution for cryoprotection 
15 g    Saccharose 
ad 50 ml 1 x PBS 
 
Storing solution for floating sections 
4 M    Glycerol 
5.4 M    Ethylenglycol 
25 mM   phosphate buffer, pH 7.2 - 7.4 
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5.5.3 Immuno-histochemistry/ cytochemistry 
10 x phosphate buffered saline (PBS) (1,5 M) 
1.5 M    NaCl 
0.03 M   KCl 
0.080 M   Na2HPO4 x 2 H2O 
0.010 M   KH2PO4 pH 7.5 
in H2Odd , pH 7.4 
 
blocking/ dilution buffer (sections) 
0.5 %    TritonX100 
10 %    goat or donkey serum 
in 1 x PBS  
 
blocking/ dilution buffer (cells) 
0.1 %    TritonX100 
10 %    goat or donkey serum 
in 1 x PBS  
 
4′,6-Diamidino-2-phenylindol (DAPI) stock 
10.9 mM   DAPI, dilactate in H2Odd  
 
Sodium citrate buffer 0,1 M 
29.41 g   sodium citrate 
ad 1000 ml H2Odd, pH 6.0  
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TO-PRO-3 Iodide stock 
1 mM in DMSO 
 
5.5.4 Western blot 
Lysis buffer (total lysates) 
50 mM   Tris-HCl, pH 7.4 
0.15 M   NaCl 
1%    TritonX 100 
10%    Glycerin 
5 mM    EDTA 
Protease inhibitors: 4.2 µM leupeptin, 100 nM aprotinin, 5.8 µM pepstatin, 1.7 
mM pefabloc 
 
4x loading dye 
2 ml   1M Tris HCl pH 8.5 
8 ml    20 % SDS 
5 ml    Glycerin 
1.6 ml   β-Mercaptoethanol 
3.4 ml   H2Odd 
50 mg   Bromphenol blue 
 
5.5.5 Electron microscopy 
Cacodylat solution 
0.2 M    Cacodylate 
21.4 g   Dimethylarsinic acid sodium salt trihydrate 
0.22 g   CaCl dehydrate  
ad 500 ml H2Odd, pH 7.2 
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Karnovski fixative 
2.5 %   Glutaraldehyde 
2 %    PFA 
0.1 %    Cacodylate solution 
in H2Odd 
 
Postfix and storing solution 
4 %    PFA 
2.5 %   Sucrose 
in H2Odd 
 
Washing solution 
0.1 %    Cacodylate 
2 %    Sucrose 
in H2Odd 
 
Osmication 
2 %   Osmium 
0.002 %   CaCl 
2%   Sucrose 
in 0.2% Cacodylate buffer 
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5.5.6 Cell culture media and supplements  
description company catalog number 
B27 Gibco 17504-044 
basic fibroblast growth factor (FGF) Gibco 13256029 
Bovine serum albumin (BSA) Sigma A4503 
D-Glucose 45% Sigma G8769 
Dulbecco’s Modified Eagle Medium 
(DMEM) + GlutaMAX™ low glucose for 
astrocytes 
Gibco 21885 
DMEM + GlutaMAX™ high glucose Gibco 61965 
DMEM + GlutaMAX™ high glucose, 
25mM Hepes 
Gibco 32430 
DMEM/ F12 + GlutaMAX™ for 
neurospheres 
Gibco 31331 
DMEM/ F12 Gibco 21331 
Earle’s Balanced Salt Solution (EBSS) Life Technologies 24010-043 
Fetal bovine serum Gibco 10106169 
Geneticin (G418) Invivogen ant-gn-1 
Hank’s Balanced Salt  Solution (HBSS) Gibco 24020 
Hepes 1M Gibco 15630 
human epidermal growth factor (EGF) Gibco 13247051 
Hyaluronidase Sigma H3884 
L-Glutamine 200mM Gibco 25030 
Lipofectamine Invitrogen 11668-019 
Neurobasal A Gibco 10888022 
OPTI-MEM® + GlutaMAX™ Gibco 51985 
Penicillin/Streptomycin 100x Gibco 15070063 
poly-L-ornithine Sigma P4957 
Sucrose Sigma S1888 
Trypsin/EDTA 0.05% Gibco 25300054 
Trypsin Sigma T4665 
Table 5-4 Cell culture reagents 
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Astrocyte medium  
DMEM, GlutaMAX™, low glucose (1 g/ L) 
10 %   Fetal bovine serum 
10   mM Hepes 
1x   Penicillin/ Streptamycin 
Filter through 0.2 µm 500 ml Steritop filter to remove particles  
Aliquote into 50 ml reaction tubes 
 
Solution 1 (HBSS-Glucose) 
50 ml   HBSS  
9 ml   D-Glucose 
7.5 ml  Hepes (1 M) 
ad 500 ml H2Odd, pH 7.5  
 
Solution 2 (Sucrose-HBSS) 
25 ml   HBSS 
154 g   Sucrose 
475 ml  H2Odd, pH 7.5  
 
Solution 3 (BSA-EBSS-Hepes) 
20 g   BSA 
10 ml   Hepes 
490 ml  EBSS, pH 7.5 
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Neurosphere medium 
48 ml   DMEM/ F12 + GlutaMAX™ 
1 ml   B27 
8 mM   Hepes 
100 units/ ml Penicillin/Streptomycin  
10 µg/ ml  EGF 
10 µg/ ml  FGF 
 
Neurosphere differentiation medium 
48 ml   Neurobasal A  
500 µl  Glutamate 
500 µl  Penicillin/Streptomycin 
1 ml   B27 
 
Dissociation medium 
10 ml   Solution 1 
13,3 mg  Trypsin (Sigma) 
7 mg   Hyaluronidase 
 
Stock medium for propagation of 293T cells 
DMEM high glucose, GlutaMAX™, Hepes 
10 %   FCS 
500 µg/ ml  Geneticin (G418) 
 
Transfection medium (lentivirus production) 
Opti-MEM, GlutaMAX™ 
(10%   FCS) 
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Packaging medium (lentivirus production) 
DMEM high glucose, GlutaMAX™, Hepes 
10%   FCS 
No G418 or any other antibiotic! 
 
TBS-5 buffer for viral vector re-suspension 
5 ml  1 M Tris-HCl, pH 7.8 (final concentration: 50 mM) 
2.6 ml  5 M NaCl (130 mM) 
1 ml   1 M KCl (10mM) 
0.5 ml  1 M MgCl2 (5 mM) 
ad 100 ml tissue culture grade water 
storage at 4 °C 
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6 Methods 
6.1 Animals 
All animal procedures were performed in accordance with the policies of the use 
of Animals and Humans in Neuroscience Research, revised and approved by 
the Society of Neuroscience and the state of Bavaria under licence number 
55.2-1-54-2531-23/04 and 55.2-1-54-2531-144/07. 
 
6.1.1 Mouse strains 
129/Sv-β1-integrin, carrying floxed alleles of β1-integrin (Potocnik et al., 2000) 
C57Bl/6//129/Sv-β1-integrin, carrying loxP sites flanking exon2 of the β1-
integrin gene (unpublished) 
C57Bl/6//129/Sv-β1-integrin null, carrying one β1-integrin knockout allele 
(Fassler and Meyer, 1995) 
C57Bl/6J//129/Sv-Cdc42, carrying floxed alleles of Cdc42 (X. Wu et al., 2006) 
C57Bl/6J//129/Sv-Rac1, carrying floxed alleles of Rac1 (Chrostek et al., 2006) 
C57Bl/6J//129/Sv-RhoA, carrying floxed alleles of RhoA (unpublished) 
C57Bl/6J-Dystroglycan, carrying floxed alleles of Dystroglycan (Moore et al., 
2002) 
C57Bl/6//129/Sv-GFAP null, carrying a deletion of the GFAP gene (Pekny et al., 
1995) 
C57Bl/6//129/Sv-vimentin null, carrying a null mutation of the vimentin gene 
(Colucci-Guyon et al., 1994) 
hGFAP-Cre, expressing Cre recombinase from the human GFAP promoter 
(Zhuo et al., 2001) 
hGFAP-eGFP, expressing enhanced GFP under the human GFAP promoter 
(Nolte et al., 2001) 
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Nex::Cre, expressing Cre recombinase in the Nex locus (Goebbels et al., 2006) 
GLAST::CreERT2, expressing a Cre recombinase estrogen receptor fusion 
protein in the GLAST locus (Mori et al., 2006) 
Z/EG reporter mouse line, expressing enhanced green fluorescent protein 
(EGFP) behind a Stop cassette flanked by loxP sites (Novak et al., 2000) 
CAG-CAT-EGFP reporter mouse line, expressing the CMV-ß-actin promoter  
and the loxP flanked chloramphenicol acetyl-transferase (CAT) gene upstream 
of the EGFP cassette (Nakamura et al., 2006) 
 
The β1-integrin floxed and full knockout lines were kindly provided by Dr. R. 
Fässler, MPI for Biochemistry, Martinsried, the lines C57Bl/6J//129/Sv-Cdc42, 
C57Bl/6J//129/Sv-Rac1 and C57Bl/6J//129/Sv-RhoA by Dr. C. Brakebusch, 
University of Copenhagen, the C57Bl/6J-Dystroglycan mice by Dr. K. Campbell, 
Howard Hughes Medical Institute, the hGFAP-Cre line by Dr. R. Klein, MPI for 
Neurobiology, Martinsried, the Nex::Cre line by Dr. S. Göbbels, MPI for 
Experimental Medicine, Göttingen, and the GFAP Vimentin full KO line by Dr. 
Milos Pekny, University of Gothenburg, Gothenburg.  
 
6.1.2 Genotyping of transgenic animals 
Genotyping by polymerase chain reaction (PCR) was performed on genomic 
DNA extracted from mouse tails.  
To identify and genotype individual animals, ears were clipped with numbered 
tags and tail biopsies of less than 5 mm length were taken. The tails were 
transferred to 1.5 ml reaction tubes and incubated in 0.5 ml lysis buffer (see 
solutions) at 55°C in a shaker at 100 rpm until the tails were dissolved (at least 
2h). After lysis hairs and tissue residues were re-moved by centrifugation at 
14,000 rpm for approximately 5 minutes. The supernatant was transferred to a 
new 1.5 ml tube and DNA was precipitated by adding 0.5 ml Isopropanol, 
followed by another centrifugation step (14,000 rpm, 10 minutes). The 
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supernatant was removed from the pellet and tubes were dried upside down for 
30 minutes at room temperature until the DNA was completely dry. The dry 
DNA was dissolved in 200 μl 10 mM Tris Buffer pH 8, followed by 30 minutes 
shaking at 55°C. 
The DNA was kept at 4°C until polymerase chain reactions (PCRs) were run. 
PCR reactions using the DNA primers listed in table 5 were pipetted on ice 
according to table 6 and cycled as described in table 7. 
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Table 6-1 Primer sequences for genotyping of transgenic animals 
line primer sequence 
β1-integrin  5’-AGG TGC CCT TCC CTC TAG A-3’  
5’-GTG AAG TAG GTG AAA GGT AAC-3’ 
β1 full KO 5’-AGG TGC CCT TCC CTC TAG A-3’ 
5’-TAA AAA GAC AGA ATA AAA CGC AC-3’ 
Cdc42 
5’-TTG TAA TGT AGT GTC TGT CCA TTG G-3’ 
5’-TGT CCT CTG CCA TCT ACA CAT ACA C-3’ 
Rac1 
5’-GTC TTG AGT TAC ATC TCT GG-3’  
5’-CTG ACG CCA ACA ACT ATG C-3’  
RhoA 
5’-AGC CAG CCT CTT GAC CGA TTT A-3’  
5’-TGT GGG ATA CCG TTT GAG CAT-3’  
5’-ATG TCA AAG AGG AAA TAC TGC-3’  
Dystroglycan 
5’-GGA GAG GAT CAA TCA TGG-3’ 
5’-CAA CTG CTG CAT CTC TAC-3’ 
GFAP full KO 
5’-TGT TCT CCT CTT CCT CAT CTC C-3’ 
5’-ATT GTC TGT TGT GCC CAG TC-3’ 
5’-GTC CAG CCG CAG CCG CAG-3’ 
5’-CTC CGA GAC GGT GGT CAG G-3’ 
Vimentin full KO 
5’-AGC TGC TCG AGC TCA GCC AGC-3’ (vas) 
5’-TGT CCT CGT CCT CCT ACC GC-3’ (vs) 
5’-CTG TTC GCC AGG CTC AAG GC-3’ (ns) 
hGFAP-Cre  
5’-ACT CCT TCA TAA AGC CCT CG-3’ 
5’-ATC ACT CGT TGC ATC GAC CG-3’ 
Nex::Cre 
5’-CCG CAT AAC CAG TGA AAC AG-3’  
5’-AGA ATG TGG AGT AGG CTG AC-3’  
5’-GAG TCC TGG AAT CAG TCT TTT TC-3’  
GLAST::CreERT2  
5’-GAG GCA CTT GGC TAG GCT CTG AGG A-3’  
5’-GAG GAG ATC CTG ACC GAT CAG TTG G-3’  
5’-GGT GTA CGG TCA GTA AAT TGG ACA T-3’  
Z/EG and hGFAP-eGFP 
5’-TTC ACC TTG ATG CCG TTC T-3’  
5’-GCC GCT ACC CCG ACC AC-3’  
CAG-CAT-EGFP 
5’-CTG CTA ACC ATG TTC ATG CC-3’  
5’-GGT ACA TTG AGC AAC TGA CTG-3’  
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Table 6-2 PCR reactions 
line 
10x 
buffer 
MgCl 
(25mM) primers dNTPs Taq 
Q-
solution DNA H2O 
β1-integrin  3 µl (A) 3 µl 1.5 µl each 0.6 µl 1 µl  1 µl 18,4 µl 
β1 full KO 3 µl (B)  1.2 µl each 0.6 µl 1 µl 6 µl 1 µl 16 µl 
Cdc42 2.5 µl (B)  1 µl each 0.5 µl 0.5 µl  2 µl 17.5 µl 
Rac1 2 (B)  1 µl each 0.5 µl 0.5 µl  2 µl 13 µl 
RhoA 2 µl (B)  0.2 µl each 0.4 µl 1 µl  2 µl 14.2 µl 
Dystroglycan 2.5 µl (B)  0.5 µl each 0.5 µl 1 µl  1 µl 19.5 µl 
GFAP full KO 2.5 µl (B)  0.75 µl each 0.5 µl 0.5 µl 
0.25 µl 
10% 
Tween20 
1 µl 17.3 µl 
Vimentin full KO 2.5 µl (A) 2.6 µl 
1µl (ns, vs) 
3 µl (vas) 
0.5 µl 0.5 µl  2 µl 11.9 µl 
hGFAP-Cre  3 µl (A) 3 µl 1 µl each 0.6 µl 1 µl 6 µl 1 µl 13.5 µl 
Nex::Cre 2 µl (NEB)  0.5 µl each 0.5 µl 
0.2 µl 
(NEB)  1 µl 14.8 µl 
GLAST::CreERT
2 2.5 µl (A) 2.5 µl 1 µl each 0.5 µl 1 µl 5 µl 1 µl 9.5 µl 
Z/EG .5 µl (A) 0.5 µl 1 µl each 0.5 µl  4 µl 1 µl 14 µl 
CAG-CAT-EGFP 2.5 µl 1.5 µl 1 µl each 0.5 µl 0.5 µl 5 µl 1 µl 12 µl 
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Table 6-3 Cycling conditions 
line annealing temperature 
annealing 
time 
elongation 
time cycles fragment size 
β1-integrin  55°C 30 sec 30 sec 35 wt: 350bp 
fl: 500bp 
β1 full KO 63°C 
53°C 
30 sec 
30 sec 
30 sec 
30 sec 
10 
35 
null allele:  
210 bp 
Cdc42 53°C 30 sec 45 sec 35 
wt: 200 bp 
fl: 300 bp 
Rac1 
63°C 
53°C 
30 sec 
30 sec 
30 sec 
30 sec 
10 
35 
wt: 200bp 
fl: 280bp 
RhoA 55°C 30 sec 30sec 35 
wt: 297 bp 
fl: 393 bp 
Dystroglycan 55°C 60 sec 60 sec 36 
wt: 509 bp 
fl: 615 bp 
GFAP full KO 
65°C 
65°C 
30 sec 
30 sec 
30 sec 
20 sec 
5 
35 
wt: 350 bp 
KO: 140 bp 
Vimentin full KO 65°C 60 sec 60 sec 35 
wt: 396 bp 
KO: 533 bp 
hGFAP-Cre  60°C 60 sec 60 sec 30 tg: 200 bp 
Nex::Cre 53°C 30 sec 60 sec 40 
wt: 770 bp 
tg: 520 bp 
GLAST::CreERT2  55°C 20 sec 30 sec 35 
wt: 700 bp 
tg: 400 bp 
Z/EG 59°C 30 sec 20 sec 30 tg: 400 bp 
CAG-CAT-EGFP 55°C 30 sec 60 sec 30 sec tg: 350 bp 
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6.1.3 Tamoxifen administration 
Mice older than 2 months received tamoxifen (250 µl; 10 mg) orally three times: 
once a day every second day for five days or by injection twice a day for five 
consecutive days (100µl; 1mg per injection). Neonatal pups gathered 
Tamoxifen via the milk of their mothers. Mothers received 12 mg tamoxifen 
orally once. 
 
6.1.4 Stereotactic operations 
Microsurgery for stab wound injuries and/or viral injections into different regions 
of the adult murine brain were performed according to the following protocol. 
 
Anesthesia 
Mice were deeply anaesthetized with around 100 μl up to 180 μl (depending on 
the body weight) using the following mix: 1.0 ml Ketamin 10 %, (injected at 
approximately 100 mg/kg), 0.25 ml 2% Xylazin Hydrochloride (injected at 5 
mg/kg body weight) and 2.5 ml 0.9 % NaCl solution. For injection of the 
anesthesia insulin needles were the most suitable device because of their very 
short and thin cannula. After injection mice were checked for fading pain 
reactions, i.e. pinching the tail or toes, and reflexes. If reflexes persisted 
additional 20 – 50 μl anesthetics were injected. 
 
Injection 
Mice were fixed in the stereotactic apparatus and eyes were kept wet using 
Bepanthen Augen- und Nasensalbe. The fur on top of the head was disinfected 
with 70 % EtOH and a small midline incision was performed. The skull was 
dried with a Sugi and bregma was searched by pressing gently on the skull with 
forceps. The digital display of the stereotactic apparatus was set to zero after an 
empty glass capillary was set onto bregma and a very small dot with a pen was 
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put on the skull under the glass capillary to find the zero point for the following 
injections easier. The capillary was set to the coordinates and a dot was put on 
the skull at the position of the coordinates. A drill was used to open the skull 
cautiously at the position of the dots so that the meninges stayed intact. 
Coordinates were re-checked, using again the empty glass capillary. A new 
capillary was inserted containing now viral suspension and set again onto 
bregma. The digital display was adjusted to zero again and 0.5 – 1 μl viral 
suspension was injected at the coordinates very slowly (5 – 10 min) using an air 
system. A pulse generator gave a pulse every 5 or 10 seconds and pulses were 
given at the lowest possible pressure and pulse length. After finishing the 
injection the capillary was retracted 2 minutes up to 5 minutes. The skin 
covering the skull was sewed by filaments with 3 stitches. For recovery from 
anesthesia mice were put in an airing cupboard at 37°C and checked every 5 – 
10 minutes. 
 
Stab wound injury 
Mice were fixed in the stereotactic apparatus and prepared as described above. 
For stab wound injuries a V-lance knife, instead of a glass capillary was inserted 
into the stereotactic apparatus. After trepanation a 1.5 mm long/ 0.6 mm deep 
cut was positioned usually in the right sensorimotor cortex avoiding large 
meningeal vessels to circumvent extensive bleeding.  
 
6.1.5 BrdU labeling 
For labeling dividing cells the DNA base analogue 5-Bromo-2′-deoxy-Uridine 
(BrdU) was injected Intraperitoneal (50 mg/kg body weight) one to two hours 
before perfusion to label fast proliferating cells (short pulse). BrdU was 
dissolved at a concentration of 5 mg/ml in sterile 0.9 % NaCl solution. Complete 
solution of BrdU could only be reached by shaking the solution for 2 hours at 37 
°C. Aliquots were stored at -20 °C. For marking slow and fast dividing cells 
BrdU was given into the drinking water at a concentration of 1 mg/ml (1 % 
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sucrose was added for better acceptance) and stirred for at least 1 hour at room 
temperature. 50 ml of BrdU-water was sufficient for 2 - 3 mice per cage for 2 - 3 
days and was exchanged two times per week. BrdU drinking water containing 
sucrose was stored in the fridge up to one week.  
 
6.2 Histology 
Adult animals were deeply anaesthetized by intraperitoneal injection of Ketamin/ 
Xylacine and, as soon as respiratory depression began, transcardially perfused 
with phosphate buffered saline (PBS) followed by 2 % or 4 % paraformaldehyde 
(PFA) in PBS (100 ml/ animal). Brains were post-fixed in the same fixative for at 
least 2 hours to maximal overnight at 4 °C and either cryoprotected in 30 % 
sucrose for cutting 30 µm floating sections at the cryostat (chamber 
temperature: 4 °C; temperature of object head: -35 °C for freezing the brain, -10 
°C for cutting) or stored in PBS for later embedding in 4 % agarose and cutting 
60 µm vibratome sections. Sections were kept in storing solution at -20 °C. 
 
6.2.1 Immunohistochemistry 
For immuno-labeling sections were incubated over night at 4 °C in a solution 
containing the first antibody, 0.5 % Triton 100 (TX) and 10 % normal goat serum 
(NGS). 
Distinct pre-treatments were used to increase the specificity of different 
antibodies: 
Citrate-buffer pre-treatment (CB) 
Sections were boiled 20-60 minutes in 0.01 M sodium citrate (pH6) at 95 °C. 
HCl-pre-treatment (HCl) 
Sections were incubated in 2 N HCl for 30 minutes and afterwards 2 times for 
15 minutes in 0.1 M Sodium-tetraborate (pH 8.5). 
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Signal amplification by Thyramid-Kit (TK) 
Secondary antibody incubation was preceded by 30 minutes of incubation in 0.3 
% H2O2 in PBS and the secondary, biotinylated antibody was detected with the 
Thyramid detection kit (Perkin Elmar Life Science). 
Secondary antibodies were applied in conditions according to the first antibody 
and incubated for 1-3 hours at room-temperature. Nuclei were visualized by 
staining with either 4.6-damindino-2-phenylindol (DAPI, 1:1000) or TO-PRO 3 
Iodide (1:10000) in the secondary antibody solution. Specimens were mounted 
with Aqua Poly-Mount and analyzed using confocal or light microscopy.  
Table 6-4 First antibodies immunohistochemistry 
recognized antigen host-animal/ Ig subtype 
pre-treatment  
incubation 
conditions* 
company 
Aquaporin4 rabbit 1:200, CB 
citrate-buffer treatment
Millipore  
(AB2218) 
Aquaporin4 rabbit 1:800 
no pre-treatment
Sigma 
(A5971) 
CollagenIV rabbit 1:100, CB 
citrate-buffer treatment
Millipore 
(AB756P) 
BrdU rat IgG2a 1:200, HCl or CB 
citrate-buffer treatment
Biozol/AbDSeroTec 
(OBT0030) 
GLT-1  guinea pig 1:100 or 1:500 (TK) Millipore 
(AB1783) 
Glutamine-
Synthetase 
mouse IgG2a 1:200 BD Bioscience  
(610517) 
Isolectin B4 (GSA) lectin-biotinyliert 1:50 
blocking not with NGS
Sigma 
(L2140) 
β-Dystroglycan mouse IgG2a 1:200, CB 
citrate-buffer treatment
A. Menarini  
(NCL-b-DG) 
Fibronectin rabbit 1:40, CB 
citrate-buffer treatment
Millipore 
(AB2047) 
GFAP mouse IgG1 1:1000 Sigma 
(G3898) 
GFAP rabbit 1:500 Dako/Invitrogen 
(Z0334) 
GFP mouse IgG1 1:1000 Millipore  
(MAB3580) 
GFP rabbit 1:1000 Invitrogen 
(A6455) 
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recognized antigen host-animal/ Ig subtype 
pre-treatment  
incubation 
conditions* 
company 
GFP chick 1:1000 Aves Lab 
(GFP-1020) 
Laminin rat 1:1000, CB 
No PFA perfusion!
Millipore  
(MAB1904) 
NeuN mouse IgG1 1:100 Millipore 
(MAB377) 
Neurofilament-70 mouse IgG1 1:100 Millipore 
(MAB1615) 
γ-tubulin mouse IgG1 1:100 Sigma  
(T5326) 
S100 rabbit 1:100 Sigma 
(S2644) 
S100β mouse IgG1 1:500 Sigma 
(S2532) 
Vimentin goat 1:20 amplification with 
biotinylated secondary 
AB 
Millipore  
AB(1620) 
* if different from general descriptions 
Table 6-5 Secondary antibodies immunohistochemistry 
antibody host species label dilutions company 
α-guinea pig goat Cy3 1:500 Dianova 
(106166003) 
α-chick goat Alexa488 1:500 Invitrogen 
(A11039) 
α-chick donkey FITC 1:200 Dianova 
(703095155) 
α-rat donkey Alexa488 1:500 Invitrogen 
(A21208) 
Alexa594 1:500 Invitrogen 
(A21209) 
goat Cy3 1:500 Dianova 
(112165167) 
rabbit biotinylated 1:200 Vector 
(BA-4001) 
α-rabbit donkey Alexa488 1:500 Invitrogen 
(A21206) 
Cy3 1:500 Dianova 
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antibody host species label dilutions company 
(711165152) 
Alexa594 1:500 Invitrogen  
(A21207) 
goat Cy3 1:500 Dianova 
(111165144) 
biotinylated 1:200 Vector 
(BA-1000) 
α-mouse IgG1 goat Alexa488 1:500 Invitrogen 
(A21121) 
Alexa594 1:500 Invitrogen 
(A21125) 
biotinylated 1:200 South.B. 
(1070-08) 
α-mouse IgG2a goat Alexa488 1:500 Invitrogen 
(A-21131) 
Alexa594 1:500 Invitrogen 
(A-21135) 
α-mouse IgG3 goat Alexa488 1:500 Invitrogen 
(MG320) 
α-mouse IgG goat Alexa488 1:500 Invitrogen 
(A11029) 
Cy3 1:500 Dianova  
(115165166) 
Cy5 1:500 Dianova 
(115176072 
donkey Alexa594 1:500 Invitrogen 
(A-21203) 
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6.3 Western Blot analysis 
6.3.1 Tissue lysis 
Brain tissue was dissected in HBSS medium, transferred to an empty reaction 
tube, frozen in liquid nitrogen and stored at -80 °C until further processing. 
Dependent on the tissue size 100 µl up to 1 ml lysis buffer (see solutions 
western blot) was added. Tissue and lysis buffer were transferred to a 1 ml 
dounce tissue grinder and grinded with the tight pestle 10-15 x. The 
homogenate was pulse sonified for 5 seconds at 10% intensity and kept on ice 
for 15 minutes. The lysate was centrifuged at 10000 g for 15 minutes at 4 °C. 
The total protein lysate containing supernatant was transferred to a new 
reaction tube and stored at -80 °C. 
 
6.3.2 Photometric quantification of protein amounts with 
Bicinchoninic acid  
Protein samples were quantified using the BCA assay (Uptima) according to the 
manufacturer protocol. The assay is based on the fact that proteins reduce 
alkaline copper (II) ions to copper (I) ions. Bicinchoninic acid (BCA) reacts with 
copper (I) ions to a violet colored complex with an absorption maximum at 562 
nm. The absorption is proportional to the protein concentration in a range from 
20 - 2000 µg/ ml and was measured using a spectral photometer. Samples with 
ascending bovine serum albumin (BSA) amounts (50 µg, 250 µg, 375 µg, 500 
µg, 750 µg, 1000 µg and 1500 µg) were measured for a standard curve before 
detection of the absorption of specific protein samples.  
 
6.3.3 Sample preparation for Western gel loading  
Protein samples were adjusted with Aqua bidest to a certain protein amount (20 
to 30 µg) depending on the specific Western Blot, 4x loading buffer was added 
and samples were boiled at 95 °C for 5 minutes. For western blots against b1-
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integrin better results could be obtained under less reduced conditions (loading 
buffer without b-Mercaptoethanol).  
 
6.3.4 Western blot and signal detection 
Sodium dodecylsulfate (SDS) polyacrylamide gels (resolving gel: 8–10%; 
stacking gel: 4%) were run in SDS-PAGE running buffer. Proteins were 
transferred to a PVDF membrane by semi dry blotting. Membranes were 
blocked for one hour with 5% milk powder in TBS and probed with rabbit b1-
integrin antibody (Wennerberg et al., 2000) over night at 4 °C. For protein 
loading control, membranes were probed with mouse anti-GAPDH antibody 
(abcam). Secondary antibodies were coupled to near infrared fluorescent dyes 
for detection with the Licor scanning system and the Odyssey V3.0 software. 
Membranes were incubated with secondary antibodies (1:15000 in TBST) for 2 
hours at room temperature. Western Blots were replicated at least three times 
for quantification.  
 
6.4 Electron Microscopy 
The electron microscopy experiments concerning the basement membrane 
integrity of β1-integrin mutant mice were performed in collaboration with Dr. 
Saida Zouba, Helmholtz Zentrum München, Institute for Pathology: The animals 
were deeply anesthetized and perfused with a 0.1 M phosphate buffered 4 % 
paraformaldehyde / 2.5 % glutaraldehyde fixative. The brain was removed and 
post-fixed in the same solution for 4 hours at 4 °C. Coronal sections of 2 mm 
thickness were cut at the vibratome. The sections were rinsed in 0.1 M sodium 
phosphate buffer, post-fixed in buffered 1.0 % osmium tetroxide, dehydrated in 
a graded series of ethanol to 100%, transitioned to propylene oxide, and 
embedded in Epon. Semi-thin sections were stained with toluidine blue to 
determine areas of interest; the grids were stained sequentially with uranyl 
acetate and lead citrate. The ultrastructure was examined by a transmission 
electron microscope.  
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The electron microscopy study examining myelin defects in β1-integrin mutant 
were done in collaboration with Dr. Leda Dimou, Munich University LMU, 
Physiological Genomics: Animals were deeply anesthetized and transcardially 
perfused using freshly prepared Karnovski fixative. Brains were taken out and 
post-fixed for 3 hours in the same solution. Then brains were transferred to the 
post-fix and storing solution and kept at 4 °C until further processing.  
Brains were washed in washing solution for 2 – 4 hours before 400 – 500 µm 
vibratome sections were cut and washed again before osmication. As a strong 
oxidant, osmium cross-links lipids mainly by reacting with unsaturated carbon-
carbon bonds, thereby fixing and labeling biological membranes and other lipid 
rich structures like myelin sheets for transmission electron microscopy, since 
osmium atoms are extremely electron dense. Sections were transferred to 
opaque glass vials filled with osmication solution standing on a pre-cooled metal 
plate. Osmication took place for 1.5 – 2 hours while slow warming of the 
solution at room temperature. The sections were washed in a 24-well plate in 
0.1 M Cacodylat for 20 minutes and dehydrated in a graded series of EtOH to 
100 % (70 %, 80 %, 90 %, 96 %, 100 %, 100 %, 20 minutes each). Sections 
were transferred to glass vials for the final 30 minutes washing step with 
propylenoxide (propylenoxide disintegrated plastic), before sections were 
incubated in a propylenoxide : araldit (1:1) mixture over night at 4 °C. Sections 
were embedded using an araldit epoxy embedding kit following the 
manufacturer’s protocol. 
The araldit blocks were sent to the LMU anatomic institute for contrasting and 
cutting semi-and ultra-thin sections. Grids were then analyzed at a transmission 
electron microscope. 
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6.5 Cell Culture 
6.5.1 Primary astrocyte cultures and in vitro scratch wound 
assay 
Primary astrocytes cultures were prepared from cortices of mice at postnatal 
day 5 – 7. Therefore, 3 – 4 pups were decapitated and heads were washed in 
70 % EtOH. Brains were taken out and transferred to Hank’s Buffered Salt 
Solution (HBSS) supplemented with Hepes (final concentration: 10mM) to 
stabilize the pH-value. Meninges were removed and hemispheres were 
separated using 2 forceps (size 5), then cortical gray and white matter was 
dissected from the underlying striatum. Finally the hippocampi which are 
located under each cortical hemisphere were removed and this cortical tissue 
was then transferred into a 15 ml Falcon tube filled with HBSS and kept on ice 
until further processing. 
 
6.5.2 Tissue dissociation and culturing of primary astrocytes 
All further steps were carried out at room temperature under sterile conditions in 
a laminar flow. Media and supplements are listed in chapter 5.5.6 Cell Culture 
media and supplements. The tissue was chopped into smaller pieces using a 10 
ml serologic pipette. Tissue pieces were collected at the bottom of the 15 ml 
reaction tube by centrifugation for 5 minutes at 1000 rpm. The supernatant was 
removed and 10 ml astrocyte medium was added. The tissue was further 
dissociated using first a 5 ml serologic and then a glass Pasteur pipette. The 
cell suspension was centrifuged for 5 minutes at 1000 rpm, the supernatant was 
drawn off and 10 ml fresh astrocyte medium was added. Cells were gently 
resuspended with a 10 ml serologic pipette and transferred to a poly-L-ornithine 
(PLO) coated T75 cell culture flask and incubated in a cell culture incubator 
ventilated with 5 % CO2. 
 
88  Methods  6 
6.5.3 Maintenance and splitting of the astrocyte culture 
The culture medium was completely exchanged each 2 - 3 days for 1 week after 
100 % confluence was reached (2-3 weeks after preparation). At this time point, 
almost all oligodendrocyte progenitors, which are the round cells located on top 
of the astrocyte monolayer, already disappeared. In case they were still present, 
the medium was replaced by PBS and oligodendrocyte precursors were 
removed by sound shaking of the flask. After washing with PBS 2 ml Trypsin/ 
EDTA was added and the flask was placed back into the incubator for maximum 
5 minutes. Astrocytes that had remained attached were loosened by shaking 
the flask, and then the trypsination was stopped by addition of 3 volumes of 
astrocyte medium. The cell suspension was transferred to a 15 ml reaction tube 
and centrifuged for 5 minutes at 1000 rpm. The supernatant was removed, 1 ml 
fresh astrocyte medium was added and cells were re-suspended by pipetting 
the suspension up and down. 10 µl of the cell suspension was transferred to an 
improved Neubauer chamber and living cells were counted. Cells were seeded 
on PLO-coated 14 mm glass coverslips in a 24-well plate or directly into a PLO-
coated 24-well plate (Falcon!) for timelapse imaging at a density of 70000 – 
100000 cells per well. The medium was changed 24 hours after plating and 
each 2 – 3 days thereafter.  
 
6.5.4 Transduction of astrocyte cultures with lentiviruses 
Astrocyte cultures were transduced during the splitting step after re-suspension 
of the cells by adding 0.8 µl lentivirus per 500 µl cell suspension and well. Cells 
were then plated and plates were placed into the incubator for 24 hours, before 
the medium was changed again. 
 
6.5.5 In vitro scratch wound assay 
At the earliest two weeks after viral transduction and one week after confluence 
on the coverslips had been reached experiments were started: A short 10µl 
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pipette tip was used to scratch the astrocyte monolayer once or twice across 
the entire width of the well. The medium was changed immediately to remove 
detached cells and the plate was either placed back into the cell culture 
incubator until fixation of the cells or into the timelapse imaging setup. 
 
6.5.6 Dissection and dissociation of adult mouse brains for 
culturing neurospheres from the SEZ  
For culturing neurosphere cells from the adult subependyma the protocol 
described by (Johansson et al., 1999) was followed. Media and supplements 
are listed in chapter 5.5.6 Cell culture. At least 3 mice per genotype were used 
for one preparation. Mice were killed by cervical dislocation and whole brains 
were isolated and kept in HBSS containing 10 mM Hepes until dissection. 
Brains were cut at the midline between the two hemispheres and in the middle. 
The medial wall of the ventricle was removed and the lateral wall was isolated 
by cutting beneath the wall with scissors. These tissue pieces were kept in 
HBSS/Hepes. At the end of the preparation the dissociation medium was freshly 
prepared and filter sterilized. Tissue was incubated in this dissociation medium 
for 15 min at 37°C, thoroughly triturated with a 5 ml pipette for at least 10 times 
up-and-down and again incubated for 15 min at 37°C. The enzyme activity was 
stopped by adding 1 volume ice cold solution 3 and cells were passed through a 
70 μm strainer into a 50 ml reaction tube to remove bigger pieces of tissue, 
followed by a centrifugation step at 1300 rpm for 5 minutes in a 15 ml reaction 
tube. The supernatant was removed and the pellet was re-suspended in 10 ml 
ice cold solution 2 and centrifuged at 2000 rpm for 10 minutes. This 
centrifugation step is similar to a sucrose gradient and gets rid of dead cells 
which are very small in size and hence fail to pellet. The supernatant was drawn 
off and cells in the pellet were re-suspended in 2 ml ice cold solution 3. A new 
15 ml tube was filled with 10 ml ice cold solution 3 and 2 ml of the cell 
suspension was added on top of the new tube, followed by another 
centrifugation step at 1500 rpm for 7 minutes. The supernatant was removed; 
cells were re-suspended in 7 ml neurosphere media and seeded in a small cell 
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culture flask. Cells were cultured in the presence of 20 ng/ ml EGF and 10 ng/ 
ml FGF2 (added each 2 – 3 days) under non-adherent conditions to allow for 
the formation of neurospheres.  
 
6.5.7 Dissection and dissociation of adult mouse brains for 
culturing neurospheres from the stab wound injury 
For culturing neurospheres from reactive astroglial cells from a stab wound 
injured cortex at least 3 mice per genotype were used 3 days after the 
operation. Animals were sacrificed by cervical dislocation and brains were 
isolated and kept in HBSS/ Hepes for dissection. A thin slice of approximately 
500 µm of the injured area was cut using a scalpel thereby strictly avoiding 
hitting the white matter. It may be advantageous to cut a 1 – 2 mm coronal slice 
first before dissecting the injured tissue. The dissociation of the tissue was 
performed as described above. Cells from the stab wound tissue were cultured 
with double the amount of growth factors (40 ng/ ml EGF and 20 ng/ ml FGF). 
 
6.5.8 Passaging Neurospheres 
For passaging the neurospheres were collected in their medium in a 15 ml tube 
and centrifuged at 800 rpm for 5 minutes. Most of the supernatant was removed 
spearing 500 μl in which cells were then dissociated mechanically. Cells were 
counted in an improved Neubauer chamber after the first split and seeded in 24-
well plates at a density of 1 cell / µl. 
 
6.5.9 Paraformaldehyde fixation of cultured cells 
Cells were fixed with 4 % paraformaldehyde (heated to 37 °C) for 15 minutes at 
37 °C and washed with 2 ml PBS twice afterwards. Coverslips were stored 
covered with PBS in 24-well plates at 4 °C until stainings were performed. 
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6.5.10 Immunocytochemistry 
F-actin was detected using fluorescent labeled Phalloidin in the secondary 
antibody solution. 
Table 6-6 First antibodies immunocytochemistry 
recognized antigen host-animal/Ig subtype 
pre-treatment & 
incubating 
conditions* 
obtained from 
β-catenin mouse IgG1 1:50 BD Biosciences 
(610153) 
Cdc42 mouse IgG3 1:100 Santa Cruz 
(8401) 
β1-Integrin rat 1:100 Millipore  
(MAB1997) 
GFAP mouse IgG1 1:1000 Sigma 
(G3898) 
GFAP rabbit 1:4000 Dako/Invitrogen 
(Z0334) 
GFP mouse IgG1 1:2000 Millipore  
(MAB3580) 
GFP rabbit 1:2000 Invitrogen 
(A6455) 
GFP chick 1:2000 Aves Lab 
(GFP-1020) 
γ-tubulin mouse IgG1 1:1000 Sigma  
(T5326) 
RFP rabbit 1:500 Millipore 
(AB3216) 
 
Table 6-7 Secondary antibodies immunocytochemistry 
antibody host species label dilutions supply 
α-chick donkey FITC 1:1000 Dianova 
(703095155) 
α-rat donkey 
 
TRITC 1:1000 Dianova 
(712025153) 
rabbit biotinylated 1:200 Vector 
(BA-4001) 
α-rabbit goat 
 
FITC 1:1000 Dianova 
(111095003) 
TRITC 1:1000 Dianova 
(111025144) 
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antibody host species label dilutions supply 
α-mouse IgG1 goat FITC 1:1000 South.Biot 
(1070-02) 
TRITC 1:1000 South.Biot 
(1070-03) 
 
In addition see secondary antibodies in 6.2.1. The antibodies listed there were 
diluted 1:2000. 
 
6.6 Virus production 
In this study mostly lentiviruses have been used. Lentiviral constructs for 
expression of the Cre recombinase (Cre-IRES-GFP, Figure 6-1) and the 
corresponding green fluorescent protein (GFP) control construct were kindly 
provided by Dr. A. Pfeiffer, University of Bonn. Lentiviruses were designed and 
produced with the help and according to the protocol of Dr. Alexandra Lepier in 
the department of Cellular Physiology.  
 
6.6.1 Viral vector design 
The GFP-expression behind an internal ribosome entry site (IRES) is weaker 
than GFP expression directly driven from the internal CMV-promoter (Figure 
6-1). Therefore GFP levels in cells transduced with GFP control virus were 
significantly higher than in cells transduced with Cre-IRES-GFP virus. As this 
has been disadvantageous for timelapse imaging, constructs were designed 
encoding the red fluorescent protein tomato directly behind the promoter 
followed by an IRES and the sequence for Cre recombinase (tomato-IRES-Cre) 
or carrying tomato alone (tomato). To ascertain that expression of Cre 
recombinase behind IRES is sufficient, double stainings for RFP and Cre were 
performed after transfection of HEK cells with the tomato-IRES-Cre construct 
and after transduction of HEK cells or astrocytes with tomato-IRES-Cre virus. 
RFP-positive Cre-negative cells were neither detected after transfection or 
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transduction of HEK cells, nor after viral transduction of astrocytes indicating 
high levels of expression of both proteins. 
 
 
 
Figure 6-1 Map of the Cre-IRES-GFP lentiviral construct 
Cre is expressed under the CMV promoter followed by an internal ribosomal entry site in 
front of the GFP sequence. Cre and tomato are switched in the tomato-IRES-Cre lentiviral 
vector. 
 
6.6.2 DNA preparation for virus production (CsCl-Gradient) 
This method provides very pure supercoiled plasmid DNA, while nicked (relaxed 
circled) DNA is separated and all proteins are removed, as non-covalent binding 
sites are eliminated due to the cesium ions absorbing remaining water 
molecules. Thus, the pure DNA is free of endotoxins and its amount can be 
defined in a reproducible way by measuring the absorbance without varying 
disturbances from damaged DNA or protein contaminations. 
 
Harvest and DNA extraction 
A 250 ml bacterial culture was used. Notably, care was taken that the culture 
was not overgrown with an optimum at around 90 % confluence. Bacteria were 
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spun down at 5000 x g for 20 minutes and drained off the supernatant. The 
pellet was re-suspended in 10 ml Qiagen buffer 1 with RNAse. After complete 
re-suspension, 10 ml Qiagen buffer 2 for lysis was added. The tube was shaken 
gently and incubated for exactly 5 minutes. 10 ml of ice-cold Qiagen buffer 3 
was added, and mixed well. The mixture was filtered through a folded paper 
filter pre-wetted with clean water into a 50 ml tube (volume around 25 ml, some 
rest may stay in the filter). 
DNA was precipitated by adding 20 ml Isopropanol to the filtrate (1:1), mixing of 
the solution, and followed by a centrifugation step at 8000 x g for 1 hour at 4°C. 
The supernatant was removed; the white pellet was washed carefully with 70 % 
EtOH and spun again for 10 minutes. After draining off EtOH the wet pellet was 
dissolved in 15 ml TE, pH 8.0. The pH of the solution should be around pH 8 
(otherwise adjust pH). 
 
Phenol extraction 
This purification step may be omitted, but then more precipitates are formed 
during cesium chloride extraction. The pure DNA solution was poured into a 
Phase Lock Heavy 50 ml tube, 7.5 ml of phenol equilibrated with TE and 7.5 ml 
Chloroform were added and shaken well. The solution was spun at 1500 x g at 
RT for 20 min in a swing out rotor. The upper, aqueous phase was transferred 
into a new 50 ml tube, 1.5 ml of 3 M Sodium Acetate pH 5.2 and 15 ml 
Isopropanol were added for DNA precipitation, mixed well and centrifuged at 
8000 x g for 1 hour at 4°C. The supernatant was removed and the pellet was 
washed with 70 % EtOH and spun again for 10 minutes. Rests of EtOH were 
removed; the DNA pellet was air-dried until it appeared transparent. Dry pellets 
may be stored at -20°C. 
 
Cesium Chloride (CsCl) - gradient preparation and ultracentrifugation 
The dry pellet was dissolved completely in 8.0 ml TE. The DNA solution (8.0 ml) 
was added to 8.80 g CsCl in a 50 ml tube and the salt was dissolved completely 
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(solution will get cold). 800 μl of saturated ethidium bromide (EtBr) was added 
and the solution was mixed until a fine precipitate was formed. Samples were 
warmed up to 37°C for 15 minutes in the water bath and centrifuged at full 
speed in a swing out rotor for 10 minutes so that the precipitate was clung to the 
surface and the wall of the Falcon tube. Less precipitates were formed, when 
The DNA solution was purified by phenol extraction. The supernatant was filled 
into an 11.2 ml OptiSeal tube (Beckmann) until the meniscus touched the basis 
of the tube’s neck. Tubes were balanced precisely to 0.0 g and sealed for the 
following ultracentrifugation step: 65.000 rpm for 5 hours and 30 minutes at 
20°C at maximum acceleration and slow brake settings. Start of the centrifuge 
was delayed so that the spin ended at the next working day. After centrifugation 
finished visible DNA bands were immediately extracted. 
 
Extraction of the ethidium bromide from the rotor tube 
For harvest of the DNA band, a UV lamp in vertical direction and a dark room 
are required, as well as skin protection (i.e. e. lab coat, nitrile gloves and face 
protection). 
When the centrifuge stopped, tubes were removed from the rotor as soon as 
possible, and the tube was fixed in front of the UV-lamp in a holder. The tube’s 
shoulder was pierced with a canula (around 22 Gauge) for ventilation of the 
tube when DNA-band was withdrawn. The tube was put in a fitting clamp, so 
that the band was visible halfway down the tube. Now the second needle (also 
22 Gauge) was put into the tube shortly under the DNA band. The UV-lamp was 
used to check the height of the DNA band (upper band: nicked DNA, lower 
band: super-coiled DNA). The needle was connected to a 2 ml syringe and as 
much as possible DNA was collected into the syringe by moving the syringe up 
and down. Content of the syringe was transferred into a 15 ml tube. DNA can 
be stored at that stage at room temperature overnight under light protection. 
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Removal of ethidium bromide from the DNA 
An equal volume of n-Butanol saturated with TE was added to the DNA + EtBr 
solution, shaken well and spun briefly in a swing out rotor after which the upper 
organic phase was removed. The extraction was repeated until the lower 
aqueous phase was completely colorless (around 5 – 6 times). An equal volume 
of Diethyl ether was added, the solution was mixed and the upper, organic 
phase was removed to separate rests of n-Butanol from the water phase. At 
room temperature the ether will evaporate during the next steps. DNA solutions 
were transferred into 50 ml tubes and diluted with 2 volumes of sterile TE. 1/10 
new volume of 3 M Sodium-Acetate pH 5.2 and another 2 volumes of cold 100 
% EtOH (stored at -20°C) were added, the solution was mixed and incubated on 
ice for 1 – 2 hours or overnight at 4°C, followed by a centrifugation step 10000 x 
g for 1 hour at 4°C. The supernatant was removed and washed with 10 ml cold 
100 % EtOH, spun again at 10000 x g for 10 minutes and again rests of EtOH 
were removed. The pellet was air-dried and appeared transparent then. DNA 
was dissolved under a tissue culture hood in 500 μl of sterile 10 mM Tris-HCl 
pH 8. Vigorous shaking was avoided! DNA solution was transferred into a 1.5 
ml reaction tube, eventually followed by another spin at full speed for 5 minutes 
to further remove insoluble particles. The average yield was around 1 mg of 
pure DNA. 
 
6.6.3 Lentiviral preparations 
Lentiviruses are a subclass within the large group of retroviruses, which stably 
integrate into the genome of the target cell. The lentiviral pre-integration 
complex recruits components of the cellular nuclear import machinery, which 
actively transport the complex through the nuclear pore. Therefore the 
integration of the lentiviral genome is - in contrast to all other retroviruses - 
independent of the cell cycle of the host cell and takes also place in post-
mitotic, non-cycling cells.  
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For security reasons retroviral vector systems have been depleted of replicative 
and pathogenic viral genes and their remaining genome has been splitted into 
different plasmids resulting in replication-incompetent vectors.  
 
Propagation of 293T cells 
Media and medium supplements are listed in chapter 5.5.6. 293T cells were 
cultured in stock medium in T175 flasks and splitted 2 – 3 times a week when 
confluence reached 80 – 90 %. Trypsin-EDTA for detachment and dissociation 
of the cells was diluted 1:5 in PBS. After 20 – 30 passages cultures were 
discarded and fresh 293T cells were thawed. For packaging cells were 
expanded to 3 T175 flasks per reaction seeded in a density that would lead to 
60 % confluence 3 days later. 
 
Transfection (day 1, evening) 
The stock and transfection medium were heated to room temperature. Per 
packaging reaction one 50 ml tube containing 9 ml Opti-MEM without serum, 45 
µg packaging vector ∆8.9, 30 µg VSVG-pseudotyping vector and 18 µg 
expression plasmid and one tube containing 9 ml Opti-MEM without serum and 
216 µl Lipofectamin 2000 were prepared. Especially important was the ratio of 
the 3 plasmids rather than the total DNA amount. The tubes were incubated for 
5 minutes before the transfection reagent was added to the DNA, gently mixed 
and incubated for another 20 minutes at room temperature. During the 
incubation 293T cells were harvested and cells from 3 flasks were pooled into 
one pellet per reaction. From a fraction of these cells new 293T stock flasks 
were seeded in stock medium. The cell pellet was re-suspended in 30 ml Opti-
MEM with 10 % FCS. The transfection mix was added to the cell suspension 
and gently mixed. Then 6 10 cm dishes were seeded with 8 ml cell suspension 
each. The confluence should be at 60 – 70 % after attachment of the cells. 
Dishes were placed into the incubator overnight. 
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Washing and changing medium (day 2, morning) 
The packaging medium was heated to 37 °C and 50 ml were filled to a reaction 
tube to avoid contamination of the stock. The supernatant from one dish was 
drawn off and immediately replaced by cautious addition of 5 ml of packaging 
medium thereby avoiding that cells fell dry or detach from the plate. The 
procedure was repeated one by one for the other 5 dishes. Then the 
supernatant from the first dish was replaced by 12 ml of fresh packaging 
medium and subsequently the other 5 dishes were washed as well. Dishes 
were placed back into the incubator. 
 
Preparation of the ultracentrifuge run 
The screw lids of the SW 28 ultracentrifuge rotor buckets were sterilized with 70 
% EtOH and dried in the laminar air flow. Rotor and buckets were assembled 
then and pre-cooled to 4 °C in the refrigerator. The rotor chamber of the 
ultracentrifuge was cooled to 4 °C as well. Ultracentrifugation tubes (2 per 
reaction) were sterilized by filling them to the rim with non-toxic 70 % EtOH 
(made from absolute EtOH and tissue-culture grade water) and letting them 
stand in the flow for a couple of minutes. The 70 % EtOH was recycled; tubes 
were dried and labeled with an EtOH-resistant marker. A working aliquot of 
TBS-5 was placed on ice. Packaging medium was pre-warmed and aliquoted as 
described before. 
 
Ultracentrifuge run and harvest (day 3, 4, 5, 6) 
The first harvest was conducted when cells were confluent and the medium 
turned light orange. The supernatant of one after the other dish was transferred 
to 50 ml tube and immediately replaced with 12 ml of fresh packaging medium 
and plates were put back into the incubator. The viral supernatant of 3 plates 
was pooled into one 50 ml tube. After the second harvest supernatant was 
removed and cells were discarded.  
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Supernatants were centrifuged for 15 minutes in a cell culture centrifuge to 
remove detached cells and debris. Meanwhile Millex 0.45 µm filters were pre-
wetted to avoid sticking of the virus to the filter. Therefore the plunger from a 30 
ml syringe was removed and filters were mounted onto syringes (one per 50 ml 
tube with viral supernatant). A few drops of packaging medium were filled onto 
filters from inside of the syringes. Viral supernatant was transferred into new 
tubes thereby avoiding any carry-over of debris and then filtered through the 
pre-wetted Millex filters by decanting the supernatant into the syringes. The 
plunger was carefully replaced and gentle pressure was applied. Exactly 30 ml 
of each supernatant was transferred into the earlier prepared ultracentrifuge 
tubes and the SW 28 rotor was assembled and centrifuged for 90 minutes at 
25000 rpm at 4 °C. The supernatant was removed revealing a brownish glassy 
viral pellet. 1 ml of ice-cold TBS-5 was added; tubes were closed with 2 layers 
of Parafilm and placed on ice for 4 hours or overnight in a cold room. For a viral 
preparation with only one ultracentrifuge run only 100 µl of TBS-5 were added 
and viral suspension was directly aliquoted and frozen after incubation on ice.  
In case problems with toxicity of the viral batches occurred or if viral 
preparations were used for injections into the brain, a second ultracentrifuge run 
was advantageous to further purify the viral particles from components of 
packaging medium. For the second run the virus was dissociated by pipetting 
up and down with a serological plastic pipette while minimizing the formation of 
air bubbles. The viral suspension was filled up to 30 ml with ice-cold TBS-5 and 
the rotor was assembled for another centrifugation for 90 minutes at 25000 rpm 
and 4 °C. The supernatant was removed and the viral pellet appeared colorless 
and translucent. 100 µl of TBS-5 were added, tubes were covered with Parafilm 
and placed on ice for 4 hours or overnight. 
 
Aliquoting and freezing of the virus 
The viral supernatant was transferred from the ultracentrifuge tube to a 1.5 ml 
reaction tube before re-suspension. The bottom of the ultracentrifuge tube was 
rinsed with another 50 µl of TBS-5 that were added the viral supernatant. The 
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supernatant was re-suspended by pipetting up and down with a 200 µl pipette 
set to 150 µl. To remove remaining debris and aggregates tubes were spun at 
5000 rpm for 30 seconds in a benchtop centrifuge. The supernatant was 
transferred to a new tube and spins were repeated until no white pellet was 
formed anymore. The viral supernatant was aliquoted into 0.5 µl tubes; 10 µl 
aliquots were frozen and stored at -80 °C.  
 
6.7 Data analysis 
6.7.1 Cell numbers per area and marker coexpression 
For quantification of cell numbers per mm2 and marker coexpression the 
Neurolucida software was used in combination with an Olympus BX50 
microscope. The analysis was performed on coronal or sagittal sections in at 
least 3 pairs of WT and mutant mice. For all data sets, the arithmetic average, 
standard deviations and standard errors of the mean (SEM) were calculated. 
The error bars in the diagrams are showing the SEM. To test the data for 
significance the unpaired student’s T-test was used in the in vivo studies. The p-
value (p) of these tests declares the probability of the conclusion being correct. 
There is a 95% chance of the means to be significant different if p = 0.05 
(indicated in graphs as *), a 99% chance of the means to be highly significant 
different for p = 0.01 (**) and a 99.9% (***) chance of the means to be very 
highly significant different for p = 0.001. 
 
6.7.2 Reorientation of centrosomes 
Reorientation of the centrosome in wounded astrocyte cultures was quantified 
by separating the space in 4 equal quadrants joining in the center of the nucleus 
of interest and placed so that one of the quadrants is facing the scratch (the 
median of each 90° angle being either perpendicular or parallel to the scratch). 
Centrosomes are scored as reoriented when the centrosome is located in the 
quadrant facing the scratch. The data were obtained from 3 independent 
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preparations of different litters. For each preparation and time point 2 different 
coverslips, each with at least 100 transduced cells in the first row at the scratch, 
were counted.  The significance of the data was tested using the Mann-Whitney 
test. The calculations and constructions of the diagrams were carried out with 
Excel and GraphPadPrism 3.0. Means were considered significantly different for 
p ≤ 0.01 (**) and p ≤ 0.001 (***). 
 
6.7.3 Quantification of astrocyte protrusions 
Scratched astrocyte cultures stained for microtubules were observed under the 
fluorescence microscope (Olympus, BX61) using a 60x objective. Transduced 
cells in the first row at the scratch with one major protrusion, which appeared at 
least three times longer than wide, were scored as “protruding” cells. The 
significance of the data was tested using the Mann-Whitney test. The 
calculations and constructions of the diagrams were done with Excel and 
GraphPadPrism 3.0. Means were considered significantly different for p ≤ 0.01 
(**) and p ≤ 0.001 (***). 
For analysis of protrusion formation of astrocytes after a stab wound injury in 
vivo confocal images were taken. Length and width of GFP+ cells as well as the 
longest process towards the stab wound was measured in the ZEN 2008 
software from Zeiss. The measurements of the cell length and width were done 
together with Sophia Bardehle (Institute of Stem Cell Research, 
HelmholtzZentrum München). To test the data for significance the unpaired 
student’s T-test was used and calculations and statistical analysis were done 
with Excel and GraphPadPrism 3.0. Means were considered significantly 
different for p ≤ 0.05 (*), p ≤ 0.01 (**) and p ≤ 0.001 (***). 
 
6.7.4 Analysis of the lesion size 
To analyze the lesion size after stab wound injury confocal pictures were taken. 
The area free of DAPI-positive nuclei within the injury, the area covered by 
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reactive astrocytes and microglia was measured in at least 3 sections from 3 
animals using the ZEN 2008 software from Zeiss. To test the data for 
significance the unpaired student’s T-test or the Mann-Whitney test was used 
and calculations and statistical analysis were done with Excel and 
GraphPadPrism 3.0. Means were considered significantly different for p ≤ 0.05 
(*), p ≤ 0.01 (**) and p ≤ 0.001 (***). 
 7 Results 
7.1 The influence of β1-integrins on gray matter 
astrocytes 
To examine the impact of signaling between the basement membrane (BM) 
surrounding blood vessels and astrocytes that contact the BM by their endfeet, 
β1-integrins were conditionally deleted. Towards this aim, mice carrying alleles 
for the β1-integrin gene that were flanked by loxP sites were crossed to mice 
expressing the Cre-recombinase under the human GFAP (hGFAP) promoter. 
Cre-expression driven from the hGFAP promoter leads to recombination from 
embryonic day (E) 13 in radial glia cells that give rise to astrocytes, 
oligodendocytes and neurons in the forebrain (Malatesta et al., 2003). Therefore 
all progeny of recombined radial glia cells carry a deletion of the complete 
coding and 3 prime uncoding sequence of the β1-integrin gene.  
 
7.1.1 Deletion of β1-integrin by the use of hGFAP-Cre causes 
partial reactive gliosis 
β1-integrin protein levels are reduced at postnatal stages 
As there is β1-integrin protein expressed before the time point of gene deletion 
the stability of the protein determines the duration until a knockout on the 
protein level is achieved. Thus, β1-integrin protein expression was examined by 
western blot analysis in conditional knockout mice (from now on referred to as 
β1-/-) and wildtype littermates (WT) with WT protein levels set to 100%. At the 
day of birth (postnatal day 0) the amount of β1-integrin protein had already 
decreased to 65 ± 14 % in b1-/- cortices (Figure 7-1 A, C) and was further 
reduced to 37 ± 3% at postnatal day (P) 7 (Figure 7-1 B, C). Consistent with 
Cre-expression in radial glia in almost all brain regions (Malatesta et al., 2003) 
β1-integrin protein levels in the adult brain were reduced to 57.7 % ± 10.7 % in 
the β1-/- cortex and to 56.7 % ± 7 % in the hindbrain (Figure 7-1 D, E). As β1-
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integrin is ubiquitously expressed the remaining b1-integrin levels are most 
likely due to not-recombined cell types like endothelial cells and mesenchymal 
derived microglia. Even in the spinal cord, where hGFAP-Cre mediated 
recombination occurs at relatively late stages in radial glia, when mainly 
astrocytes and less neurons are generated (Barry and McDermott, 2005; Mori 
et al., 2005; McMahon and McDermott, 2007; Pinto et al., 2008) β1-integrin 
protein levels were decreased to 41.7 ± 7.3 (Figure 7-1 D, E). However, in the 
midbrain protein amounts were similar in β1-/- (109.3 % ± 18.6 %) and WT 
brains (Figure 7-1 D, E), correlating with the lower Cre expression in this region 
that has been reported previously (Zhuo et al., 2001). 
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Figure 7-1 Western Blot analysis of b1-integrin protein levels 
Western blot analysis against β1-integrin revealed lower levels of the protein at the day 
of birth in total lysates of β1-/- cerebral cortices compared to WT controls (A, C) and was 
further reduced one week later (B, C). In β1-/- brains of adult animals β1-integrin protein 
levels were reduced not only in the cerebral cortex, but also in hindbrain and spinal cord 
(D; E). In the midbrain protein levels were comparable to WT controls (D, E). 
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Loss of β1-integrins at postnatal stages does not cause major abnormalities 
Consistent with preceding reports of CNS-specific deletion of β1-integrins 
(Graus-Porta et al., 2001; Blaess et al., 2004; Huang et al., 2006; Belvindrah et 
al., 2007b) knockout animals were born at normal mendelian ratios, survived 
into adult stages, had a body weight similar to WT littermates and did not show 
obvious behavioral abnormalities. In addition, no gross differences in brain 
morphology in β1-/- compared to WT brains were observed, except from the 
cerebellum, which was smaller and contained fused folia in β1-/- mice (Figure 
7-2 A, B; see also Graus-Porta et al., 2001). During forebrain development 
newborn neurons migrate along radial glia from the ventricular zone towards the 
basal lamina thereby forming six cortical layers in an inside out way (Gaiano, 
2008). Interestingly, neuronal ectopia in cortical layer I were not detected in β1-
integrin mutant cortices in contrast to previous reports of deletion of β1-integrins 
at an earlier time point (Figure 7-2 C, D and Graus-Porta et al., 2001; 
Belvindrah et al., 2007b). The cortical layering was indistinguishable in β1-/- and 
WT brains as examined by 4’,6-diamidino-2-phenylindole (DAPI) and Nissl 
staining. The density of cells quantified by counting DAPI-positive nuclei per 
area, as well as the number of neuronal nuclei (NeuN)-positive neurons was 
comparable in mutant (Fig. 4.2 D and 5334 ± 314 DAPI-positive nuclei/ mm2, n 
= 3; 2741 ± 864 NeuN-positive neurons, n = 8) and WT cortices (Fig. 4.2 C, 
6109 ± 450 DAPI-positive nuclei/ mm2, n = 3, p = 0.15; 3158 ± 335 NeuN-
positive cells / mm2, n = 5, p = 0.91). Furthermore, there were no apparent 
differences in the intensity of neurofilament-70 or myelin associated 
glycoprotein (MAG) immunofluorescence in WT and β1-/- brains suggesting that 
neither axons nor myelin are affected by the deletion of β1-integrins in almost all 
forebrain cells. Additionally, astrocytes were labeled by immunofluorescence 
staining against the astrocytic marker S100β. Quantification of S100β+ 
astrocytes per area showed similar numbers in WT and β1-/- cortices. However, 
there were obvious morphological changes of the S100β+ cells, which were then 
analyzed in more detail.  
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Figure 7-2 Gross analysis showed no differences in WT and β1-/- cerebral cortex 
Although β1-/- brains appeared to be larger in size, the layered structure of the cerebral 
cortex seemed to be normal and there were no obvious differences in cell or neuronal 
densities judged by DAPI and NeuN staining (C, D). In addition, immunofluorescent 
stainings of axons (E, F) and myelin (G, H) was comparable in the gray matter of the 
cerebral cortex of β1-/- and WT brains. 
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Loss of β1-integrins in the postnatal forebrain leads to a transition of mature 
gray matter astrocytes towards reactive astrocytes 
Single astrocytes were labeled using the Z/EG eGFP-reporter mouse line. 
Although almost all forebrain cells have been expected to be GFP-positive, I 
noticed in some animals that the Z/EG reporter activity was limited to single 
astrocytes in the cortical gray matter of adult mice (Figure 7-3 E-K). GFP-
expressing astrocytes in β1-/- brains seemed to be larger than WT astrocytes 
(Figure 7-3 E-K) and their main processes were clearly swollen (Figure 7-3 B, 
B’, C, C’ and Figure 7-3 E-K). As astrocytes have been shown to be 
hypertrophic after brain injury and these reactive astrocytes typically re-express 
the intermediate filaments GFAP and Vimentin, their expression was analyzed 
after deletion of β1-integrins. As expected there were only low numbers of 
GFAP+ astrocytes in the cortical gray matter of WT brains (13.2 ± 23.8 GFAP+ 
cells/ mm2 and Figure 7-3 A). In contrast, the number of GFAP+ cells increased 
dramatically in the β1-/- cortex (383 ± 4.5 GFAP+ cells/ mm2 and Figure 7-3 C) 
and all over the mutant telencephalon. Almost all S100β+ cells now expressed 
GFAP in the mutant cortex (97.9 % ± 1.4 % S100β+ astrocytes also contain 
GFAP), whereas only 6.9 % ± 2.7 % of the S100β+ astrocytes in the WT are co-
expressing GFAP. Additionally, a subset of the GFAP-expressing astrocytes 
also expressed Vimentin throughout the β1-/- cortex (Figure 7-3 M-M’’), 
whereas this was rarely seen in WT astrocytes, only in a few cells underneath 
the pia mater (Figure 7-3 L-L’’). It has been shown that upon brain trauma 
reactive astrocytes secret extracellular matrix molecules like chondroitin sulfate 
proteoglycans (CSPG). Two members of this ECM-molecule family, Tenascin-C 
and the DSD-1 epitope recognized by the 473HD antibody were examined by 
Swetlana Sirko in WT (Figure 7-3 N-N’’ and P-P’’) and mutant cortices. 
Strikingly, these proteins were also upregulated after deletion of β1-integrins 
(Figure 7-3 O-O’’ and Q-Q’’). Therefore it can be concluded that the loss of β1-
integrins at postnatal stages elicits several properties of reactive astrocytes 
after brain injury and integrin signaling is crucial for gray matter astrocytes to 
acquire a mature non-reactive state. 
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Figure 7-3 Partial gliosis in the cerebral cortex of β1-/- mice 
In the cortical gray matter astrocytes are negative for the intermediate filament (IMF) 
GFAP (A), but can be labeled with S100β (B, B’). After deletion of β1-integrins a strong 
upregulation of GFAP (C) in S100β-positive astrocytes (D, D’) was observed. By using a 
GFP-reporter and thus visualizing an entire cell including all processes, astrocytes 
appeared larger in size with clearly swollen main processes in β1-/- brains (H-K) 
compared to the WT (E-G). Another IMF, Vimentin, normally not expressed in the gray 
matter of the cerebral cortex (L-L’’) was upregulated after deletion of β1-integrins (M-M’’). 
The extracellular matrix molecules Tenascin C (N-O’’) and DSD-1 labeled with an 
antibody against the epitope 473HD (P-Q’’) were upregulated after loss of β1-integrins. 
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7.1.2 Deletion of β1-integrin by Nex::Cre 
To further elucidate in which cell types the loss of β1-integrins has to occur to 
elicit this phenotype, the β1-integrin gene was deleted by the use Cre-
recombinase under the control of the Nex-promoter. The basic helix-loop-helix 
transcription factor Nex is a member of the NeuroD family and is expressed 
from embryonic day E11.5 in most neocortical and hippocampal pyramidal 
neurons and their immediate progenitors, but not in astrocytes (Schwab et al., 
1998; Beggs et al., 2003; Blaess et al., 2004; S. X. Wu et al., 2005; Belvindrah 
et al., 2007b). As expected astrocytes in the white matter were positive for 
GFAP (Figure 7-4 B, insert). However, even in 6 months old animals an 
upregulation of GFAP could not be observed in the gray matter of the cerebral 
cortex in Nex::Cre, flβ1/ flβ1 or WT animals (Figure 7-4 A, B) suggesting that 
the deletion of β1-integrin in neurons only is not sufficient to cause the gliosis 
phenotype. Interestingly, the amount of myelin basic protein (MBP) and myelin 
associated glycoprotein (MAG) was massively reduced in the mutant gray 
matter (Figure 7-4 E, F) when compared to WT cortices (Figure 7-4 C, D) 
demonstrating that β1-integrins were successfully deleted in mutant cortices. 
These data suggest that deletion of β1-integrin at early stages in cortical 
neurons has severe effects on the interaction with myelinating 
oligodendrocytes, but does not affect astrocyte reactivity. 
 
7.1  The influence of β1-integrins on gray matter astrocytes  111 
 
Figure 7-4 Neuron specific deletion of the β1-integrin gene did not lead to gliosis 
No signal for GFAP could be detected after immunofluorescent staining in the gray 
matter of the cerebral cortex of WT animals (A) and animals with a neuron specific 
deletion of β1-integrins (B). However, another phenotype was observed confirming the 
successful deletion of the β1-integrin gene; levels of the myelin proteins MBP and MAG 
were reduced after loss of β1-integrins in neurons (E, F) when compared to the gray 
matter of the cerebral cortex in WT brains (C, D). 
7.1.3 Loss of β1-integrins leads to a secondary partial microglia 
activation 
Upon acute brain trauma microglial cells are thought to be the first cell type 
reacting to the injury by change of their morphology, increase in motility and 
directed migration into the lesioned area, proliferation and upregulation of 
certain molecules, for example lectins or CD11b (Figure 7-5 A-A’’). 
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Figure 7-5 Microglia activation shortly after a stab wound injury 
Microglia were labeled with Iba1 in uninjured WT brains (A) and after stab wound injury 
(C). Iba1-positive cells in the uninjured contralateral hemisphere are ramified with lots of 
fine processes (B). After stab wound injury microglia became hypertrophy with swollen 
cell bodies and main processes, whereas finer branches disappeared (D). In addition, 
activated microglia upregulated GSA-lectin (D’), which is also expressed in endothelial 
cells of blood vessels, but not in resting microglia (B’). 
 
However, this cell type was not expected to respond in the β1-/- animals, as 
microglia are of mesodermal origin (Chan et al., 2007) and should therefore not 
be recombined by hGFAP-Cre. This was confirmed by immunofluorescent 
staining for the general microglia marker Iba1 in reporter-positive WT and β1-/- 
brains. GFP-positive cells were in close proximity to Iba1+ microglia, but GFP 
was not contained within Iba1+ cells in WT or β1-/- brains (Figure 7-6 A-D). 
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Figure 7-6 Iba1 positive microglia were not recombined by hGFAP-Cre 
A GFP-reporter was used to examine whether hGFAP-Cre was also recombining 
microglia cells. In the gray matter of the cerebral cortex reporter-positive cells were in 
close proximity to each other, but no double positive cells could be detected in WT (A, 
A’, A’’, B) or β1-/- brains(C, C’, C’’, D). 
 
Surprisingly, immunofluorescent staining against Iba1 revealed differences in 
the morphology of microglia in WT and β1-/- cortices as finer processes seemed 
to be reduced and main processes showed hypertrophy in mutant brains when 
compared to WT littermates (Figure 7-6 A’’ and C’’, Figure 7-7 A, A’ and B, B’). 
Both, GSA-lectin and Cd11b were clearly upregulated in β1-/- brains (Figure 7-7 
B’’, D, D’), whereas in WT CD11b protein was at basic levels (Figure 7-7 C, C’) 
and GSA-lectin was detected in endothelial cells only (Figure 7-7 A’, A’’). After 
an injury microglia migrate towards the injury site and start to proliferate to 
increase their cell numbers. Quantification of Iba1-positive microglial cells in 
cortical layers I to III, where reactive gliosis seemed to be strongest, showed a 
significant increase in numbers in β1-/- cortices (654.5 ± 30.7 Iba1+/ mm2, n = 
3) when compared to WT cortices (536.1 ± 41.5 Iba1+/ mm2, n = 3, p ≤ 0.039). 
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Figure 7-7 Microglia were activated after loss of β1-integrins 
In WT brains microglia stained for Iba1 (A) had lots of fine and often branched processes 
(A, A’), but were negative for GSA-lectin (A’’) or Cd11b (C, C’’), both markers for activated 
microglia. After loss of β1-integrins overall less fine processes were seen (B). Instead 
some microglial cells had hypertrophy cell bodies and processes (B’) and were positive 
for GSA-lectin (B’’). Overall higher levels of Cd11b were detected in β1-/- cortices (D, D’). 
 
To examine whether proliferation contributes to the increase in microglia 
numbers BrdU was administered for 14 days via the drinking water to label all 
fast and slow dividing cells. As described before (Kettenmann and Ransom, 
2005), a low proportion of microglia proliferated in the non-injured WT cortices 
(1.6 % ± 0,4 % Iba1+ BrdU+/ Iba1+, n = 4 and Figure 7-8 A, A’). Even though the 
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overall proliferation was not significantly increased in β1-/- cortices (9.1 % ± 6.6 
%, n = 5, p = 0.14 and Figure 7-8 B, B’), a difference between animals with 3 of 
5 showing an increase in microglia proliferation (14.5 % ± 5 %, n = 3, p ≤ 0.02) 
suggesting an incomplete penetration of this phenotype. In conclusion, also 
microglia were activated after deletion of β1-integrin showing hypertrophy, 
upregulation of GSA-lectin and CD11b and an incomplete increase in 
proliferation. As microglia are not recombined by hGFAP-Cre this activation 
seems to be rather indirect and due to a non-cell-autonomous mechanism 
 
Figure 7-8 Microglia are proliferating in WT and in β1-/- cerebral cortex 
Immunofluorescent staining for Iba1 and BrdU revealed that not only activated microglia 
after loss of b1-integrins were proliferating (B, B’), but also resting microglia in uninjured 
WT cortices (A, A’). 
  
116  Results  7 
7.1.4 Could the gliosis phenotype be induced by non cell 
autonomous side effects of β1-integrin deletion? 
Given the fact that not only astrocytes but also microglia were activated after 
deletion of β1-integrin the question arose whether indirect effects like cell death 
or disruptions of the BBB could account for these effects. Integrins have been 
implicated in the regulation of cell survival (Stupack, 2005) and dying cells could 
cause astrocytes and microglia to get reactive. For necrosis Tetsuji Mori used 
Cresyl violet- and DAPI staining, for apoptosis by staining against activated 
caspase 3. Comparable low numbers of pyknotic nuclei or caspase 3 positive 
cells were found in WT and β1-/- cortices demonstrating that reactive astrocytes 
and neurons survive well after the deletion of β1-integrins and that increase in 
cell death is unlikely to induce reactive gliosis in these animals. Astrocytes are 
thought to be important for the integrity and maintenance of the BBB as their 
endfeet cover the majority of the cerebral surface of the endothelium (Wolburg 
et al., 1994; Abbott et al., 2006). After brain injury the BBB is either 
mechanically disrupted or possibly also affected indirectly as a consequence of 
loss of astrocyte polarity observed in experimental autoimmune 
encephalomyelinitis (EAE) (Wolburg-Buchholz et al., 2009; Wolburg et al., 
2009b). Additionally, in brain tumors the BBB has been reported to be leaky and 
this correlates with a loss in astrocyte polarity (Wolburg et al., 2003; Wolburg-
Buchholz et al., 2009). The integrity of the BBB was examined by intraperitoneal 
injection of one of the smallest tracers for BBB leakage, Fluoresceine-Dextran 
with a molecular weight of 3000 Da. As expected the tracer diffused into the 
brain parenchyma after stab wound injury in β1-/- animals (Figure 7-9 A). 
However, fluorescence was restricted to brain capillaries (Figure 7-9 B) and did 
not diffuse any further at the contralateral non-injured hemisphere in mutant 
animals (Figure 7-9 C) showing that the BBB is functionally intact even after 
loss of β1-integrins. Thus, one can conclude that the gliosis phenotype is not 
secondary to the above described events, cell-death or BBB disruption. 
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Figure 7-9 The blood-brain barrier is not impaired after deletion of β1-integrins 
The integrity of the blood-brain barrier (BBB) was tested by injecting a dextran coupled 
to a fluorescent dye intraperitoneal. After stab wound injury to destroy the BBB as 
control for successful injection the dye diffused into the parenchyma in β1-/- cerebral 
cortices (A). In the uninjured contralateral hemisphere the dye was restricted to the 
lumen of blood vessels (B) and did not diffused into the brain parenchyma (C). 
 
7.1.5 The basement membrane is not primarily affected after 
loss of β1-integrins at postnatal stages 
It has been demonstrated before that β1-integrins are required for cells 
contacting the basement membrane (e.g. endothelial cells and radial glia) to 
maintain BM integrity (Graus-Porta et al., 2001; Brakebusch and Fassler, 2005; 
Belvindrah et al., 2006). Thus, the condition of the BM was examined by 
staining for their three major components laminin, collagen IV and perlecan. In 
two month old animals the immunostaining for these components nicely outlined 
blood vessels for all three constituents in both, WT (Figure 7-10 A, C) and 
mutant cortices (Figure 7-10 A’, B, C’) at the lightmicroscopic level. The same 
was true for fibronectin (Figure 7-10 D), another protein present in the ECM. At 
six month of age, however, an irregular distribution of collagen IV was observed 
along the vessels in β1-/- cortices, especially at larger vessels and underneath 
the pia, where it seemed to be disrupted and sometimes punctuated (Figure 
7-10 E’). The BM around smaller vessels seemed still to be intact. 
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Figure 7-10 Basement membrane changes only at later stages in β1-/- cortices 
Immunofluorescent staining of the basement membrane components laminin, perlecan, 
collagen IV and fibronectin were comparable in WT (A) and b1-/- (A’-D) cerebral cortices 
of 2 months old mice. In 6 months old mice collagen IV staining smoothly outlined blood 
vessels in WT cerebral cortices (E). After deletion of β1-integrin collagen IV was not only 
localized to the basement membrane surrounding blood vessels, but was also deposited 
in high amounts in the extracellular matrix close by (E’). 
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To elucidate whether the zipper-like structure of the BM is changed already at 
younger ages leading to an obvious defect at the lightmicroscopy level only later 
on, an ultrastructural analysis of WT and β1-/- cortices was conducted at 2 and 
6 month of age in collaboration with Saida Zoouba (Institute for Pathology, 
HelmholtzZentrum München). The leptomeningal BM displayed some 
abnormalities already in 2 months old animals after loss of β1-integrins seen as 
bright spots separating the two BM sheets. These aberrations were observed 
also in 6 months old mutant brains (Figure 7-11 B-B’), but never occurred in WT 
brains (Figure 7-11 A-A’). In contrast, the perivascular BM around intracerebral 
vessels appeared normal in 2 months and even in 6 months old WT and mutant 
animals (Figure 7-11 C-D’). Astrocyte endfeet appeared frequently swollen not 
only in β1-/- but also in WT brains most likely due to a fixation artifact. 
Otherwise endfeet were morphologically normal and in close contact to the BM 
surrounding intracerebral capillaries (Figure 7-11 C-D’). To summarize, 
perivascular BM defects appeared only at later stages and are neither 
correlated to, nor causing the gliosis phenotype. 
 
Figure 7-11 Analysis of the basement membrane at the ultrastructural level 
At the ultrastructural level the basement membranes (BM) can be identified as two dark 
parallel lines. The leptomeningeal BM (A, A’) displayed irregularities in mutant cortices 
(B, B’). However, perivascular BMs were normal in WT (C, C’) and β1-/- cortices (D, D’) of 
6 months old animals. 
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7.1.6 The astrocyte endfeet polarity is disturbed after deletion 
of β1-integrin 
Not only any indirect effects like cell death, disruptions of the BBB or 
aberrations in the BM could be excluded as a cause for the gliosis, but also the 
loss of β1-integrins in neurons is not sufficient to elicit this phenotype. Thus, 
disturbances in astrocyte polarity itself caused by the loss of signaling from the 
BM could account for the reactivity of astrocytes. To test this hypothesis, 
proteins that are specifically localized at astrocyte endfeet, e.g. Aqp4 and 
members of the DAG complex, were examined. As expected, staining for Aqp4, 
dystrophin, β-dystroglycan and α-dystrobrevin outlined blood vessels in WT 
cortices as capillaries are almost completely covered by astrocyte endfeet 
(Figure 7-12 A, A’, C, C’, E, E’, G, G’). Strikingly, this staining pattern was 
punctuated for all examined astrocyte endfeet proteins in β1-/- cortices (Figure 
7-12 B, B’, D, D’, F, F’, H, H’). This is indicating that at least part of the 
astrocytes lost their endfeet polarity rather than their contact to the BM as no 
endfeet retraction was observed at the ultrastructural level. In conclusion, β1-
integrins are necessary to maintain the endfeet polarity of gray matter 
astrocytes enabling them to acquire a mature non-reactive state. 
7.1.7 Reactive astrocytes in β1-integrin-deficient cortices do 
not proliferate or regain stem cell properties 
After brain injury, some reactive astrocytes dedifferentiate, re-enter the cell 
cycle and even regain stem cell properties in vitro (Buffo et al., 2005; Buffo et 
al., 2008). To test, whether reactive astrocytes in β1-/- cerebral cortices 
proliferate, BrdU was administered for 2 weeks via the drinking water. BrdU-
positive cells were found scattered throughout the brain parenchyma in 
comparable numbers in WT (131.1 ± 21.5 BrdU/ mm2, n = 4) and β1-/- cerebral 
cortices (147.4 ± 53.4 BrdU/ mm2, n = 7, p = 0.65). The vast majority of these 
BrdU-incorporating cells are Olig2-positive progenitors in a normal, non-injured 
WT brain and are giving rise mainly to NG2-glia (Buffo et al., 2005; Dimou et al., 
2008). In line with the observations in WT controls only a low proportion of 
these proliferating cells are positive for GFAP (0.2 % ± 0.7 % BrdU+ GFAP+/ 
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GFAP+ cells in WT, n = 4 and Figure 7-13 D). Unexpectedly, there was no 
significant increase in proliferating astrocytes in β1-/- cortices (3 % ± 1.8 % 
BrdU+ GFAP+/ GFAP+, n = 4, p = 0.06 and Figure 7-13 C, C’, D). Similar 
results have been obtained using S100β to label astrocytes (Figure 7-13 A, B’, 
D). 
 
Figure 7-12 Astrocyte endfeet polarity is disturbed after deletion of β1-integrin 
In the cortical gray matter of WT animals immunofluorescent stainings for proteins 
localized in astrocyte endfeet, like the water channel Aqp4 (A, A’) or members of 
Dystrophin-associated glycoprotein complex including α-Dystrobrevin (C, C’), 
Dystrophin (E, E’) and β-Dystroglycan (G, G’) outline blood vessels as the latter are 
completely covered by astrocyte endfeet. After loss of b1-integrins these stainings were 
disrupted and punctated (B, B’, D, D’; F, F’, H, H’). 
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However, astrocytes in β1-/- cortices acquired several characteristics of reactive 
astrocytes after an injury and could be therefore prone to dedifferentiate under 
supporting conditions. The self-renewing and multipotency capacity of reactive 
astroglia can be tested using the in vitro neurosphere assay (Buffo et al., 2008). 
Towards this aim, tissue from uninjured WT and β1-/- cerebral cortices was 
dissociated and cultured in neurosphere medium. As expected, no 
neurospheres could be grown from WT uninjured gray matter even after 3 
weeks in culture (Figure 7-13 E). Likewise, under physiological conditions 
astrocytes from β1-/- cortices never gave rise to any neurosphere (Figure 7-13 
E), leading to the conclusion that loss of β1-integrins mediated signaling in the 
uninjured brain is not sufficient to induce dedifferentiation of astrocytes towards 
a stem cell stage. A related question is whether deletion of β1-integrin would 
even interfere with regaining a self-renewal capacity after brain injury. To tackle 
this possibility WT and β1-/- animals were injured using a V-lance knife and 
sacrificed 3 days later. Tissue around the lesion site and from the 
corresponding brain region at the contralateral hemisphere was dissected and 
dissociated according to the neurospheres culture protocol. As described 
before, neither from WT, nor from β1-/- contralateral hemispheres neurospheres 
could be generated. Comparable to (Buffo et al., 2008) a low number of plated 
cells gave rise to neurospheres in cultures from WT injured brain tissue (Figure 
7-13 E). Interestingly, preliminary data suggest that this neurosphere-forming 
capacity is reduced after deletion of β1-integrin (Figure 7-13 E). Taken together, 
although elsewise all hallmarks of reactive astrocytes can be observed in β1-/- 
cortices, the proliferative response is not elicited or may be even inhibited upon 
deletion of β1-integrins. 
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Figure 7-13 Astrocytes do not re-enter the cell-cycle after loss of β1-integrins 
After 2 weeks of BrdU administration hardly any BrdU S100β double positive astrocyte 
could be seen in WT (A, A’) and β1-/- (B, B’) cerebral cortices. The same held true for 
counter labeling with GFAP in β1-/- cortices (C, C’). D shows that numbers of BrdU-
positive cells counterlabeled with S100β or GFAP do not differ between intact WT and β1-
/- cortices. No neurospheres were formed from WT and β1-/- dissociated uninjured 
cortices (E). The formation of primary, as well as secondary neurospheres from the 
injured cerebral cortex was impaired in β1-/- mice (E).  
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7.2 The influence of β1-integrins on astroglial-like stem 
cells 
Astroglial-like stem cells in the subependymal zone make contact to and are in 
close proximity to the BM surrounding blood vessels. It has been proposed that 
this close contact is a special and essential feature of the stem cell niche (Shen 
et al., 2008).  
7.2.1 β1-integrins are dispensable for the proliferation of adult 
SEZ stem cells 
To examine the role of β1-integrins mediated signaling from the basement 
membrane, slow dividing cells were marked using a label retaining BrdU pulse. 
Therefore, BrdU was administered for two weeks via the drinking water followed 
by a two weeks chase to dilute the label in fast proliferating cells. In the SEZ of 
WT mice 40.4 % of the cells that incorporated and kept the BrdU label were 
GFAP+ stem cells (Figure 7-14 A, n = 2). Similarly, 41.9 % of the cells were 
double positive for BrdU and GFAP in the SEZ of β1-/- brains. Only a small 
proportion of the BrdU+ cells stained for Dcx in WT (14.5 %) and β1-/- (9.7 %) 
SEZs suggesting that 2 weeks chase are sufficient to dilute the label in most of 
the fast proliferating progeny of SEZ stem cells, the type C cells that then give 
rise to Dcx+ neuroblasts. Almost half of the BrdU+ cells were neither positive for 
GFAP nor for Dcx in WT (45.1 %) and β1-/- (48.5 % and Figure 7-14 A) brains 
and could be slow-proliferating NG2 or Olig2 cells, endothelial cells, ependymal 
or postmitotic progeny of the astroglial-like stem cells. To investigate the self 
renewing capacity of stem cells after loss of β1-integrins neurospheres were 
cultured from the adult SEZ. In order to do so, the SEZ of WT and β1-/- mice 
was dissected, the tissue was dissociated and cells were seeded in 
neurosphere medium containing the growth factors EGF and FGF under non-
adherent conditions in cell culture flasks. Under these conditions, one single 
stem cell can divide giving rise to daughter cells that stick together forming a 
neurosphere. Thus, one neurosphere is a clone derived from a single cell. In 
line with the results obtained in vivo, primary neurospheres were similar in 
number in WT and β1-/- cultures (Figure 7-14 B, n = 2). To test self-renewal, 
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primary neurospheres were dissociated to single cells and plated at clonal 
density (1 cell per µl). The number of secondary spheres was quantified and 
preliminary results obtained from 2 independent cultures indicated no significant 
differences between WT and β1-/- cultures (Figure 7-14 B). Taken together, 
deletion of β1-integrins did not interfere with the proliferative capacity of adult 
SEZ stem cells. 
 
 
Figure 7-14 Proliferation capacity of SEZ stem cells after deletion of β1-integrins 
A label retention BrdU pulse was used to mark slow dividing and postmitotic cells. SEZ 
stem cells were quantified after immunofluorescent staining for BrdU and GFAP in WT 
and β1-/- brains (A). Neurospheres were cultured from the adult SEZ of WT and β1-/- 
brains and the number of primary and secondary spheres was quantified (B). 
 
7.2.2 β1-integrins are important for neuroblast migration 
Newly generated neuroblasts, the progeny of the SEZ stem cells, migrate in 
chains through the RMS towards the OB (Figure 7-15 A, C, D), where they 
differentiate into interneurons. In WT brains the RMS is a clearly defined path 
characterized by blood vessels running in parallel (Saghatelyan, 2009; Snapyan 
et al., 2009) and Figure 7-15 A’), which newborn neurons leave only when they 
reached the OB. After deletion of β1-integrins, however, the RMS seemed to be 
larger containing massive amounts of neuroblasts (Figure 7-15 B, B’). These 
neuroblasts did not migrate in chains anymore, but in a rather unordered 
manner (Figure 7-15 B, E, F). Often Dcx+ cells leaving the RMS migrated into 
the striatum along and intermingled with striatal fibers (Figure 7-15 G). 
Nevertheless, some of them used blood vessels as a substrate (Figure 7-15 H), 
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as also seen for the neuroblasts migrating towards the cerebral cortex, which 
were mostly located in lower cortical layers (Figure 7-15 J). Notably, this 
phenotype was predominant in only one of these regions with migration of 
neuroblasts either largely into the striatum or the cerebral cortex. 
It has been demonstrated that the parallel organization of blood vessels is 
essential for neuroblast migration within the RMS (Snapyan et al., 2009). 
Strikingly, the arrangement of RMS blood vessels was disturbed after deletion 
of β1-integrins (Figure 7-15 B, B’). As hGFAP-Cre mediated recombination 
spares endothelial cells, it is tempting to speculate that astrocytes influence the 
organization of RMS blood vessels during development by β1-integrins 
mediated mechanisms. 
To investigate the fate of the mismigrating neuroblasts a label retention BrdU 
pulse was given to mark newly generated cells and allow them to mature. As 
expected, no overlap between BrdU and NeuN, a marker for mature neurons, 
could be detected in striatum or cortical gray matter of WT animals. However, 
the misrouted newborn neurons in the striatum matured to a certain extent, as 
NeuN BrdU double positive cells were detected in one out of three animals 
(Figure 7-15 M, N). This was not observed in the cerebral cortex. However, 
given the variability of this phenotype as described above, many more animals 
would have to be examined to assert the absence of BrdU/ NeuN positive cells 
in the cortex. Taking into account the huge number of Doublecortin cells, this 
analysis clearly shows that only few of them reach the NeuN positive state of 
neuronal maturity. 
Figure 7-15: Neuroblasts migrate within the rostral migratory stream (RMS) along blood 
vessels that are arranged in parallel (A, A’). Tangentially migrating neuroblasts formed 
chains in WT brains (C, D). After loss of b1-integrins neuroblasts leave the RMS (B), 
which lost its parallel organization of blood vessels (B’). In addition, the chain migration 
of neuroblast was lost and neuroblast were unorganized (E, F). Neuroblast that left the 
RMS migrated into the striatum using striatal fibers (G) or blood vessels (H). Neuroblasts 
migrating toward the cortical gray matter were observed in close proximity to blood 
vessels (J). Astrocytes in the RMS were in contrast to surrounding astrocytes fibrous 
and GFAP-positive clearly outlining the path (K, K’). After deleting b1-integrin RMS 
astrocytes became hypertroph and indistinguishable from surrounding astrocytes, which 
were likewise hypertroph and GFAP-positive (L, L’). Some of the neuroblasts entering the 
striatum further matured into NeuN positive neurons (arrowheads in M and N). 
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Figure 7-15 β1-integrins influence neuroblast migration 
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7.3 Polarity of astrocytes after brain injury 
Stem cell astrocytes as well as parenchymal astrocytes of the gray matter are 
polarized at their basal membrane domain and this special kind of polarity 
seems to be important for gray matter astrocytes to acquire a mature non-
reactive phenotype (see above). After traumatic brain injury, the contact of 
astrocytes directly at the injury site may be disrupted mechanically, thus 
interfering with this type of polarity. However, depending on the magnitude of 
injury astrocytes do not only upregulate IMF and modulate the ECM; in near 
proximity of the injury site they also change their morphology dramatically 
towards an elongated shape establishing another kind of polarity (Figure 7-16 
A, B and Oberheim et al., 2008) that can be modeled in vitro by using a scratch 
wound assay. In this assay a monolayer of mouse astrocytes from the postnatal 
cerebral cortex has been grown to full confluence in standard medium 
supplemented with 10 % FCS without any further growth factors to allow the 
acquisition of a relatively mature state. After 3 to 4 weeks in culture cells were 
mostly of flat morphology and could be labeled with antibodies against the 
astrocytic proteins S100β and/or GFAP (Figure 7-17 A-A’’). Most of the 
astrocytes were positive for both proteins (arrowheads in Figure 7-17 A-A’’) and 
only some cells were only S100β immunoreactive (stars in Figure 7-17 A-A’’). 
As previously described (Etienne-Manneville, 2006), after injuring the 
monolayer astrocytes extended a process into the scratch and subsequently 
migrated, which reduced the scratch size already 24 hours later (Figure 7-17 B-
E). Astrocytes adjacent to the scratch extended processes with leading tips 
mostly filled by tubulin positive fibers and stabilized by the actin cytoskeleton 
(Figure 7-17 F, G). This protrusion formation was preceded by reorientation of 
the centrosome (Figure 7-17 H) and the golgi apparatus (Figure 7-17 J) towards 
the injury site.  
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Figure 7-16 Astrocytes change their morphology after acute injury in vivo 
Astrocytes in the gray matter of the intact cerebral cortex have star like morphology with 
a few main processes ramifying into thousands of fine branches (A). After stab wound 
injury astrocytes elongate and extend a few thick processes towards the injury site, 
whereas branches at the rear of the cell seem to be retracted (B). 
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Figure 7-17 Astrocytes in vitro react to injury by polarization and migration 
Cells of postnatal astrocyte cultures were mainly double-positive for S100β and GFAP 
(arrowheads in A, A’, A’’), only few cells were only positive for S100β (stars in A, A’, A’’). 
After scratching, cells in the monolayer reacted to the injury and reduced the size of the 
gap over time (B-E). Astrocytes at the scratch formed an extension into the cell free area 
(F, G, and H). These protrusions were rich in tubulin and stabilized by the actin 
cytoskeleton (F, G). Centrosomes (arrowhead in H) or golgi (J) of polarized cells were 
reoriented facing the injury area. 
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7.3.1 Small RhoGTPases influence astrocyte polarization and 
migration in vitro 
Cdc42 is important to polarize cells after injury in vitro 
Astrocyte cultures of postnatal C57/ Bl6 mice were stained for Cdc42 at 
different time points after injuring the monolayer (Figure 7-18 A – C’). Shortly 
after the injury Cdc42 is localized mainly around the nuclei of astrocytes directly 
at the scratch wound (Figure 7-18 A), whereas the protein is relocalized towards 
the leading edge of astrocytes facing the scratch 8 hours later (Figure 7-18 B, 
C). High power magnification revealed that the protein is enriched at the tips of 
the newly formed processes (Figure 7-18 C’).  
 
Figure 7-18 Cdc42 is re-localized after scratch wound in vitro 
Cdc42 protein is distributed around the nuclei of cells shortly after scratching the 
monolayer (A). Eight hours later Cdc42 is re-localized towards the leading edge (B) and 
to the tips of tubulin filaments (C and C’). 
 
To examine the role of Cdc42 in this process, we used a genetic deletion to 
avoid unspecific side effects of constitutive active and dominant negative 
constructs (see introduction). Postnatal astrocytes of mice containing the Cdc42 
gene flanked by loxP sites (Figure 7-19 A and X. Wu et al., 2006) were cultured 
and transduced with lentiviruses containing the sequence for either Cre-IRES-
GFP/ tomato-IRES-Cre (Cdc42∆ cultures, Figure 7-19 E) or GFP/ tomato alone 
(control cultures, Figure 7-19 D).  
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Figure 7-19 Conditional alleles for Cdc42, Rac1, and RhoA and lentiviral constructs 
LoxP sites are inserted into the Cdc42 (A), Rac1 (B) or RhoA (C) gene generating 
conditional alleles, which can mediate recombination and subsequent gene deletion, 
when transduced with Cre recombinase containing lentiviruses (E). Control viruses 
encode fluorescent proteins only (D) and therefore do not recombine conditional alleles. 
Drawings of targeting constructs of Cdc42 and Rac1 from Chrostek et al., 2006; X. Wu et 
al., 2006 and for RhoA provided by Cord Brakebusch. 
 
Two weeks after transduction control and Cdc42∆ cultures were stained for 
Cdc42 (Figure 7-20). Cdc42 was enriched as dots at cell borders and within the 
cells (Figure 7-20 A, A’), as well as at cell-cell contacts (Figure 7-21 B, B’) of 
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control- and non-transduced cells (Figure 7-20 A’’, B’’, C’’). In contrast, Cdc42 
was absent in all these places in tomato-IRES-Cre transduced cells (Figure 
7-20 C-D’’) confirming that the Cdc42 gene was successfully deleted and Cdc42 
protein levels were substantially reduced 2 weeks after lentiviral transduction. 
Strong red fluorescence around the nuclei of transduced cells could be 
observed in control and Cdc42∆ cultures. This could be due to clustering of the 
tomato protein or even to a fixation or staining artifact as it has been seen only 
after enhancement with antibody stainings, but never in timelapse imaging 
using the intrinsic tomato fluorescence. 
 
Figure 7-20 Loss of Cdc42 protein after deletion of the gene 
In a culture transduced with control virus Cdc42 was enriched in dotty structures within 
the cell and at sites of cell-cell contact (red arrows, A-B’’), but vanished in cells 
transduced with Cre virus (white arrows, C-D’’). 
 
After wounding a confluent astrocyte monolayer the reaction of the astrocytes 
was followed over time in control and Cdc42∆ cultures. As expected the 
majority of first row astrocytes directly at the scratch formed long protrusions, 
defined as extensions at least 3 times longer than wide into the cell free area 48 
hours after starting the experiment in control cultures (Figure 7-21 A, A’). In 
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Cdc42∆ cultures transduced astrocytes in the first row appeared less organized 
and were largely lacking an obvious polarization towards the scratch (Figure 
7-21 B, B’). To investigate whether already initiation of polarization is disturbed 
the reorientation of the centrosome (microtubule organization center, MTOC) 
towards the site of injury was determined in transduced cells of control and 
Cdc42∆ cultures. Therefore, the space was separated into 4 equal quadrants 
joining in the center of the nucleus of interest and placed so that one quadrant 
was facing the scratch (the median of each 90° angle being either perpendicular 
or parallel to the scratch). In non-oriented cells, the centrosome is located 
randomly around the nucleus with equal chance (25 %) to be localized in any of 
the 4 quadrants. Centrosomes were scored as reoriented, when they were 
located in the quadrant facing the scratch.  
As a starting point the orientation of the centrosome was quantified 30 minutes 
after wounding the monolayer. By then the fringe of astrocytes directly at the 
scratch re-attached to the coverslip. In control cultures MTOCs were facing the 
scratch in a more or less random manner 30 minutes after the scratch (30.3 ± 
1.6 %). As soon as 4 hours post injury (HIP) some of the transduced first row 
astrocytes started to reorient their MTOC towards the scratch (39.9 ± 1.9 %). 
These numbers further increased to around 53.6 ± 1.7 % 24 HPI (Figure 7-21 
C, D). Comparable to control cultures Cdc42∆ MTOCs were facing the scratch 
area in a rather random manner at the beginning of the experiment (35.4 ± 1.7 
%). However, even 24 HPI the number of reoriented MTOCs did not increase 
further in astrocytes with Cdc42 deletion (36.9 ± 1.2 % and Figure 7-21 C, D), 
implicating that Cdc42 is necessary to reorient the centrosome towards the 
wounded area thereby initiating polarization towards the site of injury. To further 
investigate the influence of Cdc42 on astrocyte polarity the number of protrusion 
forming cells was quantified at different time points after the scratch wound 
injury. In control and Cdc42∆ cultures a small percentage of the transduced 
cells had an extension 3 times longer than wide oriented into the scratch wound 
injury 30 minutes after the start of the experiment (7.0 ± 0.9 % in control, 7.9 ± 
1.7 % in Cdc42∆ cultures and Figure 7-21 E, F). This is most likely due to 
already existing processes that were not removed by scratching the monolayer. 
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Over time an increasing number of transduced cells built a protrusion into the 
cell free area (Figure 7-21 E) and 24 HPI more than half of the cells were clearly 
polarized and elongated towards the injury site in control cultures (55.2 ± 2.4 % 
and Figure 7-21 F). In contrast, a significantly lower number of transduced cells 
formed protrusions into the scratch in Cdc42∆ cultures 24 HPI (21.6 ± 3.0 %, n 
= 6, p ≤ 0.0022; Figure 7-21 E, F). Taken together, after injury cytosolic Cdc42 
is redistributed towards the membrane domain facing the insult to initiate 
polarization of the cell by mediating MTOC reorientation and protrusion 
formation. 
 
Figure 7-21 Cdc42 is involved in establishment of astrocyte polarity after injury in vitro 
In control cultures astrocytes formed a protrusion into the scratch (A, A’); whereas Cre-
transduced cells partially lack an oriented protrusion (B, B’). The MTOC reorientation (C) 
and protrusion formation (E) was quantified at different time points. 24 h after scratch 
statistics show a significant reduction in MTOC reorientation (D) and protrusion 
formation (F) upon deletion of Cdc42. 
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Loss of Rac1 impairs the orientation of formed protrusions after injury in vitro 
To examine the specificity of this effect, I also examined cells deficient for Rac1 
and RhoA using again a genetic approach (Figure 7-19 B, C and Chrostek et 
al., 2006). Loss of Rac1 protein could not be confirmed by immunofluorescent 
staining as no specific antibodies were available. However, defects observed 
only in Rac1 fl/ fl astrocyte cultures transduced with Cre lentivirus, but not with 
control virus, are indicative for efficient loss of Rac1 protein 2 weeks after 
transduction. Two days after wounding a monolayer of astrocytes control-
transduced cells formed a long protrusion into the cell-free area (Figure 7-22 A). 
Cre-transduced astrocytes were forming a protrusion, which was, however, 
often not oriented into the scratch (Figure 7-22 B). As this phenotype seemed to 
be different from the deletion of Cdc42, again reorientation of the MTOC and 
protrusion formation of the transduced astrocytes was analyzed at different time 
points after wounding the astrocyte monolayer to address which steps in 
polarization of first row cells would be affected. As described before for the 
deletion of Cdc42, in the beginning of the experiment a random number of 
transduced cells had their MTOC facing the scratch in control (29.0 % ± 1.3 %, 
n = 8) and Rac1∆ (26.3 % ± 1.4%, n = 8) astrocytes (Figure 7-22 C, D). In 
control-transduced astrocytes the number of cells with reoriented MTOC 
increased over time reaching a plateau 24 hours after the scratch (Figure 7-22 
C). After loss of Rac1 a significant number of cells had reoriented MTOCs 24 
hours after wounding the monolayer (Figure 7-22 D). Nevertheless, this number 
was reduced when compared to control-transduced astrocytes (38.9 % ± 2.0 %, 
n = 8 Rac1∆ versus 47.0 % ± 1.7 %, n = 6 control-transduced, p ≤ 0.083 and 
Figure 7-22 D). The number of cells with reoriented MTOC did not increase 
further, even 48 HPI (Figure 7-22 C). Interestingly, this correlates with a 
reduced number of protrusions oriented into the scratch area after loss of Rac1 
(31.4 % ± 1.1 %, n = 6) when compared with control-transduced cultures (61.6 
% ± 2.5 %, n = 8) 24 HPI (Figure 7-22 E, F). In contrast to deletion of Cdc42, 
loss of Rac1 does not seem to interfere with the initiation of protrusion formation 
as a comparable number of cells started to form a protrusion 8 HPI (Figure 7-22 
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E). However, the orientation of most of the cell towards the site of injury seems 
to be impaired at later time points (Figure 7-22 C, E, F). 
 
 
Figure 7-22 The role of Rac1 after scratch wound injury in vitro 
In contrast to control-transduced cells (A), Cre-transduced astrocytes formed 
protrusions, which were randomly oriented around the cell body (B). MTOC reorientation 
(C) and oriented protrusion formation (E) were quantified at different time points. 
Statistical analysis was performed at 24 hours after injury when the number of cells 
reorienting their MTOC and forming a protrusion reached a plateau (D, F). 
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RhoA is dispensable for MTOC reorientation and protrusion formation in 
astrocytes after scratch wound injury in vitro 
The third small RhoGTPase important for cytoskeletal rearrangements in 
astrocytes, RhoA, has been analysed as decribed above using again a genetic 
approach (Figure 7-19 C). Despite the clear loss of RhoA in Cre-transduced 
cells 2 weeks after transduction, control and RhoA∆ astrocytes were 
comparable 48 hpi (Figure 7-23 A, B). Accordingly, detailed analysis of MTOC 
reorientation and protrusion formating at different timepoints after scratch 
wound injury showed that loss of RhoA did not infere with any of these 
parameters (Figure 7-23 C-F).  
Taken together, Cdc42 was necessary for orientation of the cell towards the 
injury are as well as for initializing cytoskeletal re-arrangements leading to 
protrusion formation, whereas Rac1 rather seemed to be important for 
orientation of these protrusions. On the contrary, RhoA was dispensable for 
both of these processes showing also that the Cre recombinase encoded by the 
lentiviral construct is acts specific and is not toxic in this experimental setup.  
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Figure 7-23 The role of RhoA after scratch wound injury in vitro 
No difference in protrusion formation was noted when comparing immunofluorescent 
stainings of control transduced astrocytes (A) and Cre-transduced astrocytes (B) 48 
hours after scratch wounding. Quantification of MTOC reorientation (C, D) and oriented 
protrusion formation (E, F) confirmed that deletion of RhoA had no effect on these 
parameters. 
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7.3.2 Astrocyte polarization upon injury leads to their 
subsequent migration in vitro 
The orientation of fewer cell processes towards the scratch after deletion of 
Cdc42 and Rac1 could result from a total loss of protrusion formation, random 
generation of processes or higher protrusion turnover. To investigate the 
consequences of impaired centrosome reorientation and the cause for a 
reduced number of oriented processes after deletion of Cdc42 and Rac1 by 
following single cells over several days, timelapse imaging has been 
established. In order to do so, an Axioobserver Z.1 microscope with motorized 
stage from Zeiss was equipped with an incubation chamber (Zeiss XL S1) 
connected to the TempModul S1 for keeping the cultures at 37°C. Furthermore, 
the CO2 Module S1 connected to the CO2 lid (Zeiss PM S1) allowed controlling 
CO2 concentrations and was obligatory for healthy cultures during longer 
imaging periods (more than 12hours). An additional heating module for the 24-
well plates (Zeiss M24 S1) turned out to be absolute essential to keep cultures 
in focus during imaging. In addition, not all 24-well plates were suited to either fit 
into the heating unit or to be steady despite small variations in temperature. The 
best results were achieved using BD Falcon™ 24-well multiwall plates (BD 
Falcon™ 353047). The microscope was further connected to a high resolution 
camera (AxioCam HRc Rev.3) allowing rapid time lapse sequences despite a 
high image resolution. Microscope, heating and CO2 modules, as well as the 
camera were controlled by the AxioVision Software from Zeiss. 
For timelapse imaging, astrocytes were transduced with lentiviruses and 
seeded into PLO-coated BD Falcon™ 24-well plates after growing them in T75 
cell culture flasks as described above. Two weeks after transduction the 
astrocyte monolayer was scratched using a pipette tip, thereby taking care that 
the plastic was not scraped as otherwise cells would stop there. 
In the beginning, bright field and fluorescent images were taken each 10 
minutes. The exposure time in the fluorescent channel had to be relatively long 
to detect the comparatively lower GFP levels in LV-Cre-IRES-GFP-transduced 
cells. Higher GFP levels in control-transduced astrocytes were due to 
expression of the GFP gene directly behind the CMV promoter, whereas GFP in 
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LV-Cre-IRES-GFP had to be translated from an internal ribosomal entry site 
resulting in lower efficiency. However, those cells expressing higher levels of 
GFP were observed to die more frequently than astrocytes with lower levels of 
the fluorescent dye, most likely due to phototoxicity (movie 1). Phototoxicity 
could be minimized by taking only one or two fluorescent images per hour, 
whereas bright field pictures were still taken every 10 minutes to assure high 
time resolution of the movies. At this point fluorescent images were needed only 
to identify transduced cells, whereas bright field images served to follow cellular 
movements. To further circumvent phototoxicity and different levels of the 
fluorescent dye in control and Cre-transduced cultures, the gene encoding the 
red fluorescent dye tomato was cloned behind the CMV promoter resulting in 
the control lentiviral construct LV-tomato. A second construct was designed with 
IRES-Cre behind the tomato gene (LV-tomato-IRES-Cre). Transduction of 
astrocytes with LV-tomato (movie 2) and LV-tomato-IRES-Cre (movie 3) 
resulted in comparable levels of the fluorescent dye, which allowed reducing the 
exposure time and therefore phototoxicity allowing imaging over several days. 
In movies of Cdc42 fl/ fl astrocytes transduced with LV-tomato cells, as well as 
non-transduced cells reacted to the injury as described above by extending a 
long protrusion into the scratch. Subsequently, cells started to migrate into the 
cell-free area (movie 2 and 4). Interestingly, cell divisions were observed 
regularly at the injury border (movie 4). Migration as well as proliferation were, 
nevertheless, notably slower compared to HEK (movie 5) or 3T3 (movie 5) cell 
lines. After transduction with LV-tomato-IRES-Cre Cdc42 fl/ fl astrocytes 
sometimes started to form a protrusion, but often did not relococalized their cell 
body thereupon. Meanwhile, non-transduced astrocytes in Cdc42∆ cultures 
passed by leaving the Cdc42∆ cells behind (movie 3). In general, cell divisions 
were also seen in Cdc42∆ astrocytes. Taken together, the timelapse imaging 
showed that some Cdc42∆ astrocytes were initially able to form a protrusion, 
but often failed to migrate efficiently into the scratch. I attempted then to clarify, 
whether the effect of Cdc42 on the polarity and migratory behavior of astrocytes 
is also of relevance after brain injury in vivo. 
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7.3.3 Conditional Cdc42 deletion influences morphology 
changes of astrocytes after cortical stab wound injury 
As Cdc42 had an important role in astrocyte polarity after scratch wound injury 
in vitro, the relevance of this small RhoGTPase for the reaction of astrocytes to 
an acute brain injury in vivo was investigated. To investigate the role of Cdc42 
in adult NSCs, the gene was conditionally deleted in astrocytes including the 
NSCs of adult animals taking advantage of the Glast::CreERT2 mouse line, 
which was mated to a mouse line with loxP sites flanking exon2 of the Cdc42 
gene. Recombination was achieved by administration of the estrogen analogue 
Tamoxifen (Figure 7-27 A) in 2-3 month old mice heterozygous for 
Glast::CreERT2, positive for a GFP-reporter and homo- (herein after referred to 
as Cdc42∆) or heterozygous (WT or control) for the Cdc42 allele flanked by 
loxP sites. Four weeks later, a stab wound was placed in the gray matter of the 
cerebral cortex (Figure 7-24 A). From the in vitro analysis (Figure 7-21), I 
conclude that recombined cells are deficient of Cdc42 protein at that time point. 
In the uninjured hemisphere no obvious differences in terms of astrocyte size or 
morphology have been observed after deletion of Cdc42. Similar to the analysis 
in vitro, the number of cells, which had formed a protrusion, was quantified. A 
protrusion was defined as an elongated process clearly longer than wide 
oriented in the direction of the stab wound injury (Figure 7-24 B). In WT brains 
39.2 % ± 1.7 % (n = 3) of the cells in the palisading zone, which is the region 
where astrocytes elongate their shape, formed a protrusion oriented towards 
the injury (Figure 7-24 C). Surprisingly, this number was significantly enhanced 
after loss of Cdc42 (68.4 % ± 3.6 %, n = 4, p ≤ 0.001, Figure 7-24 D, E). This 
was in contrast to the results achieved in vitro, where less astrocytes formed a 
protrusion oriented towards scratch wound (see discussion). Although the 
protrusion length itself or the length of the retracting end was not different 
between WT and Cdc42∆ cells, a significant increase in total cell length was 
noted (Figure 7-24 D, F) due to Cdc42∆ cells being larger in general after stab 
wound injury (Figure 7-24 G, H).  
The measurements of the cell length and width were done together with Sophia 
Bardehle (Institute of Stem Cell Research, HelmholtzZentrum München). 
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Quantifying the number of cells per mm2 revealed a strong tendency towards a 
reduced number of cells in the palisading zone in Cdc42∆ compared to WT 
injured brains (209.7 ± 61.4 cells per mm2 in WT, n = 3 versus 95.5 ± 9.2 in 
Cdc42∆, n = 4, p = 0.0571, (Figure 7-24 J). As the number of recombined cells 
per area in the contralateral uninjured hemispheres were comparable between 
WT and Cdc42∆ the reduction in cell numbers close to the injury site could be 
due to a migration defect as observed in vitro. Alternatively, the proliferation of 
astrocytes at the injury site could be affected. To test this, BrdU was 
administered for 3 days via the drinking water after stab wounding the animals. 
Astrocytes that had been incorporated BrdU were counted at day 3 after the 
stab wound injury. In WT brains 14.8 ± 0.7 % (n = 2) of the recombined cells at 
the injury site incorporated BrdU. In contrast, this population was reduced by 50 
% after deletion of Cdc42 3 DPL (7.8 ± 3 % GFP BrdU+ cells in Cdc42∆, n = 4, 
p ≤ 0.0376) showing that deletion of Cdc42 interferes with the proliferation 
capacity of astrocytes after stab wound injury.  
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Figure 7-24 The role of Cdc42 for the reaction of astrocytes to injury in vivo 
Genetic recombination was induced in 2-3 months old animals, which were stab wound 
injured 4 weeks later and sacrificed 3 or 7 days post lesion following the protocol in A. 
The measurements of cell length and protrusion length in recombined cells were done as 
shown in B. Recombined astrocytes positive for GFP and counterstained with GFAP 
were increased in size in Cdc42∆ (D) compared to WT (C) brains. The number of 
astrocytes forming a protrusion was increased after loss of Cdc42, as well as the total 
cell length (D). Cell width in relation to cell length is plotted for WT (G) and Cdc42∆ (H) 
showing a group of larger cells after deletion of Cdc42. The number of recombined 
astrocytes per area is reduced after Cdc42 deletion (J). 
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7.3.4 Deletion of Cdc42 in virtually all astrocytes lead to an 
increased injury size after stab wound injury in vivo 
Deletion of Cdc42 from astrocytes in the adult brain seemed to interfere with 
their reaction to an acute brain insult in a cell-autonomous way as only a subset 
of astrocytes was recombined. Whether this would be of functional 
consequence for the wound healing, was tested by deletion of Cdc42 in virtually 
all astrocytes using hGFAP-Cre. hGFAP-Cre+, Cdc42 fl/ fl animals (referred to 
as KO) survived into adult stages, when backcrossed to the C57Bl/6 genetic 
background. KO and WT (negative for hGFAP-Cre) animals were injured at the 
age of 2-3months and analyzed 3 days later. To judge whether reactivity of 
microglia and inflammation overall was changed, the area covered by 
hypertroph Iba1-positive microglia was measured. In WT (430800 ± 89460 µm2) 
and KO (548500 ± 202300 µm2) injured hemispheres a comparable area was 
covered by hypertroph microglia (n = 3, p = 0.5581). Likewise, upregulation of 
GFAP in astrocytes of the injured hemisphere was not significantly changed 
after deletion of Cdc42 (55.9 ± 1.1 % of the total area measured in WT, n = 6 
and 71.5 ± 17.1 %, n = 2 in KO, p = 0.1089). As the cells that upreguled GFAP 
sometimes even exceeded the image section, the area covered by GFAP was 
displayed as % of the total area measured. As readout for immediate neuronal 
damage, the transient downregulation of NeuN has been assessed. In WT 
animals, neurons downregulated NeuN in a defined region around the injury site 
(395000 ± 149200 µm2, n = 5). Although the mean area was increased in KO 
brains (655900 ± 362500 µm2, n = 3, p = 0.3385), variations from animal to 
animal were high, not allowing a clear-cut conclusion from this analysis 
parameter. The actual injury size was determined by measuring the DAPI-free 
area within the gray matter of the cerebral cortex, where the injury was placed. 
There was a considerable variation in WT animals as there were brains without 
any or very little tissue loss (Figure 7-25 A), the mean DAPI-free area was 
40980 ± 17470 µm2 (n = 6) in WT brains. KO ipsilateral hemispheres appeared 
to have pronounced tissue loss (Figure 7-25 B) and a 3 times larger mean injury 
size of 120200 ± 28040 µm2 (n = 3, p ≤ 0.0398 and Figure 7-25 C) suggesting 
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that Cdc42 in astrocytes is important either to preserve injured brains from 
tissue loss or for wound closure.  
 
 
Figure 7-25 Consequences of Cdc42 deletion in virtually all astrocytes 
After stab wound injury in WT normally almost no tissue is lost (A). After deletion of 
Cdc42, the injury size was larger (B). The area of tissue loss (= DAPI nuclei free) was 
quantified per animal in C.  
7.3.5 Are astrocytes migrating after acute brain trauma in vivo? 
The impaired proliferation capacity of astrocytes after loss of Cdc42 certainly 
accounts for the reduced astrocyte numbers at the injury size (see above). 
Deletion of Cdc42 in vitro suggests, however, that impairment in astrocyte 
migration possibly adds to this phenotype. To address whether migration of 
astrocytes after an acute brain trauma is part of their reactive response in vivo, 
astrocytes in the adult mouse cerebral cortex were labeled injecting a lentivirus 
encoding GFP (LV-GFP, Figure 7-26 A). As the very thin glass needle used for 
injecting the virus created a small injury itself, the stab wound was done 4 
weeks later or even before injecting the virus (Figure 7-26 B) making sure that 
astrocytes at the needle track were not reactive anymore or attractant 
molecules from the stab wound site had a “head start”. The stab wound was 
placed 3 mm distant from the injection site following the protocol of (Auguste et 
al., 2007 and Figure 7-26 B). The depth of the injection was maximal 1 mm to 
restrict the labeling to astrocytes in the gray matter. Lentiviral Injections were 
done in both hemispheres, whereas only one hemisphere was stab wounded 
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(Figure 7-26 B) and the other contralateral (CL) one served as control (Figure 
7-26 A). The virus diffused dependent on the quality of the injections up to 850 
µm into the tissue in CL hemispheres. Despite strong GFAP-upregulation 
around the lesion site GFP-positive astrocytes were not seen to be farther away 
from the injection site independent of the distance of the stab wound injury 
(Figure 7-26 A and B). Whether astrocytes closer than 1 mm from the injury site 
would migrate there could not be judged by this indirect method due to the 
widespread diffusion of the virus. That is why I attempted then to directly follow 
astrocytes by life imaging in vivo. 
2-photon imaging allows to image fluorescent labeled cells and structures like 
blood vessels intravital, in the living animal. As the animals can be repeatedly 
analyzed one might hope that it would be possible to ascertain whether 
astrocytes indeed migrate towards a site of injury. To investigate whether it is 
possible to follow astrocytes by this technique, some pilot experiments were 
done in collaboration with Frank Kirchhoff (Max Planck Institute for 
Experimental Medicine Göttingen). A transgenic mouse expressing GFP under 
the human GFAP promoter was anaesthetized, the skull was thinned and the 
mouse was fixed in a stereotactic frame underneath the microscope. Then, a 
high molecular Dextran-TexasRed was injected into the tail vein to display the 
vascular structure of the brain for orientation. First, a low resolution bright field 
picture of the meningeal vessels was taken to be able to determine roughly in 
which region pictures were taken, which was important for later imaging 
sessions. Z-stacks of GFP positive astrocytes and TexasRed-labeled blood 
vessels were collected in the intact gray matter of the cerebral cortex up to a 
depth of 600 µm (Figure 7-26 C). Then, the laser power was increased and 
focused to the wall of a blood vessel and tissue surrounded by GFP-positive 
astrocytes to observe their reaction towards this comparable small laser lesion 
(Figure 7-26 D). During the imaging period of 2 more hours no reaction of 
nearby astrocytes in regard to movement or process motility could be observed. 
When the same animal was imaged again 3 days later astrocytes surrounding 
the laser lesion changed their morphology towards an elongated shape with 
processes extended in the direction of the injury (Figure 7-26 E). However, it 
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was difficult to follow single cells, especially as hGFAP-eGFP transgenic 
animals upregulate GFP after injury resulting in more labeled cells at day 4 
(Figure 7-26 E) than had been seen at day 1 (Figure 7-26 C, D). To overcome 
this limitation astrocytes were stably labeled before the start of the experiment 
by the use of adult Glast::CreERT2 mice (Mori et al., 2006) mated to a GFP-
reporter line (Nakamura et al., 2006). The mice were induced with tamoxifen 
following the above mentioned protocol and were imaged two weeks later to 
assure that the tamoxifen has been cleared from the system and no new 
recombination events would occur anymore. Although the astrocytes labeled by 
the GFP-reporter were clearly not as bright as the ones labeled in the hGFAP-
eGFP transgenic line, the signal was sufficient for imaging (Figure 7-26 F-H). 
Before the lesion, cell bodies were seen as a bright spots surrounded by diffuse 
and less GFP-intensive signal of their processes (Figure 7-26 F). Immediately 
after the laser lesion, larger nearby blood vessels dilated in response to the 
injury, but again no immediate reaction of astrocytes was observed (Figure 7-26 
G). The same animal was imaged again two days later showing two astrocytes, 
which extended a long process towards the injury (Figure 7-26 H, cells1 and 2). 
Overall the intensity of labeled astrocytes seemed to be higher, maybe due to 
the retraction of the finer branches. Taken together, following astrocytes by 2-
photon microscopy in vivo is feasible. However, with these time intervals I could 
not determine, whether the increase in astrocyte numbers was due to cell 
migration. 
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Figure 7-26 Intravital imaging of astrocytes after an injury  
To assess whether astrocytes migrate large distances towards a site of injury, they were 
labeled using a GFP-Lentivirus (A, B) and a stab wound injury was placed 3 mm away. 
This led to upregulation of GFAP in the injury site, but not to migration of labeled 
astrocytes (B). Repeated 2-photon imaging of astrocytes in hGFAP-eGFP mice before (C) 
and after laser lesion (G, laser lesion indicated by a star), as well as 3 days later (E). 
Stable labeling of astrocytes in Glast::CreERT2 GFP reporter mice allowed following 
astrocytes (F) directly after laser lesion (G) and 2 days later (H). Astrocytes that could be 
followed were indicated with numbers. 
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7.4 The influence of Cdc42 on astroglial-like stem cells 
and their progeny 
SEZ stem cells in the adult brain bear clear morphological resemblance to their 
RG precursors, the SVZ stem cells of the developing forebrain. A hallmark of 
the appearance of both, RG cells and adult NSCs is their bipolar shape with a 
basal membrane domain (see chapters 2.2.3, 2.4.1 and 7.2) and an apical 
membrane domain where they face the ventricle (see chapters 2.2.3 and 2.4.2). 
During development the small RhoGTPase Cdc42 has been shown to be a 
major player in establishing apical polarity as loss of Cdc42 in RG leads to 
absence of normally apically localized members of the Par complex like Par3 
and aPKC, as well as adherens junctions accompanied by failure of apically 
directed interkinetic nuclear migration. This consequently leads to a premature 
depletion of apical progenitors and thus switches cell fate possibly due to the 
loss of apical polarity in RG (Cappello et al., 2006). To investigate the role of 
Cdc42 in adult NSCs, the gene was conditionally deleted in astrocytes including 
the NSCs of adult animals by the use of Glast::CreERT2 (see above and Figure 
7-27 A). Four weeks after recombination astroglial-like stem cells were marked 
using a label retaining BrdU pulse and the glia marker GFAP (Figure 7-27 A). 
Roughly, one fourth of all reporter positive cells kept the BrdU label in the SEZ 
of Glast::CreERT2/ Cdc42 fl/ wt further referred to as WT (22.3 % ± 3.5 %), and 
Glast::CreERT2/ Cdc42 fl/ fl, herein after termed as KO (24.6 % ± 3.9 %). 
Counter labeling of the reporter-positive BrdU cells with GFAP revealed 
comparable numbers of adult SEZ NSCs in WT (6.7 % ± 1.7 %; Figure 7-27 B, 
C) and KO (6.6 % ± 2.0 % Figure 7-27 B, C) brains. The number of label 
retaining Dcx+ progeny of SEZ NSCs, however, was significantly increased after 
tamoxifen application in Cdc42 animals homozygous for the floxed allele (6.3 % 
± 2.3 % in WT and 18.9 ± 2.5 in KO; n = 3, p ≤ 0.0195; Figure 7-27 B, D - E’). In 
the WT SEZ neuroblasts are organized in several layers of chains along the 
lateral ventricle and no Dcx+ cells are localized within the neighboring striatum 
(Figure 7-27 D, D’). Overall, this organization seemed to be disturbed with some 
of the Dcx+ neuroblasts even being localized within the striatum of KO brains 
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(Figure 7-27 E, E’). Given the fact that the number of NSCs is not changed after 
deletion of Cdc42, it has to be tested whether higher number of neuroblasts are 
due to enhanced proliferation of transit amplifying precursors (TAPs) or to 
impaired migration and subsequent accumulation of Dcx+ cells in the SEZ. 
Interestingly, this phenotype is similar to the phenotype after β1-integrin 
deletion.  
 
 
Figure 7-27 The role of Cdc42 in SEZ stem cells and their progeny 
The experimental schedule is shown in (A). The number of BrdU and GFAP double-
positive cells within the pool of recombined GFP-positive cells was unchanged between 
WT and Cdc42 deleted animals (B, C). Whereas Dcx-positive neuroblasts were restricted 
to the SEZ in WT brains (D, D’), these cells were rather unorganized after deleting Cdc42 
and even entered the striatum (E, E’). Quantifying the number of label retaining 
neuroblasts revealed a significant increase of these cells in the adult SEZ (B). 
 

 8 Discussion 
8.1 β1-Integrin functions in astroglial cells 
Although the role of β1-integrins in radial glial cells during development has 
been well studied (Beggs et al., 2003; Belvindrah et al., 2007a; Georges-
Labouesse et al., 1998; Haubst et al., 2006; Herms et al., 2004; Schroder et al., 
2007), still very little is known about the interaction between astrocytes and the 
leptomeningeal and vascular BMs in the postnatal and adult brain. Here the 
postnatal role of β1-integrins was studied by the use of hGFAP-driven Cre 
recombinase. Although recombination in the cortex starts around E13 in this 
mouse line (Malatesta et al., 2003) and most proteins have disappeared within 
few days after recombination (Cappello et al., 2006; Moore et al., 2002), stability 
of the integrin proteins resulted in persistence of β1-integrin for about one week 
after recombination. Indeed, the disruption of the glia limitans and BM at the pial 
surface and neuronal ectopias mostly in cortical layer I, phenotypes observed 
after earlier deletion of β1-integrin, were not observed in this study after deletion 
with hGFAP-Cre. The absence of developmental malformations therefore 
allowed to clarify the role of β1-integrins in the postnatal brain and to elucidate 
the etiology and nature of the major phenotype elicited at this later stage, 
namely the partial reactive gliosis. Notably, GFAP upregulation has been 
described in previous reports after early deletion of β1-integrin (Belvindrah et 
al., 2007a), focal adhesion kinase (Beggs et al., 2003) or Cdc42 (Cappello et 
al., 2006), but this phenotype had neither been examined more closely nor was 
its cause identifiable given the profound developmental aberrations. From the 
described data one can conclude that the reactive gliosis phenotype is due to 
an important role of β1-integrin associated complexes in postnatal astroglial 
cells. First, the gliosis phenotype occurred within the first postnatal weeks at a 
time when no other abnormalities were observed. Second, genetic evidence 
using different Cre lines, such as the Nex::Cre line, clearly demonstrated that 
deletion of β1-integrins only in neurons does not cause a reactive gliosis 
phenotype. The onset of Cre expression in the Nex locus occurs at very early 
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stages in neurons as soon as they are born (Goebbels et al., 2006; Wu et al., 
2005) in contrast to previous neuron specific deletion of β1-integrin by CAM-
Kinase-Cre in the forebrain, where only mature pyramidal neurons at postnatal 
stages were affected (Huang et al., 2006). After hGFAP-Cre-mediated β1-
integrin deletion, no obvious defects in oligodendrocytes were observed 
consistent with data obtained by oligodendrocyte specific β1-integrins deletion 
(CNP::Cre; Benninger et al., 2006). Thus, the reactive gliosis phenotype does 
not correlate with oligodendrocyte defects. On the basis of these results and the 
absence of gliosis in mice with Nex::Cre mediated β1-integrin deletion, we 
conclude that gliosis is unlikely to be influenced by the presence or absence of 
β1-integrin in oligodendrocytes and neurons. Conversely, β1-integrin mediated 
signaling is required within astrocytes to promote the acquisition of a mature 
non-reactive phenotype. Interestingly, glial reactivity was not restricted to 
astrocytes, but also included a partial activation of microglial cells. As confirmed 
by reporter analysis, hGFAP-Cre-mediated recombination does not occur in 
microglial cells, indicating that non-cell-autonomous aspects account for this 
activation. For example, astrocytes can signal to microglia by ATP or cytokine 
release (Schipke et al., 2002). These data therefore suggest that activation of 
astrocytes is further communicated to activate microglia. Interestingly, these 
signals also seem not to be sufficient to elicit a profound proliferation of 
microglia cells. Only at later stages, when BM irregularities occur, the increased 
number of microglia could also be a consequence of T-cell recruitment. T-cells, 
which are also labeled with microglia markers, have been shown to be able to 
adhere to and transmigrate over BMs containing the endothelial laminin 8, but 
are only able to enter the second barrier, the parenchymal BM produced by 
astrocytes, at sites of irregularities (Sixt et al., 2001). 
8.2 β1-integrins in reactive gliosis 
Notably, the phenotype elicited in astrocytes after the loss of β1-integrin 
containing heterodimers recapitulates many aspects of reactive gliosis as 
observed after traumatic brain injury or ischemic insult, except the reversion to a 
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proliferative progenitor/ stem cell state (Buffo et al., 2008). Given the multitude 
of changes after acute or chronic injury (Pekny and Nilsson, 2005; Ridet et al., 
1997), it is striking to see that removal of a single protein, β1-integrin, at the 
time when astrocytes differentiate is sufficient to elicit most of these changes. 
Upon loss of β1-integrins astrocytes not only up-regulate GFAP and Vimentin, 
but also Tenascin-C, and the 473HD-epitope. Further on, lack of β1-integrin 
containing subunits in the postnatal cortex resulted in not only in hypertrophy of 
astrocytes but also in the loss of endfeet polarity, including defects in deposition 
of the laminin isoforms α1 and α2, both synthesized by astrocytes (data 
acquired by Tetsuji Mori, see also Robel et al., 2009). Interestingly, virtually all 
of the changes characteristic for reactive astrocytes occur rather early (within 1–
2 weeks) after loss of β1-integrin containing proteins. This implies β1-integrin 
mediated signaling as a key pathway for astrocytes to acquire a normal, mature 
and nonreactive state. As β1-integrin protein levels are reduced already at 
postnatal stages, astrocytes may require these signals during development to 
achieve a mature state. Due to the low turnover of β1-integrins, it was not 
possible to analyze the effects of β1-integrin deletion at adult stages by the use 
of Glast::CreERT2, because protein levels were not reduced within a 
reasonable time frame. However, it is important to bear in mind that integrin 
expression is also rapidly down-regulated by endothelial and astroglial cells 
after focal cerebral ischemia (Wagner et al., 1997) even though integrin 
upregulation has also been observed after other types of injury (Fasen et al., 
2003; Kloss et al., 1999). Also, β1-integrin ligands, such as laminin, CollagenIV, 
fibronectin and perlecan are down-regulated after injury (del Zoppo and Milner, 
2006). These data would be consistent with the model that the reduction of 
integrin-mediated signaling at the astrocyte-BM interface after injury may trigger 
the reactive gliosis with the exception of the proliferation response.  
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8.3 Deletion of β1-Integrins in astrocytes leads to 
polarity defects 
Indeed, we also detected defects in the localization of proteins of the DAG-
complex, as well as Aqp4 to the astrocyte endfeet. Interestingly, aquaporins are 
involved in water homeostasis and the reduction of Aqp4 levels have been 
implicated in mediating cell swelling and hypertrophy after injury (Saadoun et 
al., 2008; Verkman et al., 2006). Moreover, the DAG, and in particular Agrin, 
has been shown to be necessary for proper targeting of Aqp4 to the endfeet of 
astroglia (Bragg et al., 2006; Noell et al., 2009; Wolburg et al., 2009b). Thus, 
initial disturbances in astrocyte polarity, as indicated by defects in targeting or 
maintenance of DGC at the endfeet-BM junction, may then lead to further 
defects at this interface illustrated by the partial disruptions of Aqp4 location. 
Careful analysis of the gliosis phenotype after β1- integrin deletion revealed the 
alterations in astrocyte polarity as one of the earliest phenotypes in these mice, 
suggesting that further changes may well be downstream of these initial 
alterations in integrin-mediated signaling at the astrocyte endfeet-BM interface. 
Already within the first two postnatal weeks, the targeted deposition of laminin 
α1 and α2 from astroglial cells is affected suggesting early aberrations at the 
astroglia-BM interface (Robel et al., 2009). Conversely, the α4 and α5 laminin 
isoforms derived from endothelial cells are still normally deposited. Notably, 
astrocytes and endothelial cells not only produce different types of laminins, but 
also exhibit a distinct laminin receptor composition: endothelial cells express 
mainly the integrin receptor α6β4 binding to laminin α5, whereas astrocytes 
additionally have α1β1, a receptor for laminin α1 (Wagner et al., 1997). Missing 
the latter receptor in mutant animals could possibly account for the disrupted 
staining pattern of the correlated ligands due to the failure of their clustering. It 
is also possible that targeted secretion at this interface may fail because of early 
defects in astrocyte polarity. These accumulating defects at the astrocyte-BM 
interface may ultimately result in the phenotype of partial reactive gliosis 
comprising astrocyte hypertrophy and upregulation of GFAP, Vimentin and 
Tenascin-C. 
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8.4 Basement membrane defects occur only secondary 
to reactive gliosis phenotype 
It has been demonstrated that β1-integrins, as well as the cell surface receptor 
dystroglycan, are important for cell surface laminin organization and ECM and 
BM assembly during early development (Fassler and Meyer, 1995; Fassler et 
al., 1995; Graus-Porta et al., 2001; Henry et al., 2001). In this regard it is 
important to consider that the BM is only mildly affected even after several 
months lacking β1 containing integrins. At the light microscopy level, analyzed 
by pan-laminin, fibronectin or CollagenIV immunostaining, no aberrations in 
localization and protein deposition in the BM along the meninges or vessels 
could be observed for several months after birth, despite the almost complete 
loss of β1-integrin within the first two postnatal weeks. This is the case although 
we could observe very early alterations in the deposition of both astrocytic 
laminin isoforms containing the α1 and α2 chains. This implies that the partial 
lack of the astrocytic laminins did not affect the overall structure and 
maintenance of the BM. Moreover, the presence and regular localization of 
many other main BM components and associated proteins, such as CollagenIV, 
fibronectin and other laminins allows the conclusion that the aberrant DGC 
location is not resulting from the lack of ligand binding for this complex. 
Furthermore, the proper localization of Dystroglycan and the presence of β1-
integrins, which are both critical for BM formation during early development 
(Williamson et al., 1997; Graus-Porta et al., 2001), are dispensable for integrity 
of the BM at postnatal stages. The lack of a strong and early BM phenotype in 
mice with hGFAP-Cre-mediated deletion of β1-integrins as observed after 
earlier interference with either β1-integrin itself (Fassler and Meyer, 1995; 
Fassler et al., 1995; Graus-Porta et al., 2001), or down-stream signaling 
components such as FAK (Beggs et al., 2003), or dystroglycan (Moore et al., 
2002), highlights the different importance of the signaling complex at the glial 
endfeet during development in radial glial cells and at postnatal stages in 
astrocytes. Although impairment of either integrin- or DGC-mediated signaling 
already in radial glial cells results in disruptions of the leptomeningeal BM within 
few days (Moore et al., 2002), such failures apparently take much longer and 
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never reach such a severity, when β1-integrin protein is only deleted at 
postnatal stages. This may be due to a decrease in the role of β1-integrin 
during development and possibly a converse increase in expression of other 
integrin subunits. The integrin subunits β3 (Hermosilla et al., 2008) and β4 
(Wagner et al., 1997) have been described to be expressed in astrocytes. The 
integrin-subunit β3 forms a functional receptor with αv and β4 dimerizes with 
α6. Astrocytes have been shown to express these integrin subunits, αv, as well 
as α1-6 (Fasen et al., 2003). Thus, it is well conceivable that β3 or β4-
containing integrins may partially compensate for the loss of β1-integrin. In any 
case, alterations in the BM occur after the onset of the gliosis phenotype. We 
therefore conclude that alterations in the BM are not the cause for the partial 
reactive gliosis upon loss of β1-integrins, but rather develop secondary to the 
alterations in astroglial polarity. 
8.5 The BBB is not affected by loss of β1-Integrins from 
astrocytes at postnatal stages 
Given the profound astroglial alterations at postnatal stages in the cortical gray 
matter of β1-/- mice, it was surprising to observe a fully functional intact BBB. 
However, the role of astrocytes in BBB formation and maintenance is still 
controversial, also in light of the early appearance of some BBB characteristics 
in brain endothelial cells prior to astrocyte differentiation (Engelhardt, 2003). 
Nonetheless, development of the BBB and maturation of astrocytes as defined 
by the polarization of astrocytes, seem to be closely correlated during 
development. Thus, precise and complete localization of Aqp4 towards 
astrocyte endfeet parallels tight junction formation in chick embryonic 
development (Nico et al., 2001). Furthermore, in autoimmune encephalomyelitis 
loss of astrocyte polarity is correlated with BBB disruptions (Wolburg-Buchholz 
et al., 2009). Here the authors postulated that loss of β-dystroglycan mediated 
astrocyte foot anchoring results in redistribution of the water channel Aqp4 und 
subsequently in edema formation in EAE. However, another study 
demonstrated that after Aqp4 gene deletion the BBB was fully functional and 
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intact (Saadoun et al., 2009). Bases on the results of this study, one can only 
conclude that β1-integrins on astrocytes (and neurons) are not required for BBB 
formation and/ or maintenance, at least not after the first postnatal week. Of 
course the lack of a BBB phenotype in the conditional β1-/- mice may also be 
due to compensation by other integrin subunits, such as α6β4 that has also 
been located in astrocyte endfeet (Su et al., 2008). However, given the gaps in 
the DAG and Aqp4 staining along the blood vessels α6β4 is obviously not able 
to achieve the appropriate location of these molecules in the absence of β1-
integrins. 
8.6 Loss of b1-integrins caused misrouting of 
neuroblasts  
After deletion of β1-integrins many newly generated neuroblasts left their path 
towards the OB and enter either the striatum or the cortical white and gray 
matter. A widely accepted model is that neuroblasts are guided through the 
RMS towards the OB by chemoattractive and chemorepulsive gradients, as well 
as guidance molecules (for review see Hagg, 2005). For example, the CSF flow 
generated by beating cilia of ependymal cells lining the ventricles produces a 
gradient of Slit proteins, which directs and repulses migrating neurons away 
from the SEZ towards the OB (W. Wu et al., 1999; Sawamoto et al., 2006). The 
chemoattractant Sonic hedgehog (Shh) is present in the adult SEZ and the Shh 
receptor patched is expressed on migrating neuroblasts in the SEZ and RMS. 
Negative regulation of Shh levels in the SEZ has been proposed to be a 
mechanism of defining the numbers of neuroblasts released into the RMS 
(Angot et al., 2008). Shh is released from reactive astrocytes after acute brain 
injury (Amankulor et al., 2009 and Pratibha Tripathi, unpublished observations). 
Under some pathological conditions including stroke adult neurogenesis is even 
enhanced and SEZ precursors are recruited into the injury sites (Massouh and 
Saghatelyan, 2010; Arvidsson et al., 2002; Kokaia and Lindvall, 2003). But also 
a comparatively small lesion due to noninvasive targeted cell death of cortical 
projection neurons (Macklis, 1993; Madison and Macklis, 1993) resulted in 
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redirecting SEZ-neuroblasts towards the cortical gray matter (Brill et al., 2009). 
It is tempting to speculate that reactive astrocytes in β1-/- brains would release 
Shh and thus lure neuroblasts towards striatum and/ or cortex.  
Besides the influence of diffusible molecules, neuronal precursor migration 
through the RMS in the adult brain depends on a specialized parallel 
organization of blood vessels, which are used as physical substrates by 
migrating neuroblasts (Saghatelyan, 2009; Snapyan et al., 2009). Surprisingly, 
this blood vessel organization was disturbed after deletion of β1-integrins, 
although hGFAP-Cre-mediated recombination does not occur in endothelial 
cells (Zhuo et al., 2001; Malatesta et al., 2003). However, it is well known that 
astrocytes are important for angiogenesis during development and after brain 
injury as they secrete angiogenic factors (Lee et al., 2009). Whether loss of β1-
integrins at postnatal stages may interfere with RMS angiogenesis leading to 
disturbed blood vessel arrangements, which consequently deprive neuroblasts 
of their usual substrate for migration, remains to be investigated in more detail.  
A further candidate for guiding migrating neuroblasts into the cortex and 
striatum may be TenascinC and the 473HD epitope. Interestingly, an increase 
of extracellular Tenascin C and the epitope 473HD was observed in the 
cerebral cortex of β1-/- mice, similar to what has been observed after brain 
injury (Laywell et al., 1992; Garwood et al., 2001; Dobbertin et al., 2003; Sirko 
et al., 2009). Under physiological conditions WT brains are devoid of these 
ECM proteins, except in embryonic and adult neurogenic niches, as well as a 
very restricted expression within the RMS (Sirko et al., 2010; Sirko et al., 2007 
and Swetlana Sirko, unpublished observations) suggesting that these ECM 
molecules could act as guidance cues for neuroblasts. Distribution of Tenascin 
C and the 473HD epitope all over the ECM of the β1-/- cortical gray matter 
could be a cause for neuroblast mismigration in these mutants.  
Besides these non cell-autonomous mechanisms one can also think of a cell-
autonomous defect in neuroblasts, because Cre expression from the hGFAP-
Cre promoter recombines astroglia-like stem cells and consequently their 
progeny. The integrin α6β1 is expressed on neuroblasts and serves as a 
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laminin receptor guiding newborn neurons through the RMS towards the OB. 
Injection of antibodies against α6 or β1 led to loss of the cohesive structure of 
the RMS (Emsley and Hagg, 2003). Therefore, one can speculate that due to 
the loss of β1-integrin containing ECM receptors neuroblasts would be unable 
to recognize the spatial different ECM composition in RMS. This is also the 
case in homozygous ES cells (β1 null), which lack adhesiveness for laminin and 
fibronectin and do not migrate towards chemoattractants in fibroblast medium. 
Furthermore, they have fewer cell-cell junctions (Fassler et al., 1995), which has 
also been observed in the β1-/- neuroblasts, where tangentially chain migration 
is lost (Belvindrah et al., 2007a). Nonetheless, the exact ECM composition in 
the RMS has not been analyzed so far. Therefore it is difficult to judge, whether 
a cell autonomous effect could contribute to the mismigration. Transplantation 
of mutant neuroblasts in the WT RMS and vice versa could answer this 
question.  
8.7 Misrouted neuroblasts mature in the striatum after 
loss of β1-integrins 
After deletion of β1-integrins in the striatum, misrouted neuroblasts survived and 
matured to a certain degree recapitulating what has been reported for de-routed 
neuroblasts after injury (R. L. Zhang et al., 2001; Ohab et al., 2006). However, 
after massive tissue disruption caused by stroke, as well as after targeted cell 
death of projection neurons without inflammatory response and necrotic tissue 
loss, only a tiny proportion of newborn neurons matured to a certain degree in 
the injured area (Arvidsson et al., 2002; Brill et al., 2009) suggesting that not 
only a hostile inflammatory environment impedes efficient maturation. 
Interestingly, also after de-routing of neuroblasts in the forebrain of β1-/- mice, 
where massive amounts of newborn neurons entered the striatum, also very 
few newborn NeuN-positive neurons could be observed. These neurons 
matured despite the fact that in the β1-/- forebrain no cell death was observed, 
suggesting that the trigger for neuroblasts to mature is not neuronal cell loss per 
se, but rather the glial reaction or cell intrinsic mechanisms. Nevertheless, also 
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in the β1-integrin mutant many neuroblasts did not mature. This is possibly due 
to changed characteristics of the astrocytes including the upregulation of ECM 
components TenascinC and 473HD. These molecules are important for 
progenitor proliferation in neurogenic niches (Sirko et al., 2010; Sirko et al., 
2007) and may interfere with neuronal maturation. 
8.8 The role of polarity cues in astrocytes and their 
stem cell potential 
8.8.1 Basal polarity mediated by b1-integrins 
Notably, β1-integrin deficient astrocytes recapitulated many, but not all aspects 
of reactive gliosis. After a stab wound injury, about half of all astrocytes resume 
proliferation (Buffo et al., 2008) and some of these also readopt neural stem cell 
properties (Buffo et al., 2008). Although the proportion of BrdU-incorporating 
astrocytes varies between different types of trauma and is related to the severity 
of injury (Buffo et al., 2005; Myer et al., 2006; Buffo et al., 2008; Sirko et al., 
2009), such a proliferative response is not elicited by conditional β1-integrin 
deletion as even after 2 weeks of continuous BrdU application only few of the 
GFAP- or S100β-positive astrocytes had incorporated BrdU in the β1-/- cortex 
and their number was not significantly different from the control. These data 
therefore imply other signals as potential regulators of this aspect of the 
proliferation response of astrogliosis. For example, FGF, EGF, and endothelin-
mediated signaling is strongly increased after brain injury (W. E. Clarke et al., 
2001; G. M. Smith and Strunz, 2005; Gadea et al., 2008). Interestingly, FGF 
and EGF also affect radial glial cells, the closest relatives of adult astrocytes, 
during development (Vaccarino et al., 2001; K. M. Smith et al., 2006; Sirko et 
al., 2007). Likewise purinergic signaling via ATP release is one of the first 
reactions to tissue damage and well known to stimulate astrocyte proliferation 
(Neary and Kang, 2005). Notably, many of these signaling pathways have also 
been implicated in the regulation of proliferation in the neural stem cell niches in 
the forebrain (Kuhn et al., 1997; Doetsch et al., 2002; Braun et al., 2003; Shukla 
et al., 2005). As the adult NSCs in the neurogenic niches have been identified 
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as astrocyte-like cells (Doetsch et al., 1997; Alvarez-Buylla et al., 2001), these 
pathways may well be involved in the regulation of astrocyte/stem cell division 
as well as in the reinstruction of proliferation and stem cell features in astrocytes 
after injury.  
From the mutant analysis one can add that β1-integrins are needed for 
neurosphere formation after stab wound injury, maybe via the well-known 
interaction between integrins and growth factor receptors (see e.g. Colognato et 
al., 2002). On the other hand, β1-integrins are important for cell-cell adhesion 
(Fassler et al., 1995; Brakebusch and Fassler, 2005; Shen et al., 2008). It is 
commonly known that formation of neurospheres is based on cell division of a 
single clone. This results in formation of cell colonies consisting of daughter 
cells that adhere to each other. Therefore, it cannot be excluded that impaired 
adhesion between β1-integrin deficient cells led to the decrease of neurosphere 
numbers, because newly formed cells cannot attach to each other to form a 
sphere. 
Apparently, β1-integrins are not needed to mediate growth factor signaling in 
SEZ astroglia, as proliferation of stem cells in this region was not affected in the 
hGFAP-Cre, flβ1/ flβ1 mice. However, the overall size of the RMS appeared 
increased in the mutant forebrain and although large numbers of neuroblasts 
left the RMS, the size of the OB seemed to be unchanged, suggesting that a 
sufficient number of neuroblasts arrived in the OB still. While these effects were 
not quantified, it appeared as larger numbers of neuroblasts are present in β1-/- 
RMS compared to the control. If the proliferation of the stem cells is not 
changed, their progeny, the transit amplifying precursors could account for 
increased generation of neuroblasts. Indeed, infusion of an antibody against α6-
integrin, which forms dimers with β1-integrin and is expressed in progenitors 
labeled with LewisX in the SEZ and in neurospheres (Shen et al., 2008), leads 
to an increase in fast proliferating SEZ cells (Shen et al., 2008).  
In conclusion, deletion of β1-integrins in the SEZ did not change the capacity of 
stem cells to proliferate, but seems to affect the generation of transit amplifying 
precursors. Notably, β1-integrin function in the SEZ may also be compensated 
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by other integrins or β-dystroglycan, another ECM receptor strongly expressed 
in the adult SEZ (Adorjan and Kalman, 2009 and Stefanie Robel, unpublished 
observations). Conversely, signaling via β1-integrins is critical for reactive 
astrocytes after injury to regain their proliferative capacity given the reduced 
number of neurospheres in β1-/- brains.  
8.8.2 Apical polarity mediated by Cdc42 
Besides the clear polarity of astrocytes towards the basal side, astroglial-like 
SEZ stem cells at the lateral wall of the lateral ventricle possess another 
specialized membrane domain, where they face the ventricle. As the basal 
membrane domain, the apical side is characterized by enrichment of certain 
proteins responsible for establishing cell polarity and cell contact/ junctions 
including catenin, cadherins, proteins of the Par complex and the small 
RhoGTPase Cdc42 (Cappello et al., 2006; Costa et al., 2008). Although Cdc42 
is a major player in keeping RG in the VZ in a self-renewing state and 
preventing premature neurogenic differentiation during development (Cappello 
et al., 2006), I showed here that Cdc42 is dispensable for proliferation of adult 
SEZ stem cells. Provided that the apical polarity of VZ stem cells is a 
precondition for proper regulation of the self renewing capacity (Machon et al., 
2003; Costa et al., 2008; Ghosh et al., 2008), it is possible that the effect of 
Cdc42 deletion during development is secondary and due to the failure of 
establishment of apical polarity assessed by staining for the apical markers β-
catenin, aPKCλ and Par3 (Cappello et al., 2006; Chen et al., 2006). In addition, 
the ventricle is lined exclusively by Radial glia (RG) that are coupled by 
adherens junctions during development (Gotz and Huttner, 2005). 
Recombination in RG with Emx1::Cre or hGFAP-Cre leads subsequently to the 
loss of Cdc42 and thus apical polarity at the entire ventricular surface. This may 
lead to the loss of a key feature of the stem cell niche and therefore impaired 
self-renewal at the apical surface. In the adult neurogenic niche the cell body of 
the stem cells are localized above the ependymal layer in the SEZ. They form a 
thin process protruding between the ependymal layer towards the ventricle and 
this apical membrane is the central point of a “pinwheel” surrounded by 
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ependymal cells, which line the ventricular surface (Mirzadeh et al., 2008). The 
ependymal cells are coupled by junctions among each other and with the apical 
process of the stem cell astrocytes. At the time point of gene deletion in this 
study, polarity was already established in adult SEZ stem cells, only a subset of 
this population was recombined and ependymal cells were excluded from 
recombination. Therefore, the niche is affected if at all on a small scale and the 
apicobasal polarity of Cdc42-deficient stem cells may be remained by 
surrounding not recombined cells.  
8.9 Polarity of astrocytes after injury and their 
dedifferentiation 
One may speculate that - inter alia - the lack of apical polarity in mature 
astrocytes correlates with their quiescent, non-proliferative state under 
physiological conditions. However, after injury they change their morphology 
towards an elongated shape, which is then similar to the bipolar shape of stem 
cell astrocytes. This can be observed in an in vitro wound healing assay where 
cultured astrocytes reorienting their centrosome and, intriguingly, establishment 
of an apical cell polarity where they face the scratch. In this experimental 
paradigm, Cdc42 in primary astrocytes was essential to induce formation of this 
front-rear axis. Genetic deletion of this small RhoGTPase interfered with 
centrosome reorientation, protrusion formation and subsequent migration 
(Figure 7-21 and Sophia Bardehle, unpublished observations). In vivo, 
astrocytes change their morphology dramatically directly at the injury border 
giving up their non-overlapping organization by building a long protrusion 
towards the injury site, thereby violating neighboring domains (Figure 7-16 and 
Oberheim et al., 2008). Some astrocytes extended a process already 3 days 
post lesion and one third of them bear a protrusion one week after the injury. 
Interestingly, this correlates with an increase in proliferating astrocytes after 
stab wound injury up to 50 % of the entire astrocyte population 7 days upon 
injury (Christiane Simon, unpublished observations). It is tempting to speculate 
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that establishment of an apicobasal polarity, similar to stem cell astrocytes 
residing in the SEZ, is necessary to allow proliferation.  
Also in the second neurogenic niche of the adult forebrain, the dentate gyrus of 
the hippocampus stem cells have a radial glia-like bipolar morphology and are 
located in close proximity to the vasculature (for review see Ehninger and 
Kempermann, 2008). Although direct evidence of an apical membrane domain 
in stem cells of the dentate gyrus is lacking, polarity cues like ephrins are 
important for their proliferation (Chumley et al., 2007). Ephrins have been 
reported to regulate cell-cell junctions through the Par complex (Lee et al., 
2008) and play a role in asymmetric cell division at least in the tunicate Ciona 
(Picco et al., 2007). Thus, polarity mediated by the Par complex may be a 
general prerequisite for cells to acquire or maintain an immature state. I showed 
here, that after deletion of Cdc42, a protein activating the Par complex in 
cultured astrocytes (Etienne-Manneville and Hall, 2001; Etienne-Manneville et 
al., 2005), the number of astrocytes at the injury site was reduced. 
Quantification of the proliferating astrocytes shortly after injury revealed that 
deletion of Cdc42 interferes with their capacity to re-enter the cell cycle. A 
possible mechanism activating Cdc42 after injury is the EGF-R pathway. Cdc42 
is activated upon EGF stimulation, interacts with MEKK1 and 4 and activates 
the JNK pathway in several cell lines (Fanger et al., 1997; Frost et al., 1997; 
Bishop and Hall, 2000). Deletion of Cdc42 in late but not early neural crest stem 
cells results in a decreased self renewing capacity due to the lack of EGF-
responsiveness (Fuchs et al., 2009). Moreover, activation of JNK was reduced, 
even though not significant, in wounded Cdc42-deficient fibroblasts cultures 
(Czuchra et al., 2005). This pathway could also explain the reduced proliferation 
observed here in Cdc42-deficient reactive astrocytes, as upregulation of the 
EGF-R and EGF-R signaling is important for proliferation of astrocytes after 
injury (Nieto-Sampedro et al., 1988; Weickert and Blum, 1995; Rabchevsky et 
al., 1998; Levison et al., 2000; Liu and Neufeld, 2004; G. M. Smith and Strunz, 
2005; Liu et al., 2006; Sharif et al., 2006; Liu and Neufeld, 2007; White et al., 
2008). Notably, even adult NSC seem to acquire an enhanced responsiveness 
to EGF in response to injury (Alagappan et al., 2009). In this regard it is also 
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interesting to note that integrins and the Rho family of GTPases share some 
signaling networks with integrins regulating RhoGTPases and vice versa (for 
review see (Schwartz and Shattil, 2000). As the proliferation of astrocytes from 
the injured cerebral cortex was also reduced after deletion of β1-integrins, a 
possible cascade could involve initially an interaction between the EGF-R and 
integrins that then would activate Cdc42. 
Although deletion of Cdc42 in astrocytes interfered with their ability to orient 
their protrusions in vitro, this effect was not seen in vivo. One possible 
explanation is that several redundant factors released in the injury site attract 
astrocyte processes, while no such signals exist in the scratch assay in vitro. 
The 3D environment of brain tissue may provide cells with a multitude of factors 
triggering alternative pathways to mediate reorganization of the cytoskeleton, 
whereas culturing astrocytes in a monolayer on poly-L-ornithine as the only 
substrate, is a rather reduced model. In future experiments, this could be 
clarified by performing the scratch assay in Cdc42-deficient astrocytes cultured 
on different ECM substrates. The enlarged cell size after Cdc42 deletion in vivo 
may, nevertheless, hint to a misregulation of cytoskeletal rearrangements 
similar to what has been shown in Cdc42-deficient fibroblasts (Czuchra et al., 
2005). 
8.10 The role of Cdc42 in astrocyte migration and 
wound healing 
It has been widely assumed that after injury astrocytes increase in density not 
only because of their proliferation, but also because they migrate towards the 
insult. However, whether astrocytes in the brain parenchyma have indeed the 
ability to migrate had been impossible to study so far. Results from this study 
revealed, that integrated mature gray matter astrocytes labeled 1-3 mm away 
from the stab wound injury were not attracted towards the injury site. On the 
contrary, perinatal astrocytes cultured to confluency prior to their transplantation 
into the striatum migrated towards an injury (Auguste et al., 2007). Nonetheless, 
this study does not resemble the situation after trauma in the adult brain, as 
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postnatal astrocytes may display a different migratory behavior than mature 
astrocytes and these cells are not integrated into the tissue. Mature astrocytes 
would need to entirely retract their processes from synapses and blood vessels 
during a migration process. This involves complex remodeling of the tissue 
surrounding an injury area, which may explain why astrocyte processes, in 
contrast to microglia (Nimmerjahn et al., 2005), are not motile immediately after 
injury (Figure 7-26). Timelapse imaging of primary astrocyte cultures allowed 
investigating the influence of Cdc42 on astrocyte migration. Whereas astrocytes 
normally migrate straight into the scratch area, Cdc42-deficient astrocytes were 
impaired in their directionality remaining behind WT cells, although their 
migration speed was not reduced (Sophia Bardehle, unpublished observations).  
8.11 The impact of astrocytes for brain repair 
Deletion of Cdc42 in almost all astrocytes by the use of hGFAP-Cre caused an 
enlargement of the injury size. Assuming that astrocytes in vivo migrate, the 
deletion of Cdc42 could reduce the number of astrocytes at the injury site by 
both interfering with proliferation and migration. Thus, Cdc42 in astrocytes is 
important for wound healing after injury highlighting thereby the importance of 
reactive astrogliosis. Reactive astrocytes have long been considered 
detrimental for repair after brain injury, because they form tight scars that are 
non-permissive for axonal regeneration. However, this reaction does not only 
provide protection of the brain from further damage, but may even serve for 
brain repair. Given the fact that upon injury astrocytes re-enter the cell cycle 
and dedifferentiate towards a state that allows them to self-renew and give rise 
to all three neural cell types in vitro (Buffo et al., 2008), this dedifferentiation 
implies a stem cell response. As the efficiency of generating neurons can be 
strongly enhanced by forced expression of neurogenic transcription factors 
(Buffo et al., 2005; Berninger et al., 2007; Heinrich et al., in press), they might 
be a powerful local source for brain repair. Nonetheless, the exact mechanism 
of dedifferentiation of reactive astrocytes is not clear. Establishment of a polarity 
with an apical membrane domain by activating Cdc42 and the Par complex may 
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play a role, as loss of Cdc42 is accompanied by a reduction in proliferation and 
thus possibly impairment of dedifferentiation. Whether polarization of astrocytes 
and their capacity to proliferate, or even give rise to an astrocyte-like stem cell, 
are directly correlated, remains to be investigated. Therefore, on the one hand, 
brain injury triggers astrocyte dedifferentiation and is therefore beneficial; on the 
other hand the environment is inhospitable for efficient neuronal genesis and 
maturation. This is partly due to the physical barrier formed by astrocytes and 
the factors they secrete upon injury. Therefore, discriminating between the 
different responses of astrocytes towards injury would be beneficial. This study 
gained further insights in the complex mechanisms involved in astrocyte 
reactivity showing that signaling from the basement membrane via integrin 
receptors is important in astrocytes to acquire a quiescent non-reactive 
phenotype, as well as the action of the polarity protein Cdc42, which play a role 
in the dedifferentiation of astrocytes after injury. 
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